A heterogeneous condition in which the heart is unable to pump out sufficient blood to meet the metabolic need of the body. Heart failure can be caused by structural defects, functional abnormalities (VENTRICULAR DYSFUNCTION), or a sudden overload beyond its capacity. Chronic heart failure is more common than acute heart failure which results from sudden insult to cardiac function, such as MYOCARDIAL INFARCTION.
The hollow, muscular organ that maintains the circulation of the blood.
The number of times the HEART VENTRICLES contract per unit of time, usually per minute.
A state of subnormal or depressed cardiac output at rest or during stress. It is a characteristic of CARDIOVASCULAR DISEASES, including congenital, valvular, rheumatic, hypertensive, coronary, and cardiomyopathic. The serious form of low cardiac output is characterized by marked reduction in STROKE VOLUME, and systemic vasoconstriction resulting in cold, pale, and sometimes cyanotic extremities.
Heart failure caused by abnormal myocardial contraction during SYSTOLE leading to defective cardiac emptying.
Heart failure caused by abnormal myocardial relaxation during DIASTOLE leading to defective cardiac filling.
The amount of BLOOD pumped out of the HEART per beat, not to be confused with cardiac output (volume/time). It is calculated as the difference between the end-diastolic volume and the end-systolic volume.
The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow.
Pathological conditions involving the HEART including its structural and functional abnormalities.
The transference of a heart from one human or animal to another.
A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein.
A PEPTIDE that is secreted by the BRAIN and the HEART ATRIA, stored mainly in cardiac ventricular MYOCARDIUM. It can cause NATRIURESIS; DIURESIS; VASODILATION; and inhibits secretion of RENIN and ALDOSTERONE. It improves heart function. It contains 32 AMINO ACIDS.
The hemodynamic and electrophysiological action of the left HEART VENTRICLE. Its measurement is an important aspect of the clinical evaluation of patients with heart disease to determine the effects of the disease on cardiac performance.
A condition in which the LEFT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE; MYOCARDIAL INFARCTION; and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the left ventricular wall.
The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM.
A measure of the quality of health care by assessment of unsuccessful results of management and procedures used in combating disease, in individual cases or series.
Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care. (Dictionary of Health Services Management, 2d ed)
Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety.
The geometric and structural changes that the HEART VENTRICLES undergo, usually following MYOCARDIAL INFARCTION. It comprises expansion of the infarct and dilatation of the healthy ventricle segments. While most prevalent in the left ventricle, it can also occur in the right ventricle.
Developmental abnormalities involving structures of the heart. These defects are present at birth but may be discovered later in life.
Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series.
Ultrasonic recording of the size, motion, and composition of the heart and surrounding tissues. The standard approach is transthoracic.
Agents that have a strengthening effect on the heart or that can increase cardiac output. They may be CARDIAC GLYCOSIDES; SYMPATHOMIMETICS; or other drugs. They are used after MYOCARDIAL INFARCT; CARDIAC SURGICAL PROCEDURES; in SHOCK; or in congestive heart failure (HEART FAILURE).
Contractile activity of the MYOCARDIUM.
Elements of limited time intervals, contributing to particular results or situations.
Regulation of the rate of contraction of the heart muscles by an artificial pacemaker.
Examinations used to diagnose and treat heart conditions.
Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease.
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group.
Enlargement of the HEART, usually indicated by a cardiothoracic ratio above 0.50. Heart enlargement may involve the right, the left, or both HEART VENTRICLES or HEART ATRIA. Cardiomegaly is a nonspecific symptom seen in patients with chronic systolic heart failure (HEART FAILURE) or several forms of CARDIOMYOPATHIES.
NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).
Striated muscle cells found in the heart. They are derived from cardiac myoblasts (MYOBLASTS, CARDIAC).
Agents that promote the excretion of urine through their effects on kidney function.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
An aspect of personal behavior or lifestyle, environmental exposure, or inborn or inherited characteristic, which, on the basis of epidemiologic evidence, is known to be associated with a health-related condition considered important to prevent.
A class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility.
The chambers of the heart, to which the BLOOD returns from the circulation.
Small pumps, often implantable, designed for temporarily assisting the heart, usually the LEFT VENTRICLE, to pump blood. They consist of a pumping chamber and a power source, which may be partially or totally external to the body and activated by electromagnetic motors.
The confinement of a patient in a hospital.
The heart of the fetus of any viviparous animal. It refers to the heart in the postembryonic period and is differentiated from the embryonic heart (HEART/embryology) only on the basis of time.
AMINO ALCOHOLS containing the propanolamine (NH2CH2CHOHCH2) group and its derivatives.
A disorder of cardiac function caused by insufficient blood flow to the muscle tissue of the heart. The decreased blood flow may be due to narrowing of the coronary arteries (CORONARY ARTERY DISEASE), to obstruction by a thrombus (CORONARY THROMBOSIS), or less commonly, to diffuse narrowing of arterioles and other small vessels within the heart. Severe interruption of the blood supply to the myocardial tissue may result in necrosis of cardiac muscle (MYOCARDIAL INFARCTION).
Controlled physical activity which is performed in order to allow assessment of physiological functions, particularly cardiovascular and pulmonary, but also aerobic capacity. Maximal (most intense) exercise is usually required but submaximal exercise is also used.
Period of contraction of the HEART, especially of the HEART VENTRICLES.
Naturally occurring or experimentally induced animal diseases with pathological processes sufficiently similar to those of human diseases. They are used as study models for human diseases.
Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, environmental exposure and its effects, disease diagnosis, metabolic processes, substance abuse, pregnancy, cell line development, epidemiologic studies, etc.
Flaps of tissue that prevent regurgitation of BLOOD from the HEART VENTRICLES to the HEART ATRIA or from the PULMONARY ARTERIES or AORTA to the ventricles.
Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder.
The lower right and left chambers of the heart. The right ventricle pumps venous BLOOD into the LUNGS and the left ventricle pumps oxygenated blood into the systemic arterial circulation.
Post-systolic relaxation of the HEART, especially the HEART VENTRICLES.
Studies used to test etiologic hypotheses in which inferences about an exposure to putative causal factors are derived from data relating to characteristics of persons under study or to events or experiences in their past. The essential feature is that some of the persons under study have the disease or outcome of interest and their characteristics are compared with those of unaffected persons.
The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065)
In screening and diagnostic tests, the probability that a person with a positive test is a true positive (i.e., has the disease), is referred to as the predictive value of a positive test; whereas, the predictive value of a negative test is the probability that the person with a negative test does not have the disease. Predictive value is related to the sensitivity and specificity of the test.
The exercise capacity of an individual as measured by endurance (maximal exercise duration and/or maximal attained work load) during an EXERCISE TEST.
A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666)
The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.
A potent natriuretic and vasodilatory peptide or mixture of different-sized low molecular weight PEPTIDES derived from a common precursor and secreted mainly by the HEART ATRIUM. All these peptides share a sequence of about 20 AMINO ACIDS.
A condition in which HEART VENTRICLES exhibit impaired function.
Benzo-indoles similar to CARBOLINES which are pyrido-indoles. In plants, carbazoles are derived from indole and form some of the INDOLE ALKALOIDS.
The thoracolumbar division of the autonomic nervous system. Sympathetic preganglionic fibers originate in neurons of the intermediolateral column of the spinal cord and project to the paravertebral and prevertebral ganglia, which in turn project to target organs. The sympathetic nervous system mediates the body's response to stressful situations, i.e., the fight or flight reactions. It often acts reciprocally to the parasympathetic system.
The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346)
Subsequent admissions of a patient to a hospital or other health care institution for treatment.
Measurement of intracardiac blood flow using an M-mode and/or two-dimensional (2-D) echocardiogram while simultaneously recording the spectrum of the audible Doppler signal (e.g., velocity, direction, amplitude, intensity, timing) reflected from the moving column of red blood cells.
Impaired conduction of cardiac impulse that can occur anywhere along the conduction pathway, such as between the SINOATRIAL NODE and the right atrium (SA block) or between atria and ventricles (AV block). Heart blocks can be classified by the duration, frequency, or completeness of conduction block. Reversibility depends on the degree of structural or functional defects.
The pressure within a CARDIAC VENTRICLE. Ventricular pressure waveforms can be measured in the beating heart by catheterization or estimated using imaging techniques (e.g., DOPPLER ECHOCARDIOGRAPHY). The information is useful in evaluating the function of the MYOCARDIUM; CARDIAC VALVES; and PERICARDIUM, particularly with simultaneous measurement of other (e.g., aortic or atrial) pressures.
The qualitative or quantitative estimation of the likelihood of adverse effects that may result from exposure to specified health hazards or from the absence of beneficial influences. (Last, Dictionary of Epidemiology, 1988)
Statistical models used in survival analysis that assert that the effect of the study factors on the hazard rate in the study population is multiplicative and does not change over time.
Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.
The blood pressure as recorded after wedging a CATHETER in a small PULMONARY ARTERY; believed to reflect the PRESSURE in the pulmonary CAPILLARIES.
A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment.
Drugs that bind to and block the activation of MINERALOCORTICOID RECEPTORS by MINERALOCORTICOIDS such as ALDOSTERONE.
A class of statistical procedures for estimating the survival function (function of time, starting with a population 100% well at a given time and providing the percentage of the population still well at later times). The survival analysis is then used for making inferences about the effects of treatments, prognostic factors, exposures, and other covariates on the function.
A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
A potassium sparing diuretic that acts by antagonism of aldosterone in the distal renal tubules. It is used mainly in the treatment of refractory edema in patients with congestive heart failure, nephrotic syndrome, or hepatic cirrhosis. Its effects on the endocrine system are utilized in the treatments of hirsutism and acne but they can lead to adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p827)
A condition of substandard growth or diminished capacity to maintain normal function.
Studies in which subsets of a defined population are identified. These groups may or may not be exposed to factors hypothesized to influence the probability of the occurrence of a particular disease or other outcome. Cohorts are defined populations which, as a whole, are followed in an attempt to determine distinguishing subgroup characteristics.
The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods.
A device designed to stimulate, by electric impulses, contraction of the heart muscles. It may be temporary (external) or permanent (internal or internal-external).
PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS.
The restoration of the sequential order of contraction and relaxation of the HEART ATRIA and HEART VENTRICLES by atrio-biventricular pacing.
An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels.
Recording of the moment-to-moment electromotive forces of the HEART as projected onto various sites on the body's surface, delineated as a scalar function of time. The recording is monitored by a tracing on slow moving chart paper or by observing it on a cardioscope, which is a CATHODE RAY TUBE DISPLAY.
Precursor of epinephrine that is secreted by the adrenal medulla and is a widespread central and autonomic neurotransmitter. Norepinephrine is the principal transmitter of most postganglionic sympathetic fibers and of the diffuse projection system in the brain arising from the locus ceruleus. It is also found in plants and is used pharmacologically as a sympathomimetic.
Disease having a short and relatively severe course.
Drugs used to cause dilation of the blood vessels.
Abnormal cardiac rhythm that is characterized by rapid, uncoordinated firing of electrical impulses in the upper chambers of the heart (HEART ATRIA). In such case, blood cannot be effectively pumped into the lower chambers of the heart (HEART VENTRICLES). It is caused by abnormal impulse generation.
Unexpected rapid natural death due to cardiovascular collapse within one hour of initial symptoms. It is usually caused by the worsening of existing heart diseases. The sudden onset of symptoms, such as CHEST PAIN and CARDIAC ARRHYTHMIAS, particularly VENTRICULAR TACHYCARDIA, can lead to the loss of consciousness and cardiac arrest followed by biological death. (from Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 7th ed., 2005)
The worsening of a disease over time. This concept is most often used for chronic and incurable diseases where the stage of the disease is an important determinant of therapy and prognosis.
Any pathological condition where fibrous connective tissue invades any organ, usually as a consequence of inflammation or other injury.
Condition where a primary dysfunction of either heart or kidney results in failure of the other organ (e.g., HEART FAILURE with worsening RENAL INSUFFICIENCY).
Enlargement of the LEFT VENTRICLE of the heart. This increase in ventricular mass is attributed to sustained abnormal pressure or volume loads and is a contributor to cardiovascular morbidity and mortality.
Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction.
A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995)
A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C.
Calcium-transporting ATPases that catalyze the active transport of CALCIUM into the SARCOPLASMIC RETICULUM vesicles from the CYTOPLASM. They are primarily found in MUSCLE CELLS and play a role in the relaxation of MUSCLES.
Difficult or labored breathing.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
A strain of albino rat used widely for experimental purposes because of its calmness and ease of handling. It was developed by the Sprague-Dawley Animal Company.
Endogenous or exogenous chemicals that regulate the WATER-ELECTROLYTE BALANCE in the body. They consist of peptides and non-peptide compounds.
The number of new cases of a given disease during a given period in a specified population. It also is used for the rate at which new events occur in a defined population. It is differentiated from PREVALENCE, which refers to all cases, new or old, in the population at a given time.
Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade.
Compounds of the general formula R:N.NR2, as resulting from the action of hydrazines with aldehydes or ketones. (Grant & Hackh's Chemical Dictionary, 5th ed)
An abnormal pattern of breathing characterized by alternating periods of apnea and deep, rapid breathing. The cycle begins with slow, shallow breaths that gradually increase in depth and rate and is then followed by a period of apnea. The period of apnea can last 5 to 30 seconds, then the cycle repeats every 45 seconds to 3 minutes.
The term "United States" in a medical context often refers to the country where a patient or study participant resides, and is not a medical term per se, but relevant for epidemiological studies, healthcare policies, and understanding differences in disease prevalence, treatment patterns, and health outcomes across various geographic locations.
Peptides that regulate the WATER-ELECTROLYTE BALANCE in the body, also known as natriuretic peptide hormones. Several have been sequenced (ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; C-TYPE NATRIURETIC PEPTIDE).
A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain.
One of two major pharmacologically defined classes of adrenergic receptors. The beta adrenergic receptors play an important role in regulating CARDIAC MUSCLE contraction, SMOOTH MUSCLE relaxation, and GLYCOGENOLYSIS.
A procedure to stop the contraction of MYOCARDIUM during HEART SURGERY. It is usually achieved with the use of chemicals (CARDIOPLEGIC SOLUTIONS) or cold temperature (such as chilled perfusate).
The volume of BLOOD passing through the HEART per unit of time. It is usually expressed as liters (volume) per minute so as not to be confused with STROKE VOLUME (volume per beat).
The presence of co-existing or additional diseases with reference to an initial diagnosis or with reference to the index condition that is the subject of study. Comorbidity may affect the ability of affected individuals to function and also their survival; it may be used as a prognostic indicator for length of hospital stay, cost factors, and outcome or survival.
Body organ that filters blood for the secretion of URINE and that regulates ion concentrations.
The study of the heart, its physiology, and its functions.
The force that opposes the flow of BLOOD through a vascular bed. It is equal to the difference in BLOOD PRESSURE across the vascular bed divided by the CARDIAC OUTPUT.
Conditions in which the KIDNEYS perform below the normal level in the ability to remove wastes, concentrate URINE, and maintain ELECTROLYTE BALANCE; BLOOD PRESSURE; and CALCIUM metabolism. Renal insufficiency can be classified by the degree of kidney damage (as measured by the level of PROTEINURIA) and reduction in GLOMERULAR FILTRATION RATE.
Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time.
Implantable devices which continuously monitor the electrical activity of the heart and automatically detect and terminate ventricular tachycardia (TACHYCARDIA, VENTRICULAR) and VENTRICULAR FIBRILLATION. They consist of an impulse generator, batteries, and electrodes.
Agents that antagonize ANGIOTENSIN II TYPE 1 RECEPTOR. Included are ANGIOTENSIN II analogs such as SARALASIN and biphenylimidazoles such as LOSARTAN. Some are used as ANTIHYPERTENSIVE AGENTS.
Studies which start with the identification of persons with a disease of interest and a control (comparison, referent) group without the disease. The relationship of an attribute to the disease is examined by comparing diseased and non-diseased persons with regard to the frequency or levels of the attribute in each group.
Pathological conditions involving the CARDIOVASCULAR SYSTEM including the HEART; the BLOOD VESSELS; or the PERICARDIUM.
Procedures in which placement of CARDIAC CATHETERS is performed for therapeutic or diagnostic procedures.
A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
Theoretical representations that simulate the behavior or activity of the cardiovascular system, processes, or phenomena; includes the use of mathematical equations, computers and other electronic equipment.
A basic element found in nearly all organized tissues. It is a member of the alkaline earth family of metals with the atomic symbol Ca, atomic number 20, and atomic weight 40. Calcium is the most abundant mineral in the body and combines with phosphorus to form calcium phosphate in the bones and teeth. It is essential for the normal functioning of nerves and muscles and plays a role in blood coagulation (as factor IV) and in many enzymatic processes.
A benzoic-sulfonamide-furan. It is a diuretic with fast onset and short duration that is used for EDEMA and chronic RENAL INSUFFICIENCY.
The relationship between the dose of an administered drug and the response of the organism to the drug.
A progressive condition usually characterized by combined failure of several organs such as the lungs, liver, kidney, along with some clotting mechanisms, usually postinjury or postoperative.
Severe inability of the LIVER to perform its normal metabolic functions, as evidenced by severe JAUNDICE and abnormal serum levels of AMMONIA; BILIRUBIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; LACTATE DEHYDROGENASES; and albumin/globulin ratio. (Blakiston's Gould Medical Dictionary, 4th ed)
Tetrazoles are heterocyclic organic compounds containing a 1,3,5-triazole ring with an additional nitrogen atom, often used in pharmaceuticals as bioisosteres for carboxylic acid groups due to their isoelectronic nature and similar hydrogen bonding capabilities.
**Pyridazine** is a heterocyclic organic compound, consisting of a six-membered ring containing two nitrogen atoms, which is a basic structure found in certain pharmaceuticals and natural compounds, though it does not have a specific medical definition itself as a component or condition.
Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation.
Drugs that selectively bind to and activate beta-adrenergic receptors.
A set of techniques used when variation in several variables has to be studied simultaneously. In statistics, multivariate analysis is interpreted as any analytic method that allows simultaneous study of two or more dependent variables.
An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE.
Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS.
Physical activity which is usually regular and done with the intention of improving or maintaining PHYSICAL FITNESS or HEALTH. Contrast with PHYSICAL EXERTION which is concerned largely with the physiologic and metabolic response to energy expenditure.
Failure of equipment to perform to standard. The failure may be due to defects or improper use.
A vasodilator used in the treatment of ANGINA PECTORIS. Its actions are similar to NITROGLYCERIN but with a slower onset of action.
Method in which prolonged electrocardiographic recordings are made on a portable tape recorder (Holter-type system) or solid-state device ("real-time" system), while the patient undergoes normal daily activities. It is useful in the diagnosis and management of intermittent cardiac arrhythmias and transient myocardial ischemia.
A direct-acting vasodilator that is used as an antihypertensive agent.
The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality.
Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral and social environment; the overall condition of a human life.
Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
A condition in which the RIGHT VENTRICLE of the heart was functionally impaired. This condition usually leads to HEART FAILURE or MYOCARDIAL INFARCTION, and other cardiovascular complications. Diagnosis is made by measuring the diminished ejection fraction and a depressed level of motility of the right ventricular wall.
A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin.
A pumping mechanism that duplicates the output, rate, and blood pressure of the natural heart. It may replace the function of the entire heart or a portion of it, and may be an intracorporeal, extracorporeal, or paracorporeal heart. (Dorland, 28th ed)
Agents that antagonize ANGIOTENSIN RECEPTORS. Many drugs in this class specifically target the ANGIOTENSIN TYPE 1 RECEPTOR.
The volume of the HEART, usually relating to the volume of BLOOD contained within it at various periods of the cardiac cycle. The amount of blood ejected from a ventricle at each beat is STROKE VOLUME.
A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material.
The ENTERIC NERVOUS SYSTEM; PARASYMPATHETIC NERVOUS SYSTEM; and SYMPATHETIC NERVOUS SYSTEM taken together. Generally speaking, the autonomic nervous system regulates the internal environment during both peaceful activity and physical or emotional stress. Autonomic activity is controlled and integrated by the CENTRAL NERVOUS SYSTEM, especially the HYPOTHALAMUS and the SOLITARY NUCLEUS, which receive information relayed from VISCERAL AFFERENTS.
A distribution in which a variable is distributed like the sum of the squares of any given independent random variable, each of which has a normal distribution with mean of zero and variance of one. The chi-square test is a statistical test based on comparison of a test statistic to a chi-square distribution. The oldest of these tests are used to detect whether two or more population distributions differ from one another.
A positive inotropic cardiotonic agent with vasodilator properties. It inhibits cAMP phosphodiesterase type 3 activity in myocardium and vascular smooth muscle. Milrinone is a derivative of amrinone and has 20-30 times the inotropic potency of amrinone.
A condition associated with multiple episodes of sleep apnea which are distinguished from obstructive sleep apnea (SLEEP APNEA, OBSTRUCTIVE) by the complete cessation of efforts to breathe. This disorder is associated with dysfunction of central nervous system centers that regulate respiration.
Cardiac manifestation of systemic rheumatological conditions, such as RHEUMATIC FEVER. Rheumatic heart disease can involve any part the heart, most often the HEART VALVES and the ENDOCARDIUM.
A type of impedance plethysmography in which bioelectrical impedance is measured between electrodes positioned around the neck and around the lower thorax. It is used principally to calculate stroke volume and cardiac volume, but it is also related to myocardial contractility, thoracic fluid content, and circulation to the extremities.
Abrupt reduction in kidney function. Acute kidney injury encompasses the entire spectrum of the syndrome including acute kidney failure; ACUTE KIDNEY TUBULAR NECROSIS; and other less severe conditions.
A condition characterized by the thickening of the ventricular ENDOCARDIUM and subendocardium (MYOCARDIUM), seen mostly in children and young adults in the TROPICAL CLIMATE. The fibrous tissue extends from the apex toward and often involves the HEART VALVES causing restrictive blood flow into the respective ventricles (CARDIOMYOPATHY, RESTRICTIVE).
The total number of cases of a given disease in a specified population at a designated time. It is differentiated from INCIDENCE, which refers to the number of new cases in the population at a given time.
A BLOOD PRESSURE regulating system of interacting components that include RENIN; ANGIOTENSINOGEN; ANGIOTENSIN CONVERTING ENZYME; ANGIOTENSIN I; ANGIOTENSIN II; and angiotensinase. Renin, an enzyme produced in the kidney, acts on angiotensinogen, an alpha-2 globulin produced by the liver, forming ANGIOTENSIN I. Angiotensin-converting enzyme, contained in the lung, acts on angiotensin I in the plasma converting it to ANGIOTENSIN II, an extremely powerful vasoconstrictor. Angiotensin II causes contraction of the arteriolar and renal VASCULAR SMOOTH MUSCLE, leading to retention of salt and water in the KIDNEY and increased arterial blood pressure. In addition, angiotensin II stimulates the release of ALDOSTERONE from the ADRENAL CORTEX, which in turn also increases salt and water retention in the kidney. Angiotensin-converting enzyme also breaks down BRADYKININ, a powerful vasodilator and component of the KALLIKREIN-KININ SYSTEM.
A vital statistic measuring or recording the rate of death from any cause in hospitalized populations.
A voluntary organization concerned with the prevention and treatment of heart and vascular diseases.
Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.
A subtype of striated muscle, attached by TENDONS to the SKELETON. Skeletal muscles are innervated and their movement can be consciously controlled. They are also called voluntary muscles.
Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia.
A response by the BARORECEPTORS to increased BLOOD PRESSURE. Increased pressure stretches BLOOD VESSELS which activates the baroreceptors in the vessel walls. The net response of the CENTRAL NERVOUS SYSTEM is a reduction of central sympathetic outflow. This reduces blood pressure both by decreasing peripheral VASCULAR RESISTANCE and by lowering CARDIAC OUTPUT. Because the baroreceptors are tonically active, the baroreflex can compensate rapidly for both increases and decreases in blood pressure.
RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm.
Factors which produce cessation of all vital bodily functions. They can be analyzed from an epidemiologic viewpoint.
Procedures for finding the mathematical function which best describes the relationship between a dependent variable and one or more independent variables. In linear regression (see LINEAR MODELS) the relationship is constrained to be a straight line and LEAST-SQUARES ANALYSIS is used to determine the best fit. In logistic regression (see LOGISTIC MODELS) the dependent variable is qualitative rather than continuously variable and LIKELIHOOD FUNCTIONS are used to find the best relationship. In multiple regression, the dependent variable is considered to depend on more than a single independent variable.
A hormone secreted by the ADRENAL CORTEX that regulates electrolyte and water balance by increasing the renal retention of sodium and the excretion of potassium.
A guanidine analog with specific affinity for tissues of the sympathetic nervous system and related tumors. The radiolabeled forms are used as antineoplastic agents and radioactive imaging agents. (Merck Index, 12th ed) MIBG serves as a neuron-blocking agent which has a strong affinity for, and retention in, the adrenal medulla and also inhibits ADP-ribosyltransferase.
Failure to adequately provide oxygen to cells of the body and to remove excess carbon dioxide from them. (Stedman, 25th ed)
A phenoxypropanolamine derivative that is a selective beta-1-adrenergic agonist.
This structure includes the thin muscular atrial septum between the two HEART ATRIA, and the thick muscular ventricular septum between the two HEART VENTRICLES.
Creatinine is a waste product that's generated from muscle metabolism, typically filtered through the kidneys and released in urine, with increased levels in blood indicating impaired kidney function.
Agents that inhibit SODIUM-POTASSIUM-CHLORIDE SYMPORTERS which are concentrated in the thick ascending limb at the junction of the LOOP OF HENLE and KIDNEY TUBULES, DISTAL. They act as DIURETICS. Excess use is associated with HYPOKALEMIA and HYPERGLYCEMIA.
Therapy with two or more separate preparations given for a combined effect.
Damage to the MYOCARDIUM resulting from MYOCARDIAL REPERFUSION (restoration of blood flow to ischemic areas of the HEART.) Reperfusion takes place when there is spontaneous thrombolysis, THROMBOLYTIC THERAPY, collateral flow from other coronary vascular beds, or reversal of vasospasm.
An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
The hemodynamic and electrophysiological action of the right HEART VENTRICLE.
A network of tubules and sacs in the cytoplasm of SKELETAL MUSCLE FIBERS that assist with muscle contraction and relaxation by releasing and storing calcium ions.
Treatment process involving the injection of fluid into an organ or tissue.
A catecholamine derivative with specificity for BETA-1 ADRENERGIC RECEPTORS. It is commonly used as a cardiotonic agent after CARDIAC SURGERY and during DOBUTAMINE STRESS ECHOCARDIOGRAPHY.
The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results.
Cessation of heart beat or MYOCARDIAL CONTRACTION. If it is treated within a few minutes, heart arrest can be reversed in most cases to normal cardiac rhythm and effective circulation.
The intracellular transfer of information (biological activation/inhibition) through a signal pathway. In each signal transduction system, an activation/inhibition signal from a biologically active molecule (hormone, neurotransmitter) is mediated via the coupling of a receptor/enzyme to a second messenger system or to an ion channel. Signal transduction plays an important role in activating cellular functions, cell differentiation, and cell proliferation. Examples of signal transduction systems are the GAMMA-AMINOBUTYRIC ACID-postsynaptic receptor-calcium ion channel system, the receptor-mediated T-cell activation pathway, and the receptor-mediated activation of phospholipases. Those coupled to membrane depolarization or intracellular release of calcium include the receptor-mediated activation of cytotoxic functions in granulocytes and the synaptic potentiation of protein kinase activation. Some signal transduction pathways may be part of larger signal transduction pathways; for example, protein kinase activation is part of the platelet activation signal pathway.
General or unspecified injuries to the heart.
A subclass of beta-adrenergic receptors (RECEPTORS, ADRENERGIC, BETA). The adrenergic beta-1 receptors are equally sensitive to EPINEPHRINE and NOREPINEPHRINE and bind the agonist DOBUTAMINE and the antagonist METOPROLOL with high affinity. They are found in the HEART, juxtaglomerular cells, and in the central and peripheral nervous systems.
Surgery performed on the heart.
Strains of mice in which certain GENES of their GENOMES have been disrupted, or "knocked-out". To produce knockouts, using RECOMBINANT DNA technology, the normal DNA sequence of the gene being studied is altered to prevent synthesis of a normal gene product. Cloned cells in which this DNA alteration is successful are then injected into mouse EMBRYOS to produce chimeric mice. The chimeric mice are then bred to yield a strain in which all the cells of the mouse contain the disrupted gene. Knockout mice are used as EXPERIMENTAL ANIMAL MODELS for diseases (DISEASE MODELS, ANIMAL) and to clarify the functions of the genes.
The volume of water filtered out of plasma through glomerular capillary walls into Bowman's capsules per unit of time. It is considered to be equivalent to INULIN clearance.
A 21-amino acid peptide produced in a variety of tissues including endothelial and vascular smooth-muscle cells, neurons and astrocytes in the central nervous system, and endometrial cells. It acts as a modulator of vasomotor tone, cell proliferation, and hormone production. (N Eng J Med 1995;333(6):356-63)
Inbred C57BL mice are a strain of laboratory mice that have been produced by many generations of brother-sister matings, resulting in a high degree of genetic uniformity and homozygosity, making them widely used for biomedical research, including studies on genetics, immunology, cancer, and neuroscience.
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
Glycosides from plants of the genus DIGITALIS. Some of these are useful as cardiotonic and anti-arrhythmia agents. Included also are semi-synthetic derivatives of the naturally occurring glycosides. The term has sometimes been used more broadly to include all CARDIAC GLYCOSIDES, but here is restricted to those related to Digitalis.
The flow of BLOOD through or around an organ or region of the body.
A statistical technique that isolates and assesses the contributions of categorical independent variables to variation in the mean of a continuous dependent variable.
Statistical models which describe the relationship between a qualitative dependent variable (that is, one which can take only certain discrete values, such as the presence or absence of a disease) and an independent variable. A common application is in epidemiology for estimating an individual's risk (probability of a disease) as a function of a given risk factor.
An abnormally rapid ventricular rhythm usually in excess of 150 beats per minute. It is generated within the ventricle below the BUNDLE OF HIS, either as autonomic impulse formation or reentrant impulse conduction. Depending on the etiology, onset of ventricular tachycardia can be paroxysmal (sudden) or nonparoxysmal, its wide QRS complexes can be uniform or polymorphic, and the ventricular beating may be independent of the atrial beating (AV dissociation).
A disturbance in the prooxidant-antioxidant balance in favor of the former, leading to potential damage. Indicators of oxidative stress include damaged DNA bases, protein oxidation products, and lipid peroxidation products (Sies, Oxidative Stress, 1991, pxv-xvi).
Inbred rats derived from Sprague-Dawley rats and used for the study of salt-dependent hypertension. Salt-sensitive and salt-resistant strains have been selectively bred to show the opposite genetically determined blood pressure responses to excess sodium chloride ingestion.

Left ventricle diastolic dysfunction in diabetes: an update. (1/130)

Diabetes mellitus, a disease that has been reaching epidemic proportions, is an important risk factor to the development of cardiovascular complication. Diabetes causes changes within the cardiac structure and function, even in the absence of atherosclerotic disease. The left ventricular diastolic dysfunction (VE) represents the earliest pre-clinical manifestation of diabetic cardiomyopathy, preceding the systolic dysfunction and being able to evolve to symptomatic heart failure. The doppler echocardiography has emerged as an important noninvasive diagnostic tool, providing reliable data in the stages of diastolic function, as well as for systolic function. With the advent of recent echocardiographic techniques, such as tissue Doppler and color M-mode, the accuracy in identifying the moderate diastolic dysfunction, the pseudonormal pattern, has significantly improved. Due to cardio-metabolic repercussions of DM, a detailed evaluation of cardiovascular function in diabetic patients is important, and some alterations may be seen even in patients with gestational diabetes.  (+info)

Characterization of left ventricular filling abnormalities and its relation to elevated plasma brain natriuretic peptide level in acute to chronic diastolic heart failure. (2/130)

BACKGROUND: Although Doppler left ventricular (LV) filling abnormalities have been extensively analyzed in patients with systolic heart failure (SHF), they have not yet been well characterized in patients with acute to chronic diastolic heart failure (DHF) in the light of plasma brain natriuretic peptide (BNP) levels. METHODS AND RESULTS: In 25 patients presenting with acute DHF and 25 with acute SHF, echo Doppler parameters and plasma BNP levels were obtained on admission and in the chronic stage. The mitral E/A ratio was lower in DHF patients than in SHF patients in the acute stage (1.3 +/-0.4 vs 1.8+/-0.9, p<0.05), and in the chronic stage of DHF the ratio decreased with plasma BNP level, but plasma BNP level was still greater than 100 pg/ml in 15 patients (60%). Among patients with DHF the plasma BNP level did not correlate with the mitral E/A ratio or deceleration time (r=0,25, p=NS; r=0,23, p=NS), but did with estimated pulmonary artery systolic pressure (r=0.64, p<0.01). CONCLUSIONS: A restrictive mitral flow velocity pattern is observed in only 25% of patients with DHF, so it is particularly important to recognize pseudonormalization in those with possible DHF. Persistently elevated plasma BNP level is not primarily caused by LV diastolic dysfunction, but by secondary alteration for hemodynamic adjustment (elevated LV end-diastolic pressure) in patients with DHF.  (+info)

Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. (3/130)

OBJECTIVE: The mechanism and role of angiotensin II-induced vascular endothelial injury is unclear. We examined the molecular mechanism of angiotensin (AII)-induced vascular endothelial injury and its significance for hypertensive diastolic heart failure. METHODS AND RESULTS: We compared the effect of valsartan and amlodipine on Dahl salt-sensitive hypertensive rats (DS rats). Valsartan improved vascular endothelial dysfunction of DS rats more than amlodipine, by inhibiting endothelial apoptosis and eNOS uncoupling more. Moreover, valsartan inhibited vascular apoptosis signal-regulating kinase 1 (ASK1) more than amlodipine. Thus, AT1 receptor contributed to vascular endothelial apoptosis, eNOS uncoupling, and ASK1 activation of DS rats. Using ASK1(-/-) mice, we examined the causative role of ASK1 in endothelial apoptosis and eNOS uncoupling. AII infusion in wild-type mice markedly caused vascular endothelial apoptosis and eNOS uncoupling accompanied by vascular endothelial dysfunction, whereas these effects of AII were absent in ASK1(-/-) mice. Therefore, ASK1 participated in AII-induced vascular endothelial apoptosis and eNOS uncoupling. Using tetrahydrobiopterin, we found that eNOS uncoupling was involved in vascular endothelial dysfunction in DS rats with established diastolic heart failure. CONCLUSIONS: AII-induced vascular endothelial apoptosis and eNOS uncoupling were mediated by ASK1 and contributed to vascular injury in diastolic heart failure of salt-sensitive hypertension.  (+info)

Left ventricular untwisting rate by speckle tracking echocardiography. (4/130)

BACKGROUND: Recent studies validated the measurement of left ventricular (LV) untwisting rate (UR) by speckle tracking echocardiography. A few reports suggest that it may provide additional noninvasive insight into LV diastolic function. METHODS AND RESULTS: Simultaneous echocardiographic imaging and LV pressure measurements (7F Millar catheters) were performed in 8 adult dogs. Loading conditions were altered by caval occlusion, whereas lusitropic state was changed by dobutamine and esmolol infusion. Inferior vena cava occlusion at all experimental stages (baseline, dobutamine, esmolol) led to a significant decrease (P < or = 0.01) in LV end-systolic volume (ESV) and a significant increase in UR (P = 0.03). The best relation was observed between LV UR and ESV (r = -0.8, P < 0.001). The clinical study was conducted in 67 patients (age 57+/-17 years, 19 women) undergoing simultaneous right heart catheterization and echocardiographic imaging, with 20 healthy subjects as a control group. There were 34 patients with ejection fraction (EF) <50% (25+/-9%), and 33 patients with normal EF and diastolic dysfunction (64+/-7%). Patients with LV systolic dysfunction had a significantly lower UR (-55 omicron/s) in comparison with the control group (-89 omicron/s) and patients with normal EF (-104 omicron/s, P < 0.05), and the determinants of LV UR were twist, ESV, and tau (r2 = 0.83, P < 0.001). In patients with diastolic dysfunction and normal EF, twist and ESV were the independent predictors (r2 = 0.71, P < 0.001). CONCLUSIONS: LV UR is reduced in patients with depressed EF, but not in those with diastolic dysfunction and normal EF, and is primarily determined by twist and ESV.  (+info)

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study. (5/130)

BACKGROUND: High-sensitivity C-reactive protein (CRP) is an inflammatory marker that predicts coronary heart disease (CHD) and, in recent studies, incident heart failure (HF). Whether the association of inflammation with incident HF is explained by worse baseline left ventricular dysfunction or by underlying CHD is unknown. METHODS AND RESULTS: Serum CRP was measured in a cohort of 985 outpatients with established CHD from the Heart and Soul Study. During 3 years of follow-up, 15% of the participants with elevated CRP levels (>3 mg/L) were hospitalised for HF, compared with 7% of those with CRP +info)

Mechanical dyssynchrony in congestive heart failure: diagnostic and therapeutic implications. (6/130)

 (+info)

Cystatin C concentration as a predictor of systolic and diastolic heart failure. (7/130)

 (+info)

Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. (8/130)

 (+info)

Heart failure is a pathophysiological state in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body or do so only at the expense of elevated filling pressures. It can be caused by various cardiac disorders, including coronary artery disease, hypertension, valvular heart disease, cardiomyopathy, and arrhythmias. Symptoms may include shortness of breath, fatigue, and fluid retention. Heart failure is often classified based on the ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle during each contraction. A reduced EF (less than 40%) is indicative of heart failure with reduced ejection fraction (HFrEF), while a preserved EF (greater than or equal to 50%) is indicative of heart failure with preserved ejection fraction (HFpEF). There is also a category of heart failure with mid-range ejection fraction (HFmrEF) for those with an EF between 40-49%.

In medical terms, the heart is a muscular organ located in the thoracic cavity that functions as a pump to circulate blood throughout the body. It's responsible for delivering oxygen and nutrients to the tissues and removing carbon dioxide and other wastes. The human heart is divided into four chambers: two atria on the top and two ventricles on the bottom. The right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, while the left side receives oxygenated blood from the lungs and pumps it out to the rest of the body. The heart's rhythmic contractions and relaxations are regulated by a complex electrical conduction system.

Heart rate is the number of heartbeats per unit of time, often expressed as beats per minute (bpm). It can vary significantly depending on factors such as age, physical fitness, emotions, and overall health status. A resting heart rate between 60-100 bpm is generally considered normal for adults, but athletes and individuals with high levels of physical fitness may have a resting heart rate below 60 bpm due to their enhanced cardiovascular efficiency. Monitoring heart rate can provide valuable insights into an individual's health status, exercise intensity, and response to various treatments or interventions.

Cardiac output is a measure of the amount of blood that the heart pumps in one minute. It is calculated by multiplying the stroke volume (the amount of blood pumped by the left ventricle during each contraction) by the heart rate (the number of times the heart beats per minute). Low cardiac output refers to a condition in which the heart is not able to pump enough blood to meet the body's needs. This can occur due to various reasons such as heart failure, heart attack, or any other conditions that weaken the heart muscle. Symptoms of low cardiac output may include fatigue, shortness of breath, and decreased mental status. Treatment for low cardiac output depends on the underlying cause and may include medications, surgery, or medical devices to help support heart function.

Heart failure, systolic is a type of heart failure in which the heart's lower chambers, the ventricles, are not able to contract with enough force to pump an adequate amount of blood throughout the body. This means that the heart cannot effectively pump oxygenated blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, and fluid buildup in the lungs and other parts of the body.

Systolic heart failure is often caused by damage to the heart muscle, such as from a heart attack or long-standing high blood pressure. Over time, this damage can weaken the heart muscle and make it harder for the ventricles to contract with enough force to pump blood efficiently.

Treatment for systolic heart failure typically involves medications to help improve heart function, reduce symptoms, and prevent further damage to the heart. Lifestyle changes, such as following a healthy diet, getting regular exercise, and quitting smoking, can also help manage this condition. In some cases, more advanced treatments such as implantable devices or heart transplantation may be necessary.

Diastolic heart failure, also known as heart failure with normal ejection fraction or heart failure with preserved ejection fraction, is a type of heart failure in which the heart's lower chambers, the ventricles, are unable to fill properly with blood during the diastole (relaxation) phase of the heartbeat. This is often due to increased stiffness of the heart muscle, which can be caused by conditions such as hypertension, aging, or diabetes. As a result, the heart cannot pump enough oxygen-rich blood to meet the body's needs, leading to symptoms such as shortness of breath, fatigue, and fluid retention. Diastolic dysfunction can be assessed by echocardiography, measuring the E/e' ratio, tissue doppler, and other diagnostics tools.

Stroke volume is a term used in cardiovascular physiology and medicine. It refers to the amount of blood that is pumped out of the left ventricle of the heart during each contraction (systole). Specifically, it is the difference between the volume of blood in the left ventricle at the end of diastole (when the ventricle is filled with blood) and the volume at the end of systole (when the ventricle has contracted and ejected its contents into the aorta).

Stroke volume is an important measure of heart function, as it reflects the ability of the heart to pump blood effectively to the rest of the body. A low stroke volume may indicate that the heart is not pumping efficiently, while a high stroke volume may suggest that the heart is working too hard. Stroke volume can be affected by various factors, including heart disease, high blood pressure, and physical fitness level.

The formula for calculating stroke volume is:

Stroke Volume = End-Diastolic Volume - End-Systolic Volume

Where end-diastolic volume (EDV) is the volume of blood in the left ventricle at the end of diastole, and end-systolic volume (ESV) is the volume of blood in the left ventricle at the end of systole.

The myocardium is the middle layer of the heart wall, composed of specialized cardiac muscle cells that are responsible for pumping blood throughout the body. It forms the thickest part of the heart wall and is divided into two sections: the left ventricle, which pumps oxygenated blood to the rest of the body, and the right ventricle, which pumps deoxygenated blood to the lungs.

The myocardium contains several types of cells, including cardiac muscle fibers, connective tissue, nerves, and blood vessels. The muscle fibers are arranged in a highly organized pattern that allows them to contract in a coordinated manner, generating the force necessary to pump blood through the heart and circulatory system.

Damage to the myocardium can occur due to various factors such as ischemia (reduced blood flow), infection, inflammation, or genetic disorders. This damage can lead to several cardiac conditions, including heart failure, arrhythmias, and cardiomyopathy.

Heart disease is a broad term for a class of diseases that involve the heart or blood vessels. It's often used to refer to conditions that include:

1. Coronary artery disease (CAD): This is the most common type of heart disease. It occurs when the arteries that supply blood to the heart become hardened and narrowed due to the buildup of cholesterol and other substances, which can lead to chest pain (angina), shortness of breath, or a heart attack.

2. Heart failure: This condition occurs when the heart is unable to pump blood efficiently to meet the body's needs. It can be caused by various conditions, including coronary artery disease, high blood pressure, and cardiomyopathy.

3. Arrhythmias: These are abnormal heart rhythms, which can be too fast, too slow, or irregular. They can lead to symptoms such as palpitations, dizziness, and fainting.

4. Valvular heart disease: This involves damage to one or more of the heart's four valves, which control blood flow through the heart. Damage can be caused by various conditions, including infection, rheumatic fever, and aging.

5. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood efficiently. It can be caused by various factors, including genetics, viral infections, and drug abuse.

6. Pericardial disease: This involves inflammation or other problems with the sac surrounding the heart (pericardium). It can cause chest pain and other symptoms.

7. Congenital heart defects: These are heart conditions that are present at birth, such as a hole in the heart or abnormal blood vessels. They can range from mild to severe and may require medical intervention.

8. Heart infections: The heart can become infected by bacteria, viruses, or parasites, leading to various symptoms and complications.

It's important to note that many factors can contribute to the development of heart disease, including genetics, lifestyle choices, and certain medical conditions. Regular check-ups and a healthy lifestyle can help reduce the risk of developing heart disease.

Heart transplantation is a surgical procedure where a diseased, damaged, or failing heart is removed and replaced with a healthy donor heart. This procedure is usually considered as a last resort for patients with end-stage heart failure or severe coronary artery disease who have not responded to other treatments. The donor heart typically comes from a brain-dead individual whose family has agreed to donate their loved one's organs for transplantation. Heart transplantation is a complex and highly specialized procedure that requires a multidisciplinary team of healthcare professionals, including cardiologists, cardiac surgeons, anesthesiologists, perfusionists, nurses, and other support staff. The success rates for heart transplantation have improved significantly over the past few decades, with many patients experiencing improved quality of life and increased survival rates. However, recipients of heart transplants require lifelong immunosuppressive therapy to prevent rejection of the donor heart, which can increase the risk of infections and other complications.

Dilated cardiomyopathy (DCM) is a type of cardiomyopathy characterized by the enlargement and weakened contraction of the heart's main pumping chamber (the left ventricle). This enlargement and weakness can lead to symptoms such as shortness of breath, fatigue, and fluid retention. DCM can be caused by various factors including genetics, viral infections, alcohol and drug abuse, and other medical conditions like high blood pressure and diabetes. It is important to note that this condition can lead to heart failure if left untreated.

Brain Natriuretic Peptide (BNP) is a type of natriuretic peptide that is primarily produced in the heart, particularly in the ventricles. Although it was initially identified in the brain, hence its name, it is now known that the cardiac ventricles are the main source of BNP in the body.

BNP is released into the bloodstream in response to increased stretching or distension of the heart muscle cells due to conditions such as heart failure, hypertension, and myocardial infarction (heart attack). Once released, BNP binds to specific receptors in the kidneys, causing an increase in urine production and excretion of sodium, which helps reduce fluid volume and decrease the workload on the heart.

BNP also acts as a hormone that regulates various physiological functions, including blood pressure, cardiac remodeling, and inflammation. Measuring BNP levels in the blood is a useful diagnostic tool for detecting and monitoring heart failure, as higher levels of BNP are associated with more severe heart dysfunction.

Left ventricular function refers to the ability of the left ventricle (the heart's lower-left chamber) to contract and relax, thereby filling with and ejecting blood. The left ventricle is responsible for pumping oxygenated blood to the rest of the body. Its function is evaluated by measuring several parameters, including:

1. Ejection fraction (EF): This is the percentage of blood that is pumped out of the left ventricle with each heartbeat. A normal ejection fraction ranges from 55% to 70%.
2. Stroke volume (SV): The amount of blood pumped by the left ventricle in one contraction. A typical SV is about 70 mL/beat.
3. Cardiac output (CO): The total volume of blood that the left ventricle pumps per minute, calculated as the product of stroke volume and heart rate. Normal CO ranges from 4 to 8 L/minute.

Assessment of left ventricular function is crucial in diagnosing and monitoring various cardiovascular conditions such as heart failure, coronary artery disease, valvular heart diseases, and cardiomyopathies.

Left ventricular dysfunction (LVD) is a condition characterized by the impaired ability of the left ventricle of the heart to pump blood efficiently during contraction. The left ventricle is one of the four chambers of the heart and is responsible for pumping oxygenated blood to the rest of the body.

LVD can be caused by various underlying conditions, such as coronary artery disease, cardiomyopathy, valvular heart disease, or hypertension. These conditions can lead to structural changes in the left ventricle, including remodeling, hypertrophy, and dilation, which ultimately impair its contractile function.

The severity of LVD is often assessed by measuring the ejection fraction (EF), which is the percentage of blood that is pumped out of the left ventricle during each contraction. A normal EF ranges from 55% to 70%, while an EF below 40% is indicative of LVD.

LVD can lead to various symptoms, such as shortness of breath, fatigue, fluid retention, and decreased exercise tolerance. It can also increase the risk of complications, such as heart failure, arrhythmias, and cardiac arrest. Treatment for LVD typically involves managing the underlying cause, along with medications to improve contractility, reduce fluid buildup, and control heart rate. In severe cases, devices such as implantable cardioverter-defibrillators (ICDs) or left ventricular assist devices (LVADs) may be required.

Hemodynamics is the study of how blood flows through the cardiovascular system, including the heart and the vascular network. It examines various factors that affect blood flow, such as blood volume, viscosity, vessel length and diameter, and pressure differences between different parts of the circulatory system. Hemodynamics also considers the impact of various physiological and pathological conditions on these variables, and how they in turn influence the function of vital organs and systems in the body. It is a critical area of study in fields such as cardiology, anesthesiology, and critical care medicine.

Treatment failure is a term used in medicine to describe the situation when a prescribed treatment or intervention is not achieving the desired therapeutic goals or objectives. This may occur due to various reasons, such as:

1. Development of drug resistance by the pathogen or disease being treated.
2. Inadequate dosage or frequency of the medication.
3. Poor adherence or compliance to the treatment regimen by the patient.
4. The presence of underlying conditions or comorbidities that may affect the efficacy of the treatment.
5. The severity or progression of the disease despite appropriate treatment.

When treatment failure occurs, healthcare providers may need to reassess the patient's condition and modify the treatment plan accordingly, which may include adjusting the dosage, changing the medication, adding new medications, or considering alternative treatments.

A chronic disease is a long-term medical condition that often progresses slowly over a period of years and requires ongoing management and care. These diseases are typically not fully curable, but symptoms can be managed to improve quality of life. Common chronic diseases include heart disease, stroke, cancer, diabetes, arthritis, and COPD (chronic obstructive pulmonary disease). They are often associated with advanced age, although they can also affect children and younger adults. Chronic diseases can have significant impacts on individuals' physical, emotional, and social well-being, as well as on healthcare systems and society at large.

Adrenergic beta-antagonists, also known as beta blockers, are a class of medications that block the effects of adrenaline and noradrenaline (also known as epinephrine and norepinephrine) on beta-adrenergic receptors. These receptors are found in various tissues throughout the body, including the heart, lungs, and blood vessels.

Beta blockers work by binding to these receptors and preventing the activation of certain signaling pathways that lead to increased heart rate, force of heart contractions, and relaxation of blood vessels. As a result, beta blockers can lower blood pressure, reduce heart rate, and decrease the workload on the heart.

Beta blockers are used to treat a variety of medical conditions, including hypertension (high blood pressure), angina (chest pain), heart failure, irregular heart rhythms, migraines, and certain anxiety disorders. Some common examples of beta blockers include metoprolol, atenolol, propranolol, and bisoprolol.

It is important to note that while beta blockers can have many benefits, they can also cause side effects such as fatigue, dizziness, and shortness of breath. Additionally, sudden discontinuation of beta blocker therapy can lead to rebound hypertension or worsening chest pain. Therefore, it is important to follow the dosing instructions provided by a healthcare provider carefully when taking these medications.

Ventricular remodeling is a structural adaptation process of the heart in response to stress or injury, such as myocardial infarction (heart attack) or pressure overload. This process involves changes in size, shape, and function of the ventricles (the lower chambers of the heart).

In ventricular remodeling, the heart muscle may thicken, enlarge, or become more stiff, leading to alterations in the pumping ability of the heart. These changes can ultimately result in cardiac dysfunction, heart failure, and an increased risk of arrhythmias (irregular heart rhythms).

Ventricular remodeling is often classified into two types:

1. Concentric remodeling: This occurs when the ventricular wall thickens (hypertrophy) without a significant increase in chamber size, leading to a decrease in the cavity volume and an increase in the thickness of the ventricular wall.
2. Eccentric remodeling: This involves an increase in both the ventricular chamber size and wall thickness due to the addition of new muscle cells (hyperplasia) or enlargement of existing muscle cells (hypertrophy). As a result, the overall shape of the ventricle becomes more spherical and less elliptical.

Both types of remodeling can negatively impact heart function and contribute to the development of heart failure. Close monitoring and appropriate treatment are essential for managing ventricular remodeling and preventing further complications.

Congenital heart defects (CHDs) are structural abnormalities in the heart that are present at birth. They can affect any part of the heart's structure, including the walls of the heart, the valves inside the heart, and the major blood vessels that lead to and from the heart.

Congenital heart defects can range from mild to severe and can cause various symptoms depending on the type and severity of the defect. Some common symptoms of CHDs include cyanosis (a bluish tint to the skin, lips, and fingernails), shortness of breath, fatigue, poor feeding, and slow growth in infants and children.

There are many different types of congenital heart defects, including:

1. Septal defects: These are holes in the walls that separate the four chambers of the heart. The two most common septal defects are atrial septal defect (ASD) and ventricular septal defect (VSD).
2. Valve abnormalities: These include narrowed or leaky valves, which can affect blood flow through the heart.
3. Obstruction defects: These occur when blood flow is blocked or restricted due to narrowing or absence of a part of the heart's structure. Examples include pulmonary stenosis and coarctation of the aorta.
4. Cyanotic heart defects: These cause a lack of oxygen in the blood, leading to cyanosis. Examples include tetralogy of Fallot and transposition of the great arteries.

The causes of congenital heart defects are not fully understood, but genetic factors and environmental influences during pregnancy may play a role. Some CHDs can be detected before birth through prenatal testing, while others may not be diagnosed until after birth or later in childhood. Treatment for CHDs may include medication, surgery, or other interventions to improve blood flow and oxygenation of the body's tissues.

Treatment outcome is a term used to describe the result or effect of medical treatment on a patient's health status. It can be measured in various ways, such as through symptoms improvement, disease remission, reduced disability, improved quality of life, or survival rates. The treatment outcome helps healthcare providers evaluate the effectiveness of a particular treatment plan and make informed decisions about future care. It is also used in clinical research to compare the efficacy of different treatments and improve patient care.

Echocardiography is a medical procedure that uses sound waves to produce detailed images of the heart's structure, function, and motion. It is a non-invasive test that can help diagnose various heart conditions, such as valve problems, heart muscle damage, blood clots, and congenital heart defects.

During an echocardiogram, a transducer (a device that sends and receives sound waves) is placed on the chest or passed through the esophagus to obtain images of the heart. The sound waves produced by the transducer bounce off the heart structures and return to the transducer, which then converts them into electrical signals that are processed to create images of the heart.

There are several types of echocardiograms, including:

* Transthoracic echocardiography (TTE): This is the most common type of echocardiogram and involves placing the transducer on the chest.
* Transesophageal echocardiography (TEE): This type of echocardiogram involves passing a specialized transducer through the esophagus to obtain images of the heart from a closer proximity.
* Stress echocardiography: This type of echocardiogram is performed during exercise or medication-induced stress to assess how the heart functions under stress.
* Doppler echocardiography: This type of echocardiogram uses sound waves to measure blood flow and velocity in the heart and blood vessels.

Echocardiography is a valuable tool for diagnosing and managing various heart conditions, as it provides detailed information about the structure and function of the heart. It is generally safe, non-invasive, and painless, making it a popular choice for doctors and patients alike.

Cardiotonic agents are a type of medication that have a positive inotropic effect on the heart, meaning they help to improve the contractility and strength of heart muscle contractions. These medications are often used to treat heart failure, as they can help to improve the efficiency of the heart's pumping ability and increase cardiac output.

Cardiotonic agents work by increasing the levels of calcium ions inside heart muscle cells during each heartbeat, which in turn enhances the force of contraction. Some common examples of cardiotonic agents include digitalis glycosides (such as digoxin), which are derived from the foxglove plant, and synthetic medications such as dobutamine and milrinone.

While cardiotonic agents can be effective in improving heart function, they can also have potentially serious side effects, including arrhythmias, electrolyte imbalances, and digestive symptoms. As a result, they are typically used under close medical supervision and their dosages may need to be carefully monitored to minimize the risk of adverse effects.

Myocardial contraction refers to the rhythmic and forceful shortening of heart muscle cells (myocytes) in the myocardium, which is the muscular wall of the heart. This process is initiated by electrical signals generated by the sinoatrial node, causing a wave of depolarization that spreads throughout the heart.

During myocardial contraction, calcium ions flow into the myocytes, triggering the interaction between actin and myosin filaments, which are the contractile proteins in the muscle cells. This interaction causes the myofilaments to slide past each other, resulting in the shortening of the sarcomeres (the functional units of muscle contraction) and ultimately leading to the contraction of the heart muscle.

Myocardial contraction is essential for pumping blood throughout the body and maintaining adequate circulation to vital organs. Any impairment in myocardial contractility can lead to various cardiac disorders, such as heart failure, cardiomyopathy, and arrhythmias.

In the field of medicine, "time factors" refer to the duration of symptoms or time elapsed since the onset of a medical condition, which can have significant implications for diagnosis and treatment. Understanding time factors is crucial in determining the progression of a disease, evaluating the effectiveness of treatments, and making critical decisions regarding patient care.

For example, in stroke management, "time is brain," meaning that rapid intervention within a specific time frame (usually within 4.5 hours) is essential to administering tissue plasminogen activator (tPA), a clot-busting drug that can minimize brain damage and improve patient outcomes. Similarly, in trauma care, the "golden hour" concept emphasizes the importance of providing definitive care within the first 60 minutes after injury to increase survival rates and reduce morbidity.

Time factors also play a role in monitoring the progression of chronic conditions like diabetes or heart disease, where regular follow-ups and assessments help determine appropriate treatment adjustments and prevent complications. In infectious diseases, time factors are crucial for initiating antibiotic therapy and identifying potential outbreaks to control their spread.

Overall, "time factors" encompass the significance of recognizing and acting promptly in various medical scenarios to optimize patient outcomes and provide effective care.

Artificial cardiac pacing is a medical procedure that involves the use of an artificial device to regulate and stimulate the contraction of the heart muscle. This is often necessary when the heart's natural pacemaker, the sinoatrial node, is not functioning properly and the heart is beating too slowly or irregularly.

The artificial pacemaker consists of a small generator that produces electrical impulses and leads that are positioned in the heart to transmit the impulses. The generator is typically implanted just under the skin in the chest, while the leads are inserted into the heart through a vein.

There are different types of artificial cardiac pacing systems, including single-chamber pacemakers, which stimulate either the right atrium or right ventricle, and dual-chamber pacemakers, which stimulate both chambers of the heart. Some pacemakers also have additional features that allow them to respond to changes in the body's needs, such as during exercise or sleep.

Artificial cardiac pacing is a safe and effective treatment for many people with abnormal heart rhythms, and it can significantly improve their quality of life and longevity.

Heart function tests are a group of diagnostic exams that are used to evaluate the structure and functioning of the heart. These tests help doctors assess the pumping efficiency of the heart, the flow of blood through the heart, the presence of any heart damage, and the overall effectiveness of the heart in delivering oxygenated blood to the rest of the body.

Some common heart function tests include:

1. Echocardiogram (Echo): This test uses sound waves to create detailed images of the heart's structure and functioning. It can help detect any damage to the heart muscle, valves, or sac surrounding the heart.
2. Nuclear Stress Test: This test involves injecting a small amount of radioactive substance into the patient's bloodstream and taking images of the heart while it is at rest and during exercise. The test helps evaluate blood flow to the heart and detect any areas of reduced blood flow, which could indicate coronary artery disease.
3. Cardiac Magnetic Resonance Imaging (MRI): This test uses magnetic fields and radio waves to create detailed images of the heart's structure and function. It can help detect any damage to the heart muscle, valves, or other structures of the heart.
4. Electrocardiogram (ECG): This test measures the electrical activity of the heart and helps detect any abnormalities in the heart's rhythm or conduction system.
5. Exercise Stress Test: This test involves walking on a treadmill or riding a stationary bike while being monitored for changes in heart rate, blood pressure, and ECG readings. It helps evaluate exercise capacity and detect any signs of coronary artery disease.
6. Cardiac Catheterization: This is an invasive procedure that involves inserting a catheter into the heart to measure pressures and take samples of blood from different parts of the heart. It can help diagnose various heart conditions, including heart valve problems, congenital heart defects, and coronary artery disease.

Overall, heart function tests play an essential role in diagnosing and managing various heart conditions, helping doctors provide appropriate treatment and improve patient outcomes.

Follow-up studies are a type of longitudinal research that involve repeated observations or measurements of the same variables over a period of time, in order to understand their long-term effects or outcomes. In medical context, follow-up studies are often used to evaluate the safety and efficacy of medical treatments, interventions, or procedures.

In a typical follow-up study, a group of individuals (called a cohort) who have received a particular treatment or intervention are identified and then followed over time through periodic assessments or data collection. The data collected may include information on clinical outcomes, adverse events, changes in symptoms or functional status, and other relevant measures.

The results of follow-up studies can provide important insights into the long-term benefits and risks of medical interventions, as well as help to identify factors that may influence treatment effectiveness or patient outcomes. However, it is important to note that follow-up studies can be subject to various biases and limitations, such as loss to follow-up, recall bias, and changes in clinical practice over time, which must be carefully considered when interpreting the results.

Cardiomyopathies are a group of diseases that affect the heart muscle, leading to mechanical and/or electrical dysfunction. The American Heart Association (AHA) defines cardiomyopathies as "a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not always) exhibit inappropriate ventricular hypertrophy or dilatation and frequently lead to heart failure."

There are several types of cardiomyopathies, including:

1. Dilated cardiomyopathy (DCM): This is the most common type of cardiomyopathy, characterized by an enlarged left ventricle and impaired systolic function, leading to heart failure.
2. Hypertrophic cardiomyopathy (HCM): In this type, there is abnormal thickening of the heart muscle, particularly in the septum between the two ventricles, which can obstruct blood flow and increase the risk of arrhythmias.
3. Restrictive cardiomyopathy (RCM): This is a rare form of cardiomyopathy characterized by stiffness of the heart muscle, impaired relaxation, and diastolic dysfunction, leading to reduced filling of the ventricles and heart failure.
4. Arrhythmogenic right ventricular cardiomyopathy (ARVC): In this type, there is replacement of the normal heart muscle with fatty or fibrous tissue, primarily affecting the right ventricle, which can lead to arrhythmias and sudden cardiac death.
5. Unclassified cardiomyopathies: These are conditions that do not fit into any of the above categories but still significantly affect the heart muscle and function.

Cardiomyopathies can be caused by genetic factors, acquired conditions (e.g., infections, toxins, or autoimmune disorders), or a combination of both. The diagnosis typically involves a comprehensive evaluation, including medical history, physical examination, electrocardiogram (ECG), echocardiography, cardiac magnetic resonance imaging (MRI), and sometimes genetic testing. Treatment depends on the type and severity of the condition but may include medications, lifestyle modifications, implantable devices, or even heart transplantation in severe cases.

Prospective studies, also known as longitudinal studies, are a type of cohort study in which data is collected forward in time, following a group of individuals who share a common characteristic or exposure over a period of time. The researchers clearly define the study population and exposure of interest at the beginning of the study and follow up with the participants to determine the outcomes that develop over time. This type of study design allows for the investigation of causal relationships between exposures and outcomes, as well as the identification of risk factors and the estimation of disease incidence rates. Prospective studies are particularly useful in epidemiology and medical research when studying diseases with long latency periods or rare outcomes.

Cardiomegaly is a medical term that refers to an enlarged heart. It can be caused by various conditions such as high blood pressure, heart valve problems, cardiomyopathy, or fluid accumulation around the heart (pericardial effusion). Cardiomegaly can be detected through imaging tests like chest X-rays or echocardiograms. Depending on the underlying cause, treatment options may include medications, lifestyle changes, or in some cases, surgery. It is important to consult with a healthcare professional for proper diagnosis and treatment.

Myocardial infarction (MI), also known as a heart attack, is a medical condition characterized by the death of a segment of heart muscle (myocardium) due to the interruption of its blood supply. This interruption is most commonly caused by the blockage of a coronary artery by a blood clot formed on the top of an atherosclerotic plaque, which is a buildup of cholesterol and other substances in the inner lining of the artery.

The lack of oxygen and nutrients supply to the heart muscle tissue results in damage or death of the cardiac cells, causing the affected area to become necrotic. The extent and severity of the MI depend on the size of the affected area, the duration of the occlusion, and the presence of collateral circulation.

Symptoms of a myocardial infarction may include chest pain or discomfort, shortness of breath, nausea, lightheadedness, and sweating. Immediate medical attention is necessary to restore blood flow to the affected area and prevent further damage to the heart muscle. Treatment options for MI include medications, such as thrombolytics, antiplatelet agents, and pain relievers, as well as procedures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).

Cardiac myocytes are the muscle cells that make up the heart muscle, also known as the myocardium. These specialized cells are responsible for contracting and relaxing in a coordinated manner to pump blood throughout the body. They differ from skeletal muscle cells in several ways, including their ability to generate their own electrical impulses, which allows the heart to function as an independent rhythmical pump. Cardiac myocytes contain sarcomeres, the contractile units of the muscle, and are connected to each other by intercalated discs that help coordinate contraction and ensure the synchronous beating of the heart.

Diuretics are a type of medication that increase the production of urine and help the body eliminate excess fluid and salt. They work by interfering with the reabsorption of sodium in the kidney tubules, which in turn causes more water to be excreted from the body. Diuretics are commonly used to treat conditions such as high blood pressure, heart failure, liver cirrhosis, and kidney disease. There are several types of diuretics, including loop diuretics, thiazide diuretics, potassium-sparing diuretics, and osmotic diuretics, each with its own mechanism of action and potential side effects. It is important to use diuretics under the guidance of a healthcare professional, as they can interact with other medications and have an impact on electrolyte balance in the body.

Prognosis is a medical term that refers to the prediction of the likely outcome or course of a disease, including the chances of recovery or recurrence, based on the patient's symptoms, medical history, physical examination, and diagnostic tests. It is an important aspect of clinical decision-making and patient communication, as it helps doctors and patients make informed decisions about treatment options, set realistic expectations, and plan for future care.

Prognosis can be expressed in various ways, such as percentages, categories (e.g., good, fair, poor), or survival rates, depending on the nature of the disease and the available evidence. However, it is important to note that prognosis is not an exact science and may vary depending on individual factors, such as age, overall health status, and response to treatment. Therefore, it should be used as a guide rather than a definitive forecast.

Medical Definition:

"Risk factors" are any attribute, characteristic or exposure of an individual that increases the likelihood of developing a disease or injury. They can be divided into modifiable and non-modifiable risk factors. Modifiable risk factors are those that can be changed through lifestyle choices or medical treatment, while non-modifiable risk factors are inherent traits such as age, gender, or genetic predisposition. Examples of modifiable risk factors include smoking, alcohol consumption, physical inactivity, and unhealthy diet, while non-modifiable risk factors include age, sex, and family history. It is important to note that having a risk factor does not guarantee that a person will develop the disease, but rather indicates an increased susceptibility.

Angiotensin-Converting Enzyme (ACE) inhibitors are a class of medications that are commonly used to treat various cardiovascular conditions, such as hypertension (high blood pressure), heart failure, and diabetic nephropathy (kidney damage in people with diabetes).

ACE inhibitors work by blocking the action of angiotensin-converting enzyme, an enzyme that converts the hormone angiotensin I to angiotensin II. Angiotensin II is a potent vasoconstrictor, meaning it narrows blood vessels and increases blood pressure. By inhibiting the conversion of angiotensin I to angiotensin II, ACE inhibitors cause blood vessels to relax and widen, which lowers blood pressure and reduces the workload on the heart.

Some examples of ACE inhibitors include captopril, enalapril, lisinopril, ramipril, and fosinopril. These medications are generally well-tolerated, but they can cause side effects such as cough, dizziness, headache, and elevated potassium levels in the blood. It is important for patients to follow their healthcare provider's instructions carefully when taking ACE inhibitors and to report any unusual symptoms or side effects promptly.

The heart atria are the upper chambers of the heart that receive blood from the veins and deliver it to the lower chambers, or ventricles. There are two atria in the heart: the right atrium receives oxygen-poor blood from the body and pumps it into the right ventricle, which then sends it to the lungs to be oxygenated; and the left atrium receives oxygen-rich blood from the lungs and pumps it into the left ventricle, which then sends it out to the rest of the body. The atria contract before the ventricles during each heartbeat, helping to fill the ventricles with blood and prepare them for contraction.

Heart-assist devices, also known as mechanical circulatory support devices, are medical equipment designed to help the heart function more efficiently. These devices can be used in patients with advanced heart failure who are not responding to medication or other treatments. They work by taking over some or all of the heart's pumping functions, reducing the workload on the heart and improving blood flow to the rest of the body.

There are several types of heart-assist devices, including:

1. Intra-aortic balloon pumps (IABPs): These devices are inserted into the aorta, the large artery that carries blood from the heart to the rest of the body. The IABP inflates and deflates in time with the heartbeat, helping to improve blood flow to the coronary arteries and reduce the workload on the heart.
2. Ventricular assist devices (VADs): These devices are more invasive than IABPs and are used to support the function of one or both ventricles, the lower chambers of the heart. VADs can be used to support the heart temporarily while a patient recovers from surgery or heart failure, or they can be used as a long-term solution for patients who are not candidates for a heart transplant.
3. Total artificial hearts (TAHs): These devices replace both ventricles and all four valves of the heart. TAHs are used in patients who are not candidates for a heart transplant and have severe biventricular failure, meaning that both ventricles are no longer functioning properly.

Heart-assist devices can be life-saving for some patients with advanced heart failure, but they also carry risks, such as infection, bleeding, and device malfunction. As with any medical treatment, the benefits and risks of using a heart-assist device must be carefully weighed for each individual patient.

Hospitalization is the process of admitting a patient to a hospital for the purpose of receiving medical treatment, surgery, or other health care services. It involves staying in the hospital as an inpatient, typically under the care of doctors, nurses, and other healthcare professionals. The length of stay can vary depending on the individual's medical condition and the type of treatment required. Hospitalization may be necessary for a variety of reasons, such as to receive intensive care, to undergo diagnostic tests or procedures, to recover from surgery, or to manage chronic illnesses or injuries.

The fetal heart is the cardiovascular organ that develops in the growing fetus during pregnancy. It starts to form around 22 days after conception and continues to develop throughout the first trimester. By the end of the eighth week of gestation, the fetal heart has developed enough to pump blood throughout the body.

The fetal heart is similar in structure to the adult heart but has some differences. It is smaller and more compact, with a four-chambered structure that includes two atria and two ventricles. The fetal heart also has unique features such as the foramen ovale, which is a hole between the right and left atria that allows blood to bypass the lungs, and the ductus arteriosus, a blood vessel that connects the pulmonary artery to the aorta and diverts blood away from the lungs.

The fetal heart is responsible for pumping oxygenated blood from the placenta to the rest of the body and returning deoxygenated blood back to the placenta for re-oxygenation. The rate of the fetal heartbeat is faster than that of an adult, typically ranging from 120 to 160 beats per minute. Fetal heart rate monitoring is a common method used during pregnancy and childbirth to assess the health and well-being of the developing fetus.

Propanolamines are a class of pharmaceutical compounds that contain a propan-2-olamine functional group, which is a secondary amine formed by the replacement of one hydrogen atom in an ammonia molecule with a propan-2-ol group. They are commonly used as decongestants and bronchodilators in medical treatments.

Examples of propanolamines include:

* Phenylephrine: a decongestant used to relieve nasal congestion.
* Pseudoephedrine: a decongestant and stimulant used to treat nasal congestion and sinus pressure.
* Ephedrine: a bronchodilator, decongestant, and stimulant used to treat asthma, nasal congestion, and low blood pressure.

It is important to note that propanolamines can have side effects such as increased heart rate, elevated blood pressure, and insomnia, so they should be used with caution and under the supervision of a healthcare professional.

Myocardial ischemia is a condition in which the blood supply to the heart muscle (myocardium) is reduced or blocked, leading to insufficient oxygen delivery and potential damage to the heart tissue. This reduction in blood flow typically results from the buildup of fatty deposits, called plaques, in the coronary arteries that supply the heart with oxygen-rich blood. The plaques can rupture or become unstable, causing the formation of blood clots that obstruct the artery and limit blood flow.

Myocardial ischemia may manifest as chest pain (angina pectoris), shortness of breath, fatigue, or irregular heartbeats (arrhythmias). In severe cases, it can lead to myocardial infarction (heart attack) if the oxygen supply is significantly reduced or cut off completely, causing permanent damage or death of the heart muscle. Early diagnosis and treatment of myocardial ischemia are crucial for preventing further complications and improving patient outcomes.

An exercise test, also known as a stress test or an exercise stress test, is a medical procedure used to evaluate the heart's function and response to physical exertion. It typically involves walking on a treadmill or pedaling a stationary bike while being monitored for changes in heart rate, blood pressure, electrocardiogram (ECG), and sometimes other variables such as oxygen consumption or gas exchange.

During the test, the patient's symptoms, such as chest pain or shortness of breath, are also closely monitored. The exercise test can help diagnose coronary artery disease, assess the severity of heart-related symptoms, and evaluate the effectiveness of treatments for heart conditions. It may also be used to determine a person's safe level of physical activity and fitness.

There are different types of exercise tests, including treadmill stress testing, stationary bike stress testing, nuclear stress testing, and stress echocardiography. The specific type of test used depends on the patient's medical history, symptoms, and overall health status.

Systole is the phase of the cardiac cycle during which the heart muscle contracts to pump blood out of the heart. Specifically, it refers to the contraction of the ventricles, the lower chambers of the heart. This is driven by the action of the electrical conduction system of the heart, starting with the sinoatrial node and passing through the atrioventricular node and bundle branches to the Purkinje fibers.

During systole, the pressure within the ventricles increases as they contract, causing the aortic and pulmonary valves to open and allowing blood to be ejected into the systemic and pulmonary circulations, respectively. The duration of systole is typically shorter than that of diastole, the phase during which the heart muscle relaxes and the chambers fill with blood.

In clinical settings, the terms "systolic" and "diastolic" are often used to describe blood pressure measurements, with the former referring to the pressure exerted on the artery walls when the ventricles contract and eject blood, and the latter referring to the pressure when the ventricles are relaxed and filling with blood.

Animal disease models are specialized animals, typically rodents such as mice or rats, that have been genetically engineered or exposed to certain conditions to develop symptoms and physiological changes similar to those seen in human diseases. These models are used in medical research to study the pathophysiology of diseases, identify potential therapeutic targets, test drug efficacy and safety, and understand disease mechanisms.

The genetic modifications can include knockout or knock-in mutations, transgenic expression of specific genes, or RNA interference techniques. The animals may also be exposed to environmental factors such as chemicals, radiation, or infectious agents to induce the disease state.

Examples of animal disease models include:

1. Mouse models of cancer: Genetically engineered mice that develop various types of tumors, allowing researchers to study cancer initiation, progression, and metastasis.
2. Alzheimer's disease models: Transgenic mice expressing mutant human genes associated with Alzheimer's disease, which exhibit amyloid plaque formation and cognitive decline.
3. Diabetes models: Obese and diabetic mouse strains like the NOD (non-obese diabetic) or db/db mice, used to study the development of type 1 and type 2 diabetes, respectively.
4. Cardiovascular disease models: Atherosclerosis-prone mice, such as ApoE-deficient or LDLR-deficient mice, that develop plaque buildup in their arteries when fed a high-fat diet.
5. Inflammatory bowel disease models: Mice with genetic mutations affecting intestinal barrier function and immune response, such as IL-10 knockout or SAMP1/YitFc mice, which develop colitis.

Animal disease models are essential tools in preclinical research, but it is important to recognize their limitations. Differences between species can affect the translatability of results from animal studies to human patients. Therefore, researchers must carefully consider the choice of model and interpret findings cautiously when applying them to human diseases.

A biological marker, often referred to as a biomarker, is a measurable indicator that reflects the presence or severity of a disease state, or a response to a therapeutic intervention. Biomarkers can be found in various materials such as blood, tissues, or bodily fluids, and they can take many forms, including molecular, histologic, radiographic, or physiological measurements.

In the context of medical research and clinical practice, biomarkers are used for a variety of purposes, such as:

1. Diagnosis: Biomarkers can help diagnose a disease by indicating the presence or absence of a particular condition. For example, prostate-specific antigen (PSA) is a biomarker used to detect prostate cancer.
2. Monitoring: Biomarkers can be used to monitor the progression or regression of a disease over time. For instance, hemoglobin A1c (HbA1c) levels are monitored in diabetes patients to assess long-term blood glucose control.
3. Predicting: Biomarkers can help predict the likelihood of developing a particular disease or the risk of a negative outcome. For example, the presence of certain genetic mutations can indicate an increased risk for breast cancer.
4. Response to treatment: Biomarkers can be used to evaluate the effectiveness of a specific treatment by measuring changes in the biomarker levels before and after the intervention. This is particularly useful in personalized medicine, where treatments are tailored to individual patients based on their unique biomarker profiles.

It's important to note that for a biomarker to be considered clinically valid and useful, it must undergo rigorous validation through well-designed studies, including demonstrating sensitivity, specificity, reproducibility, and clinical relevance.

Heart valves are specialized structures in the heart that ensure unidirectional flow of blood through its chambers during the cardiac cycle. There are four heart valves: the tricuspid valve and the mitral (bicuspid) valve, located between the atria and ventricles, and the pulmonic (pulmonary) valve and aortic valve, located between the ventricles and the major blood vessels leaving the heart.

The heart valves are composed of thin flaps of tissue called leaflets or cusps, which are supported by a fibrous ring. The aortic and pulmonic valves have three cusps each, while the tricuspid and mitral valves have three and two cusps, respectively.

The heart valves open and close in response to pressure differences across them, allowing blood to flow forward into the ventricles during diastole (filling phase) and preventing backflow of blood into the atria during systole (contraction phase). A properly functioning heart valve ensures efficient pumping of blood by the heart and maintains normal blood circulation throughout the body.

A Severity of Illness Index is a measurement tool used in healthcare to assess the severity of a patient's condition and the risk of mortality or other adverse outcomes. These indices typically take into account various physiological and clinical variables, such as vital signs, laboratory values, and co-morbidities, to generate a score that reflects the patient's overall illness severity.

Examples of Severity of Illness Indices include the Acute Physiology and Chronic Health Evaluation (APACHE) system, the Simplified Acute Physiology Score (SAPS), and the Mortality Probability Model (MPM). These indices are often used in critical care settings to guide clinical decision-making, inform prognosis, and compare outcomes across different patient populations.

It is important to note that while these indices can provide valuable information about a patient's condition, they should not be used as the sole basis for clinical decision-making. Rather, they should be considered in conjunction with other factors, such as the patient's overall clinical presentation, treatment preferences, and goals of care.

The heart ventricles are the two lower chambers of the heart that receive blood from the atria and pump it to the lungs or the rest of the body. The right ventricle pumps deoxygenated blood to the lungs, while the left ventricle pumps oxygenated blood to the rest of the body. Both ventricles have thick, muscular walls to generate the pressure necessary to pump blood through the circulatory system.

Diastole is the phase of the cardiac cycle during which the heart muscle relaxes and the chambers of the heart fill with blood. It follows systole, the phase in which the heart muscle contracts and pumps blood out to the body. In a normal resting adult, diastole lasts for approximately 0.4-0.5 seconds during each heartbeat. The period of diastole is divided into two phases: early diastole and late diastole. During early diastole, the ventricles fill with blood due to the pressure difference between the atria and ventricles. During late diastole, the atrioventricular valves close, and the ventricles continue to fill with blood due to the relaxation of the ventricular muscle and the compliance of the ventricular walls. The duration and pressure changes during diastole are important for maintaining adequate cardiac output and blood flow to the body.

Retrospective studies, also known as retrospective research or looking back studies, are a type of observational study that examines data from the past to draw conclusions about possible causal relationships between risk factors and outcomes. In these studies, researchers analyze existing records, medical charts, or previously collected data to test a hypothesis or answer a specific research question.

Retrospective studies can be useful for generating hypotheses and identifying trends, but they have limitations compared to prospective studies, which follow participants forward in time from exposure to outcome. Retrospective studies are subject to biases such as recall bias, selection bias, and information bias, which can affect the validity of the results. Therefore, retrospective studies should be interpreted with caution and used primarily to generate hypotheses for further testing in prospective studies.

I believe there might be a misunderstanding in your question. "Dogs" is not a medical term or condition. It is the common name for a domesticated carnivore of the family Canidae, specifically the genus Canis, which includes wolves, foxes, and other extant and extinct species of mammals. Dogs are often kept as pets and companions, and they have been bred in a wide variety of forms and sizes for different purposes, such as hunting, herding, guarding, assisting police and military forces, and providing companionship and emotional support.

If you meant to ask about a specific medical condition or term related to dogs, please provide more context so I can give you an accurate answer.

The Predictive Value of Tests, specifically the Positive Predictive Value (PPV) and Negative Predictive Value (NPV), are measures used in diagnostic tests to determine the probability that a positive or negative test result is correct.

Positive Predictive Value (PPV) is the proportion of patients with a positive test result who actually have the disease. It is calculated as the number of true positives divided by the total number of positive results (true positives + false positives). A higher PPV indicates that a positive test result is more likely to be a true positive, and therefore the disease is more likely to be present.

Negative Predictive Value (NPV) is the proportion of patients with a negative test result who do not have the disease. It is calculated as the number of true negatives divided by the total number of negative results (true negatives + false negatives). A higher NPV indicates that a negative test result is more likely to be a true negative, and therefore the disease is less likely to be present.

The predictive value of tests depends on the prevalence of the disease in the population being tested, as well as the sensitivity and specificity of the test. A test with high sensitivity and specificity will generally have higher predictive values than a test with low sensitivity and specificity. However, even a highly sensitive and specific test can have low predictive values if the prevalence of the disease is low in the population being tested.

Exercise tolerance is a term used to describe the ability of an individual to perform physical activity or exercise without experiencing symptoms such as shortness of breath, chest pain, or undue fatigue. It is often used as a measure of cardiovascular fitness and can be assessed through various tests, such as a stress test or a six-minute walk test. Exercise intolerance may indicate the presence of underlying medical conditions, such as heart disease, lung disease, or deconditioning.

Digoxin is a medication that belongs to a class of drugs called cardiac glycosides. It is used to treat various heart conditions, such as heart failure and atrial fibrillation, by helping the heart beat stronger and more regularly. Digoxin works by inhibiting the sodium-potassium pump in heart muscle cells, which leads to an increase in intracellular calcium and a strengthening of heart contractions. It is important to monitor digoxin levels closely, as too much can lead to toxicity and serious side effects.

Chronic kidney failure, also known as chronic kidney disease (CKD) stage 5 or end-stage renal disease (ESRD), is a permanent loss of kidney function that occurs gradually over a period of months to years. It is defined as a glomerular filtration rate (GFR) of less than 15 ml/min, which means the kidneys are filtering waste and excess fluids at less than 15% of their normal capacity.

CKD can be caused by various underlying conditions such as diabetes, hypertension, glomerulonephritis, polycystic kidney disease, and recurrent kidney infections. Over time, the damage to the kidneys can lead to a buildup of waste products and fluids in the body, which can cause a range of symptoms including fatigue, weakness, shortness of breath, nausea, vomiting, and confusion.

Treatment for chronic kidney failure typically involves managing the underlying condition, making lifestyle changes such as following a healthy diet, and receiving supportive care such as dialysis or a kidney transplant to replace lost kidney function.

Atrial natriuretic factor (ANF), also known as atrial natriuretic peptide (ANP), is a hormone that is primarily produced and secreted by the atria of the heart in response to stretching of the cardiac muscle cells due to increased blood volume. ANF plays a crucial role in regulating body fluid homeostasis, blood pressure, and cardiovascular function.

The main physiological action of ANF is to promote sodium and water excretion by the kidneys, which helps lower blood volume and reduce blood pressure. ANF also relaxes vascular smooth muscle, dilates blood vessels, and inhibits the renin-angiotensin-aldosterone system (RAAS), further contributing to its blood pressure-lowering effects.

Defects in ANF production or action have been implicated in several cardiovascular disorders, including heart failure, hypertension, and kidney disease. Therefore, ANF and its analogs are being investigated as potential therapeutic agents for the treatment of these conditions.

Ventricular dysfunction is a term that refers to the impaired ability of the ventricles, which are the lower chambers of the heart, to fill with blood or pump it efficiently to the rest of the body. This condition can lead to reduced cardiac output and may cause symptoms such as shortness of breath, fatigue, and fluid retention.

There are two types of ventricular dysfunction:

1. Systolic dysfunction: This occurs when the ventricles cannot contract forcefully enough to eject an adequate amount of blood out of the heart during each beat. This is often due to damage to the heart muscle, such as that caused by a heart attack or cardiomyopathy.
2. Diastolic dysfunction: This happens when the ventricles are unable to relax and fill properly with blood between beats. This can be caused by stiffening of the heart muscle, often due to aging, high blood pressure, or diabetes.

Both types of ventricular dysfunction can lead to heart failure, a serious condition in which the heart is unable to pump blood effectively to meet the body's needs. Treatment for ventricular dysfunction may include medications, lifestyle changes, and in some cases, medical procedures or surgery.

Carbazoles are aromatic organic compounds that consist of a tricyclic structure with two benzene rings fused to a five-membered ring containing two nitrogen atoms. The chemical formula for carbazole is C12H9N. Carbazoles are found in various natural sources, including coal tar and certain plants. They also have various industrial applications, such as in the production of dyes, pigments, and pharmaceuticals. In a medical context, carbazoles are not typically referred to as a single entity but rather as a class of compounds with potential therapeutic activity. Some carbazole derivatives have been studied for their anti-cancer, anti-inflammatory, and anti-microbial properties.

The sympathetic nervous system (SNS) is a part of the autonomic nervous system that operates largely below the level of consciousness, and it functions to produce appropriate physiological responses to perceived danger. It's often associated with the "fight or flight" response. The SNS uses nerve impulses to stimulate target organs, causing them to speed up (e.g., increased heart rate), prepare for action, or otherwise respond to stressful situations.

The sympathetic nervous system is activated due to stressful emotional or physical situations and it prepares the body for immediate actions. It dilates the pupils, increases heart rate and blood pressure, accelerates breathing, and slows down digestion. The primary neurotransmitter involved in this system is norepinephrine (also known as noradrenaline).

Oxygen consumption, also known as oxygen uptake, is the amount of oxygen that is consumed or utilized by the body during a specific period of time, usually measured in liters per minute (L/min). It is a common measurement used in exercise physiology and critical care medicine to assess an individual's aerobic metabolism and overall health status.

In clinical settings, oxygen consumption is often measured during cardiopulmonary exercise testing (CPET) to evaluate cardiovascular function, pulmonary function, and exercise capacity in patients with various medical conditions such as heart failure, chronic obstructive pulmonary disease (COPD), and other respiratory or cardiac disorders.

During exercise, oxygen is consumed by the muscles to generate energy through a process called oxidative phosphorylation. The amount of oxygen consumed during exercise can provide important information about an individual's fitness level, exercise capacity, and overall health status. Additionally, measuring oxygen consumption can help healthcare providers assess the effectiveness of treatments and rehabilitation programs in patients with various medical conditions.

Patient readmission refers to the event when a patient who was previously discharged from a hospital or healthcare facility returns for further treatment, often within a specified period. It is measured as a percentage of patients who are readmitted within a certain time frame, such as 30, 60, or 90 days after discharge. Readmissions may be planned or unplanned and can occur due to various reasons, including complications from the initial illness or treatment, inadequate post-discharge follow-up care, or the patient's inability to manage their health conditions effectively at home. High readmission rates are often considered an indicator of the quality of care provided during the initial hospitalization and may also signify potential issues with care coordination and transitions between healthcare settings.

Doppler echocardiography is a type of ultrasound test that uses high-frequency sound waves to produce detailed images of the heart and its blood vessels. It measures the direction and speed of blood flow in the heart and major blood vessels leading to and from the heart. This helps to evaluate various conditions such as valve problems, congenital heart defects, and heart muscle diseases.

In Doppler echocardiography, a small handheld device called a transducer is placed on the chest, which emits sound waves that bounce off the heart and blood vessels. The transducer then picks up the returning echoes, which are processed by a computer to create moving images of the heart.

The Doppler effect is used to measure the speed and direction of blood flow. This occurs when the frequency of the sound waves changes as they bounce off moving objects, such as red blood cells. By analyzing these changes, the ultrasound machine can calculate the velocity and direction of blood flow in different parts of the heart.

Doppler echocardiography is a non-invasive test that does not require any needles or dyes. It is generally safe and painless, although patients may experience some discomfort from the pressure applied by the transducer on the chest. The test usually takes about 30 to 60 minutes to complete.

Heart block is a cardiac condition characterized by the interruption of electrical impulse transmission from the atria (the upper chambers of the heart) to the ventricles (the lower chambers of the heart). This disruption can lead to abnormal heart rhythms, including bradycardia (a slower-than-normal heart rate), and in severe cases, can cause the heart to stop beating altogether. Heart block is typically caused by damage to the heart's electrical conduction system due to various factors such as aging, heart disease, or certain medications.

There are three types of heart block: first-degree, second-degree, and third-degree (also known as complete heart block). Each type has distinct electrocardiogram (ECG) findings and symptoms. Treatment for heart block depends on the severity of the condition and may include monitoring, medication, or implantation of a pacemaker to regulate the heart's electrical activity.

Ventricular pressure refers to the pressure within the ventricles, which are the lower chambers of the heart. In the left ventricle, the pressure measures the force that the blood exerts on the walls as it is pumped out to the rest of the body. In the right ventricle, the pressure measures the force of the blood being pumped into the pulmonary artery and ultimately to the lungs for oxygenation.

Normally, the left ventricular pressure ranges from 8-12 mmHg at rest when the heart is relaxed (diastolic pressure) and can increase up to 120-140 mmHg during contraction (systolic pressure). The right ventricular pressure is lower than the left, with a normal diastolic pressure of 0-6 mmHg and a systolic pressure ranging from 15-30 mmHg.

Abnormal ventricular pressures can indicate various heart conditions, such as heart failure, hypertension, or valvular heart disease. Regular monitoring of ventricular pressure is essential in managing these conditions and ensuring proper heart function.

Risk assessment in the medical context refers to the process of identifying, evaluating, and prioritizing risks to patients, healthcare workers, or the community related to healthcare delivery. It involves determining the likelihood and potential impact of adverse events or hazards, such as infectious diseases, medication errors, or medical devices failures, and implementing measures to mitigate or manage those risks. The goal of risk assessment is to promote safe and high-quality care by identifying areas for improvement and taking action to minimize harm.

Proportional hazards models are a type of statistical analysis used in medical research to investigate the relationship between covariates (predictor variables) and survival times. The most common application of proportional hazards models is in the Cox regression model, which is named after its developer, Sir David Cox.

In a proportional hazards model, the hazard rate or risk of an event occurring at a given time is assumed to be proportional to the hazard rate of a reference group, after adjusting for the covariates. This means that the ratio of the hazard rates between any two individuals remains constant over time, regardless of their survival times.

Mathematically, the hazard function h(t) at time t for an individual with a set of covariates X can be expressed as:

h(t|X) = h0(t) \* exp(β1X1 + β2X2 + ... + βpXp)

where h0(t) is the baseline hazard function, X1, X2, ..., Xp are the covariates, and β1, β2, ..., βp are the regression coefficients that represent the effect of each covariate on the hazard rate.

The assumption of proportionality is crucial in the interpretation of the results from a Cox regression model. If the assumption is violated, then the estimated regression coefficients may be biased and misleading. Therefore, it is important to test for the proportional hazards assumption before interpreting the results of a Cox regression analysis.

Cardiovascular agents are a class of medications that are used to treat various conditions related to the cardiovascular system, which includes the heart and blood vessels. These agents can be further divided into several subcategories based on their specific mechanisms of action and therapeutic effects. Here are some examples:

1. Antiarrhythmics: These drugs are used to treat abnormal heart rhythms or arrhythmias. They work by stabilizing the electrical activity of the heart and preventing irregular impulses from spreading through the heart muscle.
2. Antihypertensives: These medications are used to lower high blood pressure, also known as hypertension. There are several classes of antihypertensive drugs, including diuretics, beta-blockers, calcium channel blockers, and angiotensin-converting enzyme (ACE) inhibitors.
3. Anticoagulants: These drugs are used to prevent blood clots from forming or growing larger. They work by interfering with the coagulation cascade, which is a series of chemical reactions that lead to the formation of a blood clot.
4. Antiplatelet agents: These medications are used to prevent platelets in the blood from sticking together and forming clots. They work by inhibiting the aggregation of platelets, which are small cells in the blood that help form clots.
5. Lipid-lowering agents: These drugs are used to lower cholesterol and other fats in the blood. They work by reducing the production or absorption of cholesterol in the body or increasing the removal of cholesterol from the bloodstream. Examples include statins, bile acid sequestrants, and PCSK9 inhibitors.
6. Vasodilators: These medications are used to widen blood vessels and improve blood flow. They work by relaxing the smooth muscle in the walls of blood vessels, causing them to dilate or widen. Examples include nitrates, calcium channel blockers, and ACE inhibitors.
7. Inotropes: These drugs are used to increase the force of heart contractions. They work by increasing the sensitivity of heart muscle cells to calcium ions, which are necessary for muscle contraction.

These are just a few examples of cardiovascular medications that are used to treat various conditions related to the heart and blood vessels. It is important to note that these medications can have side effects and should be taken under the guidance of a healthcare provider.

Pulmonary wedge pressure, also known as pulmonary capillary wedge pressure (PCWP) or left heart filling pressure, is a measurement obtained during right heart catheterization. It reflects the pressure in the left atrium, which is an estimate of the diastolic pressure in the left ventricle. Normal PCWP ranges from 4 to 12 mmHg. Increased pulmonary wedge pressure can indicate heart failure or other cardiac disorders that affect the left side of the heart.

The double-blind method is a study design commonly used in research, including clinical trials, to minimize bias and ensure the objectivity of results. In this approach, both the participants and the researchers are unaware of which group the participants are assigned to, whether it be the experimental group or the control group. This means that neither the participants nor the researchers know who is receiving a particular treatment or placebo, thus reducing the potential for bias in the evaluation of outcomes. The assignment of participants to groups is typically done by a third party not involved in the study, and the codes are only revealed after all data have been collected and analyzed.

Mineralocorticoid receptor antagonists (MRAs) are a class of medications that block the action of aldosterone, a hormone produced by the adrenal glands. Aldosterone helps regulate sodium and potassium balance and blood pressure by binding to mineralocorticoid receptors in the kidneys, heart, blood vessels, and brain.

When aldosterone binds to these receptors, it promotes sodium retention and potassium excretion, which can lead to an increase in blood volume and blood pressure. MRAs work by blocking the binding of aldosterone to its receptors, thereby preventing these effects.

MRAs are primarily used to treat heart failure, hypertension, and kidney disease. By reducing sodium retention and increasing potassium excretion, MRAs can help lower blood pressure, reduce fluid buildup in the body, and improve heart function. Examples of MRAs include spironolactone and eplerenone.

Survival analysis is a branch of statistics that deals with the analysis of time to event data. It is used to estimate the time it takes for a certain event of interest to occur, such as death, disease recurrence, or treatment failure. The event of interest is called the "failure" event, and survival analysis estimates the probability of not experiencing the failure event until a certain point in time, also known as the "survival" probability.

Survival analysis can provide important information about the effectiveness of treatments, the prognosis of patients, and the identification of risk factors associated with the event of interest. It can handle censored data, which is common in medical research where some participants may drop out or be lost to follow-up before the event of interest occurs.

Survival analysis typically involves estimating the survival function, which describes the probability of surviving beyond a certain time point, as well as hazard functions, which describe the instantaneous rate of failure at a given time point. Other important concepts in survival analysis include median survival times, restricted mean survival times, and various statistical tests to compare survival curves between groups.

Metoprolol is a type of medication known as a beta blocker. According to the US National Library of Medicine's MedlinePlus, metoprolol is used to treat high blood pressure, angina (chest pain), and heart conditions that may occur after a heart attack. It works by blocking the action of certain natural chemicals in your body, such as epinephrine, on the heart and blood vessels. This helps to reduce the heart's workload, lower its blood pressure, and regulate its rhythm.

Metoprolol is available under various brand names, including Lopressor and Toprol-XL. It can be taken orally as a tablet or an extended-release capsule. As with any medication, metoprolol should be used under the supervision of a healthcare provider, who can monitor its effectiveness and potential side effects.

It is important to note that this definition is intended to provide a general overview of the medical use of metoprolol and should not be considered a substitute for professional medical advice.

Spironolactone is a prescription medication that belongs to a class of drugs known as potassium-sparing diuretics. It works by blocking the action of aldosterone, a hormone that helps regulate sodium and potassium balance in your body. This results in increased urine production (diuresis) and decreased salt and fluid retention.

Spironolactone is primarily used to treat edema (fluid buildup) associated with heart failure, liver cirrhosis, or kidney disease. It's also prescribed for the treatment of high blood pressure and primary hyperaldosteronism, a condition where the adrenal glands produce too much aldosterone.

Furthermore, spironolactone is used off-label to treat conditions such as acne, hirsutism (excessive hair growth in women), and hormone-sensitive breast cancer in postmenopausal women.

It's important to note that spironolactone can cause increased potassium levels in the blood (hyperkalemia) and should be used with caution in patients with kidney impairment or those taking other medications that affect potassium balance. Regular monitoring of electrolyte levels, including potassium and sodium, is essential during spironolactone therapy.

"Failure to Thrive" is a medical term used to describe a condition in infants and children who are not growing and gaining weight as expected. It is typically defined as significant deviation from normal growth patterns, such as poor weight gain or loss, slow increase in length/height, and delayed developmental milestones. The condition can have various causes, including medical, psychological, social, and environmental factors. Early identification and intervention are crucial to address the underlying cause and promote healthy growth and development.

A cohort study is a type of observational study in which a group of individuals who share a common characteristic or exposure are followed up over time to determine the incidence of a specific outcome or outcomes. The cohort, or group, is defined based on the exposure status (e.g., exposed vs. unexposed) and then monitored prospectively to assess for the development of new health events or conditions.

Cohort studies can be either prospective or retrospective in design. In a prospective cohort study, participants are enrolled and followed forward in time from the beginning of the study. In contrast, in a retrospective cohort study, researchers identify a cohort that has already been assembled through medical records, insurance claims, or other sources and then look back in time to assess exposure status and health outcomes.

Cohort studies are useful for establishing causality between an exposure and an outcome because they allow researchers to observe the temporal relationship between the two. They can also provide information on the incidence of a disease or condition in different populations, which can be used to inform public health policy and interventions. However, cohort studies can be expensive and time-consuming to conduct, and they may be subject to bias if participants are not representative of the population or if there is loss to follow-up.

Medical survival rate is a statistical measure used to determine the percentage of patients who are still alive for a specific period of time after their diagnosis or treatment for a certain condition or disease. It is often expressed as a five-year survival rate, which refers to the proportion of people who are alive five years after their diagnosis. Survival rates can be affected by many factors, including the stage of the disease at diagnosis, the patient's age and overall health, the effectiveness of treatment, and other health conditions that the patient may have. It is important to note that survival rates are statistical estimates and do not necessarily predict an individual patient's prognosis.

An artificial pacemaker is a medical device that uses electrical impulses to regulate the beating of the heart. It is typically used when the heart's natural pacemaker, the sinoatrial node, is not functioning properly and the heart rate is too slow or irregular. The pacemaker consists of a small generator that contains a battery and electronic circuits, which are connected to one or more electrodes that are placed in the heart.

The generator sends electrical signals through the electrodes to stimulate the heart muscle and cause it to contract, thereby maintaining a regular heart rhythm. Artificial pacemakers can be programmed to deliver electrical impulses at a specific rate or in response to the body's needs. They are typically implanted in the chest during a surgical procedure and can last for many years before needing to be replaced.

Artificial pacemakers are an effective treatment for various types of bradycardia, which is a heart rhythm disorder characterized by a slow heart rate. Pacemakers can significantly improve symptoms associated with bradycardia, such as fatigue, dizziness, shortness of breath, and fainting spells.

Blood pressure is the force exerted by circulating blood on the walls of the blood vessels. It is measured in millimeters of mercury (mmHg) and is given as two figures:

1. Systolic pressure: This is the pressure when the heart pushes blood out into the arteries.
2. Diastolic pressure: This is the pressure when the heart rests between beats, allowing it to fill with blood.

Normal blood pressure for adults is typically around 120/80 mmHg, although this can vary slightly depending on age, sex, and other factors. High blood pressure (hypertension) is generally considered to be a reading of 130/80 mmHg or higher, while low blood pressure (hypotension) is usually defined as a reading below 90/60 mmHg. It's important to note that blood pressure can fluctuate throughout the day and may be affected by factors such as stress, physical activity, and medication use.

Cardiac Resynchronization Therapy (CRT) is a medical treatment for heart failure that involves the use of a specialized device, called a biventricular pacemaker or a cardiac resynchronization therapy device, to help coordinate the timing of contractions between the left and right ventricles of the heart.

In a healthy heart, the ventricles contract in a coordinated manner, with the left ventricle contracting slightly before the right ventricle. However, in some people with heart failure, the electrical signals that control the contraction of the heart become disrupted, causing the ventricles to contract at different times. This is known as ventricular dyssynchrony and can lead to reduced pumping efficiency and further worsening of heart failure symptoms.

CRT works by delivering small electrical impulses to both ventricles simultaneously or in a coordinated manner, which helps restore normal synchrony and improve the efficiency of the heart's pumping function. This can lead to improved symptoms, reduced hospitalizations, and increased survival rates in some people with heart failure.

CRT is typically recommended for people with moderate to severe heart failure who have evidence of ventricular dyssynchrony and a wide QRS complex on an electrocardiogram (ECG). The procedure involves the implantation of a small device under the skin, usually in the upper chest area, which is connected to leads that are placed in the heart through veins.

While CRT can be an effective treatment for some people with heart failure, it is not without risks and potential complications, such as infection, bleeding, or damage to blood vessels or nerves. Therefore, careful consideration should be given to the potential benefits and risks of CRT before deciding whether it is appropriate for a particular individual.

Coronary artery disease, often simply referred to as coronary disease, is a condition in which the blood vessels that supply oxygen-rich blood to the heart become narrowed or blocked due to the buildup of fatty deposits called plaques. This can lead to chest pain (angina), shortness of breath, or in severe cases, a heart attack.

The medical definition of coronary artery disease is:

A condition characterized by the accumulation of atheromatous plaques in the walls of the coronary arteries, leading to decreased blood flow and oxygen supply to the myocardium (heart muscle). This can result in symptoms such as angina pectoris, shortness of breath, or arrhythmias, and may ultimately lead to myocardial infarction (heart attack) or heart failure.

Risk factors for coronary artery disease include age, smoking, high blood pressure, high cholesterol, diabetes, obesity, physical inactivity, and a family history of the condition. Lifestyle changes such as quitting smoking, exercising regularly, eating a healthy diet, and managing stress can help reduce the risk of developing coronary artery disease. Medical treatments may include medications to control blood pressure, cholesterol levels, or irregular heart rhythms, as well as procedures such as angioplasty or bypass surgery to improve blood flow to the heart.

Electrocardiography (ECG or EKG) is a medical procedure that records the electrical activity of the heart. It provides a graphic representation of the electrical changes that occur during each heartbeat. The resulting tracing, called an electrocardiogram, can reveal information about the heart's rate and rhythm, as well as any damage to its cells or abnormalities in its conduction system.

During an ECG, small electrodes are placed on the skin of the chest, arms, and legs. These electrodes detect the electrical signals produced by the heart and transmit them to a machine that amplifies and records them. The procedure is non-invasive, painless, and quick, usually taking only a few minutes.

ECGs are commonly used to diagnose and monitor various heart conditions, including arrhythmias, coronary artery disease, heart attacks, and electrolyte imbalances. They can also be used to evaluate the effectiveness of certain medications or treatments.

Norepinephrine, also known as noradrenaline, is a neurotransmitter and a hormone that is primarily produced in the adrenal glands and is released into the bloodstream in response to stress or physical activity. It plays a crucial role in the "fight-or-flight" response by preparing the body for action through increasing heart rate, blood pressure, respiratory rate, and glucose availability.

As a neurotransmitter, norepinephrine is involved in regulating various functions of the nervous system, including attention, perception, motivation, and arousal. It also plays a role in modulating pain perception and responding to stressful or emotional situations.

In medical settings, norepinephrine is used as a vasopressor medication to treat hypotension (low blood pressure) that can occur during septic shock, anesthesia, or other critical illnesses. It works by constricting blood vessels and increasing heart rate, which helps to improve blood pressure and perfusion of vital organs.

An acute disease is a medical condition that has a rapid onset, develops quickly, and tends to be short in duration. Acute diseases can range from minor illnesses such as a common cold or flu, to more severe conditions such as pneumonia, meningitis, or a heart attack. These types of diseases often have clear symptoms that are easy to identify, and they may require immediate medical attention or treatment.

Acute diseases are typically caused by an external agent or factor, such as a bacterial or viral infection, a toxin, or an injury. They can also be the result of a sudden worsening of an existing chronic condition. In general, acute diseases are distinct from chronic diseases, which are long-term medical conditions that develop slowly over time and may require ongoing management and treatment.

Examples of acute diseases include:

* Acute bronchitis: a sudden inflammation of the airways in the lungs, often caused by a viral infection.
* Appendicitis: an inflammation of the appendix that can cause severe pain and requires surgical removal.
* Gastroenteritis: an inflammation of the stomach and intestines, often caused by a viral or bacterial infection.
* Migraine headaches: intense headaches that can last for hours or days, and are often accompanied by nausea, vomiting, and sensitivity to light and sound.
* Myocardial infarction (heart attack): a sudden blockage of blood flow to the heart muscle, often caused by a buildup of plaque in the coronary arteries.
* Pneumonia: an infection of the lungs that can cause coughing, chest pain, and difficulty breathing.
* Sinusitis: an inflammation of the sinuses, often caused by a viral or bacterial infection.

It's important to note that while some acute diseases may resolve on their own with rest and supportive care, others may require medical intervention or treatment to prevent complications and promote recovery. If you are experiencing symptoms of an acute disease, it is always best to seek medical attention to ensure proper diagnosis and treatment.

Vasodilator agents are pharmacological substances that cause the relaxation or widening of blood vessels by relaxing the smooth muscle in the vessel walls. This results in an increase in the diameter of the blood vessels, which decreases vascular resistance and ultimately reduces blood pressure. Vasodilators can be further classified based on their site of action:

1. Systemic vasodilators: These agents cause a generalized relaxation of the smooth muscle in the walls of both arteries and veins, resulting in a decrease in peripheral vascular resistance and preload (the volume of blood returning to the heart). Examples include nitroglycerin, hydralazine, and calcium channel blockers.
2. Arterial vasodilators: These agents primarily affect the smooth muscle in arterial vessel walls, leading to a reduction in afterload (the pressure against which the heart pumps blood). Examples include angiotensin-converting enzyme (ACE) inhibitors, angiotensin receptor blockers (ARBs), and direct vasodilators like sodium nitroprusside.
3. Venous vasodilators: These agents primarily affect the smooth muscle in venous vessel walls, increasing venous capacitance and reducing preload. Examples include nitroglycerin and other organic nitrates.

Vasodilator agents are used to treat various cardiovascular conditions such as hypertension, heart failure, angina, and pulmonary arterial hypertension. It is essential to monitor their use carefully, as excessive vasodilation can lead to orthostatic hypotension, reflex tachycardia, or fluid retention.

Atrial fibrillation (A-tre-al fi-bru-la'shun) is a type of abnormal heart rhythm characterized by rapid and irregular beating of the atria, the upper chambers of the heart. In this condition, the electrical signals that coordinate heartbeats don't function properly, causing the atria to quiver instead of contracting effectively. As a result, blood may not be pumped efficiently into the ventricles, which can lead to blood clots, stroke, and other complications. Atrial fibrillation is a common type of arrhythmia and can cause symptoms such as palpitations, shortness of breath, fatigue, and dizziness. It can be caused by various factors, including heart disease, high blood pressure, age, and genetics. Treatment options include medications, electrical cardioversion, and surgical procedures to restore normal heart rhythm.

Sudden cardiac death (SCD) is a sudden, unexpected natural death caused by the cessation of cardiac activity. It is often caused by cardiac arrhythmias, particularly ventricular fibrillation, and is often associated with underlying heart disease, although it can occur in people with no known heart condition. SCD is typically defined as a natural death due to cardiac causes that occurs within one hour of the onset of symptoms, or if the individual was last seen alive in a normal state of health, it can be defined as occurring within 24 hours.

It's important to note that sudden cardiac arrest (SCA) is different from SCD, although they are related. SCA refers to the sudden cessation of cardiac activity, which if not treated immediately can lead to SCD.

Disease progression is the worsening or advancement of a medical condition over time. It refers to the natural course of a disease, including its development, the severity of symptoms and complications, and the impact on the patient's overall health and quality of life. Understanding disease progression is important for developing appropriate treatment plans, monitoring response to therapy, and predicting outcomes.

The rate of disease progression can vary widely depending on the type of medical condition, individual patient factors, and the effectiveness of treatment. Some diseases may progress rapidly over a short period of time, while others may progress more slowly over many years. In some cases, disease progression may be slowed or even halted with appropriate medical interventions, while in other cases, the progression may be inevitable and irreversible.

In clinical practice, healthcare providers closely monitor disease progression through regular assessments, imaging studies, and laboratory tests. This information is used to guide treatment decisions and adjust care plans as needed to optimize patient outcomes and improve quality of life.

Fibrosis is a pathological process characterized by the excessive accumulation and/or altered deposition of extracellular matrix components, particularly collagen, in various tissues and organs. This results in the formation of fibrous scar tissue that can impair organ function and structure. Fibrosis can occur as a result of chronic inflammation, tissue injury, or abnormal repair mechanisms, and it is a common feature of many diseases, including liver cirrhosis, lung fibrosis, heart failure, and kidney disease.

In medical terms, fibrosis is defined as:

"The process of producing scar tissue (consisting of collagen) in response to injury or chronic inflammation in normal connective tissue. This can lead to the thickening and stiffening of affected tissues and organs, impairing their function."

Cardio-renal syndrome (CRS) is a term used to describe the interplay between heart and kidney dysfunction, where acute or chronic damage in one organ can lead to dysfunction in the other. It is typically classified into five subtypes based on the primary organ dysfunction and the temporal relationship between cardiac and renal dysfunction.

The medical definition of CRS is:

A complex pathophysiological disorder involving heart and kidney interactions, where acute or chronic dysfunction in one organ can lead to dysfunction in the other. It is characterized by a spectrum of clinical presentations ranging from subtle biochemical changes to overt cardiac or renal failure. The syndrome encompasses five subtypes based on the primary organ dysfunction and the temporal relationship between heart and kidney involvement:

1. CRS Type 1 (Acute Cardio-Renal Syndrome): Acute worsening of heart function leading to acute kidney injury (AKI)
2. CRS Type 2 (Chronic Cardio-Renal Syndrome): Chronic abnormalities in cardiac function causing progressive and chronic kidney disease (CKD)
3. CRS Type 3 (Acute Reno-Cardiac Syndrome): Sudden worsening of renal function leading to acute cardiac injury or dysfunction
4. CRS Type 4 (Chronic Reno-Cardiac Syndrome): Chronic kidney disease contributing to decreased cardiac function, heart failure, and/or cardiovascular morbidity and mortality
5. CRS Type 5 (Secondary Cardio-Renal Syndrome): Systemic conditions causing simultaneous dysfunction in both the heart and kidneys

The pathophysiology of CRS involves complex interactions between neurohormonal, inflammatory, and hemodynamic factors that can lead to a vicious cycle of worsening organ function. Early recognition and management of CRS are crucial for improving patient outcomes.

Left ventricular hypertrophy (LVH) is a medical condition in which the left ventricle of the heart undergoes an enlargement or thickening of its muscle wall. The left ventricle is the main pumping chamber of the heart that supplies oxygenated blood to the rest of the body.

In response to increased workload, such as hypertension (high blood pressure), aortic valve stenosis, or athletic training, the left ventricular muscle may thicken and enlarge. This process is called "hypertrophy." While some degree of hypertrophy can be adaptive in athletes, significant or excessive hypertrophy can lead to impaired relaxation and filling of the left ventricle during diastole, reduced pumping capacity, and decreased compliance of the chamber.

Left ventricular hypertrophy is often asymptomatic initially but can increase the risk of various cardiovascular complications such as heart failure, arrhythmias, myocardial infarction (heart attack), and sudden cardiac death over time. It is typically diagnosed through imaging techniques like echocardiography or cardiac MRI and confirmed by measuring the thickness of the left ventricular wall.

Cardiac arrhythmias are abnormal heart rhythms that result from disturbances in the electrical conduction system of the heart. The heart's normal rhythm is controlled by an electrical signal that originates in the sinoatrial (SA) node, located in the right atrium. This signal travels through the atrioventricular (AV) node and into the ventricles, causing them to contract and pump blood throughout the body.

An arrhythmia occurs when there is a disruption in this electrical pathway or when the heart's natural pacemaker produces an abnormal rhythm. This can cause the heart to beat too fast (tachycardia), too slow (bradycardia), or irregularly.

There are several types of cardiac arrhythmias, including:

1. Atrial fibrillation: A rapid and irregular heartbeat that starts in the atria (the upper chambers of the heart).
2. Atrial flutter: A rapid but regular heartbeat that starts in the atria.
3. Supraventricular tachycardia (SVT): A rapid heartbeat that starts above the ventricles, usually in the atria or AV node.
4. Ventricular tachycardia: A rapid and potentially life-threatening heart rhythm that originates in the ventricles.
5. Ventricular fibrillation: A chaotic and disorganized electrical activity in the ventricles, which can be fatal if not treated immediately.
6. Heart block: A delay or interruption in the conduction of electrical signals from the atria to the ventricles.

Cardiac arrhythmias can cause various symptoms, such as palpitations, dizziness, shortness of breath, chest pain, and fatigue. In some cases, they may not cause any symptoms and go unnoticed. However, if left untreated, certain types of arrhythmias can lead to serious complications, including stroke, heart failure, or even sudden cardiac death.

Treatment for cardiac arrhythmias depends on the type, severity, and underlying causes. Options may include lifestyle changes, medications, cardioversion (electrical shock therapy), catheter ablation, implantable devices such as pacemakers or defibrillators, and surgery. It is essential to consult a healthcare professional for proper evaluation and management of cardiac arrhythmias.

The Kaplan-Meier estimate is a statistical method used to calculate the survival probability over time in a population. It is commonly used in medical research to analyze time-to-event data, such as the time until a patient experiences a specific event like disease progression or death. The Kaplan-Meier estimate takes into account censored data, which occurs when some individuals are lost to follow-up before experiencing the event of interest.

The method involves constructing a survival curve that shows the proportion of subjects still surviving at different time points. At each time point, the survival probability is calculated as the product of the conditional probabilities of surviving from one time point to the next. The Kaplan-Meier estimate provides an unbiased and consistent estimator of the survival function, even when censoring is present.

In summary, the Kaplan-Meier estimate is a crucial tool in medical research for analyzing time-to-event data and estimating survival probabilities over time while accounting for censored observations.

Acute liver failure is a sudden and severe loss of liver function that occurs within a few days or weeks. It can be caused by various factors such as drug-induced liver injury, viral hepatitis, or metabolic disorders. In acute liver failure, the liver cannot perform its vital functions, including protein synthesis, detoxification, and metabolism of carbohydrates, fats, and proteins.

The symptoms of acute liver failure include jaundice (yellowing of the skin and eyes), coagulopathy (bleeding disorders), hepatic encephalopathy (neurological symptoms such as confusion, disorientation, and coma), and elevated levels of liver enzymes in the blood. Acute liver failure is a medical emergency that requires immediate hospitalization and treatment, which may include medications, supportive care, and liver transplantation.

Sarcoplasmic Reticulum Calcium-Transporting ATPases (SERCA) are a type of calcium pumps that are located in the sarcoplasmic reticulum (SR) of muscle cells. They play a crucial role in excitation-contraction coupling, which is the process by which muscles contract and relax.

During muscle contraction, calcium ions (Ca2+) are released from the SR into the cytosol, triggering muscle fiber contraction. After the muscle fiber has contracted, Ca2+ must be actively transported back into the SR to allow the muscle fiber to relax. This is where SERCA comes in.

SERCA uses energy from ATP hydrolysis to transport Ca2+ against its concentration gradient from the cytosol back into the lumen of the SR. By doing so, it helps maintain low cytosolic Ca2+ concentrations and high SR Ca2+ concentrations, which are necessary for muscle relaxation and subsequent contraction.

There are several isoforms of SERCA, each with slightly different properties and tissue distributions. For example, SERCA1 is primarily found in fast-twitch skeletal muscle fibers, while SERCA2a is found in both slow-twitch and fast-twitch skeletal muscle fibers as well as cardiac muscle. Mutations in the genes encoding these pumps can lead to various muscle disorders, including certain forms of muscular dystrophy and heart failure.

Dyspnea is defined as difficulty or discomfort in breathing, often described as shortness of breath. It can range from mild to severe, and may occur during rest, exercise, or at any time. Dyspnea can be caused by various medical conditions, including heart and lung diseases, anemia, and neuromuscular disorders. It is important to seek medical attention if experiencing dyspnea, as it can be a sign of a serious underlying condition.

Myocarditis is an inflammation of the myocardium, which is the middle layer of the heart wall. The myocardium is composed of cardiac muscle cells and is responsible for the heart's pumping function. Myocarditis can be caused by various infectious and non-infectious agents, including viruses, bacteria, fungi, parasites, autoimmune diseases, toxins, and drugs.

In myocarditis, the inflammation can damage the cardiac muscle cells, leading to decreased heart function, arrhythmias (irregular heart rhythms), and in severe cases, heart failure or even sudden death. Symptoms of myocarditis may include chest pain, shortness of breath, fatigue, palpitations, and swelling in the legs, ankles, or abdomen.

The diagnosis of myocarditis is often based on a combination of clinical presentation, laboratory tests, electrocardiogram (ECG), echocardiography, cardiac magnetic resonance imaging (MRI), and endomyocardial biopsy. Treatment depends on the underlying cause and severity of the disease and may include medications to support heart function, reduce inflammation, control arrhythmias, and prevent further damage to the heart muscle. In some cases, hospitalization and intensive care may be necessary.

Sprague-Dawley rats are a strain of albino laboratory rats that are widely used in scientific research. They were first developed by researchers H.H. Sprague and R.C. Dawley in the early 20th century, and have since become one of the most commonly used rat strains in biomedical research due to their relatively large size, ease of handling, and consistent genetic background.

Sprague-Dawley rats are outbred, which means that they are genetically diverse and do not suffer from the same limitations as inbred strains, which can have reduced fertility and increased susceptibility to certain diseases. They are also characterized by their docile nature and low levels of aggression, making them easier to handle and study than some other rat strains.

These rats are used in a wide variety of research areas, including toxicology, pharmacology, nutrition, cancer, and behavioral studies. Because they are genetically diverse, Sprague-Dawley rats can be used to model a range of human diseases and conditions, making them an important tool in the development of new drugs and therapies.

Natriuretic agents are substances that increase the secretion of sodium in the urine (natriuresis), which subsequently leads to a decrease in extracellular fluid volume and blood pressure. These agents can be endogenous, such as atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP), which are produced by the heart in response to increased stretching of cardiac muscle cells due to volume or pressure overload. Excessive production of these endogenous natriuretic peptides can contribute to the pathophysiology of heart failure.

Exogenous natriuretic agents, such as loop diuretics (e.g., furosemide), thiazide diuretics, and potassium-sparing diuretics, are used in clinical practice to treat conditions associated with fluid overload, like heart failure, liver cirrhosis, and kidney diseases. These medications act on different parts of the nephron to inhibit sodium reabsorption, thereby promoting natriuresis and diuresis.

In epidemiology, the incidence of a disease is defined as the number of new cases of that disease within a specific population over a certain period of time. It is typically expressed as a rate, with the number of new cases in the numerator and the size of the population at risk in the denominator. Incidence provides information about the risk of developing a disease during a given time period and can be used to compare disease rates between different populations or to monitor trends in disease occurrence over time.

Anti-arrhythmia agents are a class of medications used to treat abnormal heart rhythms or arrhythmias. These drugs work by modifying the electrical activity of the heart to restore and maintain a normal heart rhythm. There are several types of anti-arrhythmia agents, including:

1. Sodium channel blockers: These drugs slow down the conduction of electrical signals in the heart, which helps to reduce rapid or irregular heartbeats. Examples include flecainide, propafenone, and quinidine.
2. Beta-blockers: These medications work by blocking the effects of adrenaline on the heart, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include metoprolol, atenolol, and esmolol.
3. Calcium channel blockers: These drugs block the entry of calcium into heart muscle cells, which helps to slow down the heart rate and reduce the force of heart contractions. Examples include verapamil and diltiazem.
4. Potassium channel blockers: These medications work by prolonging the duration of the heart's electrical cycle, which helps to prevent abnormal rhythms. Examples include amiodarone and sotalol.
5. Digoxin: This drug increases the force of heart contractions and slows down the heart rate, which can help to restore a normal rhythm in certain types of arrhythmias.

It's important to note that anti-arrhythmia agents can have significant side effects and should only be prescribed by a healthcare professional who has experience in managing arrhythmias. Close monitoring is necessary to ensure the medication is working effectively and not causing any adverse effects.

A hydrazone is not a medical term per se, but rather a chemical compound. However, it's important for medical professionals to understand the properties and reactions of various chemical compounds, including hydrazones, in the context of pharmacology, toxicology, and medicinal chemistry. Here's a general definition:

Hydrazones are organic compounds that contain a functional group with the structure R1R2C=NNR3, where R1, R2, and R3 are hydrogen atoms or organic groups. They are formed by the condensation reaction of a carbonyl compound (aldehyde or ketone) with hydrazine or its derivatives. Hydrazones can exhibit various biological activities, such as antibacterial, antifungal, and anticancer properties. Some hydrazones are also used as intermediates in the synthesis of pharmaceuticals and other organic compounds.

Cheyne-Stokes respiration is a pattern of breathing characterized by cyclical changes in the depth and rate of respirations. It is often associated with various medical conditions that affect the brainstem, such as stroke, brain injury, or certain neurological disorders.

In Cheyne-Stokes respiration, the individual's breathing starts with a series of deeper and faster breaths (hyperventilation), which gradually become shallower and slower (hypoventilation). This cycle repeats every few minutes, resulting in a pattern of waxing and waning of the depth and rate of respirations.

The underlying mechanism for Cheyne-Stokes respiration is related to the regulation of breathing by the brainstem. When there are abnormalities in this area, it can lead to instability in the control of breathing, resulting in the cyclical pattern of hyperventilation and hypoventilation.

Cheyne-Stokes respiration can be a sign of serious underlying medical conditions, and it is important to seek medical attention if you or someone else experiences this type of breathing pattern. Treatment may involve addressing the underlying cause, such as managing heart failure or reducing intracranial pressure in patients with brain injury or stroke.

I'm sorry for any confusion, but "United States" is a geopolitical entity, specifically the name of the country consisting of 50 states, and it is not a medical term or concept. Therefore, I can't provide a medical definition for it. If you have any questions related to health, medicine, or biology, I would be happy to try to help answer those!

Natriuretic peptides are a group of hormones that help regulate the balance of sodium and water in the body, as well as blood volume and blood pressure. They are produced by the heart and other tissues in response to stretching or distension of the cells due to increased fluid volume.

There are several types of natriuretic peptides, including:

1. Atrial natriuretic peptide (ANP): This hormone is produced by the atria of the heart in response to stretching of the atrial walls caused by increased blood volume. ANP promotes sodium and water excretion by the kidneys, which helps lower blood pressure and reduce fluid volume.
2. Brain natriuretic peptide (BNP): This hormone is produced by the ventricles of the heart in response to stretching of the ventricular walls caused by increased blood volume or pressure. BNP also promotes sodium and water excretion by the kidneys, as well as dilating blood vessels and reducing the force of heart contractions.
3. C-type natriuretic peptide (CNP): This hormone is produced by endothelial cells lining the blood vessels and has similar effects to ANP and BNP, but its main role is to regulate bone growth and development.

Natriuretic peptides have important diagnostic and therapeutic implications in various medical conditions, such as heart failure, hypertension, and kidney disease. Elevated levels of natriuretic peptides may indicate the presence of cardiac dysfunction or damage, while administering synthetic forms of these hormones has been shown to have beneficial effects on blood pressure, fluid balance, and cardiovascular function.

"Wistar rats" are a strain of albino rats that are widely used in laboratory research. They were developed at the Wistar Institute in Philadelphia, USA, and were first introduced in 1906. Wistar rats are outbred, which means that they are genetically diverse and do not have a fixed set of genetic characteristics like inbred strains.

Wistar rats are commonly used as animal models in biomedical research because of their size, ease of handling, and relatively low cost. They are used in a wide range of research areas, including toxicology, pharmacology, nutrition, cancer, cardiovascular disease, and behavioral studies. Wistar rats are also used in safety testing of drugs, medical devices, and other products.

Wistar rats are typically larger than many other rat strains, with males weighing between 500-700 grams and females weighing between 250-350 grams. They have a lifespan of approximately 2-3 years. Wistar rats are also known for their docile and friendly nature, making them easy to handle and work with in the laboratory setting.

Adrenergic receptors are a type of G protein-coupled receptor that binds and responds to catecholamines, such as epinephrine (adrenaline) and norepinephrine (noradrenaline). Beta adrenergic receptors (β-adrenergic receptors) are a subtype of adrenergic receptors that include three distinct subclasses: β1, β2, and β3. These receptors are widely distributed throughout the body and play important roles in various physiological functions, including cardiovascular regulation, bronchodilation, lipolysis, and glucose metabolism.

β1-adrenergic receptors are primarily located in the heart and regulate cardiac contractility, chronotropy (heart rate), and relaxation. β2-adrenergic receptors are found in various tissues, including the lungs, vascular smooth muscle, liver, and skeletal muscle. They mediate bronchodilation, vasodilation, glycogenolysis, and lipolysis. β3-adrenergic receptors are mainly expressed in adipose tissue, where they stimulate lipolysis and thermogenesis.

Agonists of β-adrenergic receptors include catecholamines like epinephrine and norepinephrine, as well as synthetic drugs such as dobutamine (a β1-selective agonist) and albuterol (a non-selective β2-agonist). Antagonists of β-adrenergic receptors are commonly used in the treatment of various conditions, including hypertension, angina pectoris, heart failure, and asthma. Examples of β-blockers include metoprolol (a β1-selective antagonist) and carvedilol (a non-selective β-blocker with additional α1-adrenergic receptor blocking activity).

Induced heart arrest, also known as controlled cardiac arrest or planned cardiac arrest, is a deliberate medical intervention where cardiac activity is temporarily stopped through the use of medications or electrical disruption. This procedure is typically carried out during a surgical procedure, such as open-heart surgery, where the heart needs to be stilled to allow surgeons to work on it safely.

The most common method used to induce heart arrest is by administering a medication called potassium chloride, which stops the heart's electrical activity. Alternatively, an electrical shock may be delivered to the heart to achieve the same effect. Once the procedure is complete, the heart can be restarted using various resuscitation techniques, such as defibrillation or medication administration.

It's important to note that induced heart arrest is a carefully monitored and controlled medical procedure carried out by trained healthcare professionals in a hospital setting. It should not be confused with sudden cardiac arrest, which is an unexpected and often unpredictable event that occurs outside of a medical setting.

Cardiac output is a measure of the amount of blood that is pumped by the heart in one minute. It is defined as the product of stroke volume (the amount of blood pumped by the left ventricle during each contraction) and heart rate (the number of contractions per minute). Normal cardiac output at rest for an average-sized adult is about 5 to 6 liters per minute. Cardiac output can be increased during exercise or other conditions that require more blood flow, such as during illness or injury. It can be measured noninvasively using techniques such as echocardiography or invasively through a catheter placed in the heart.

Comorbidity is the presence of one or more additional health conditions or diseases alongside a primary illness or condition. These co-occurring health issues can have an impact on the treatment plan, prognosis, and overall healthcare management of an individual. Comorbidities often interact with each other and the primary condition, leading to more complex clinical situations and increased healthcare needs. It is essential for healthcare professionals to consider and address comorbidities to provide comprehensive care and improve patient outcomes.

A kidney, in medical terms, is one of two bean-shaped organs located in the lower back region of the body. They are essential for maintaining homeostasis within the body by performing several crucial functions such as:

1. Regulation of water and electrolyte balance: Kidneys help regulate the amount of water and various electrolytes like sodium, potassium, and calcium in the bloodstream to maintain a stable internal environment.

2. Excretion of waste products: They filter waste products from the blood, including urea (a byproduct of protein metabolism), creatinine (a breakdown product of muscle tissue), and other harmful substances that result from normal cellular functions or external sources like medications and toxins.

3. Endocrine function: Kidneys produce several hormones with important roles in the body, such as erythropoietin (stimulates red blood cell production), renin (regulates blood pressure), and calcitriol (activated form of vitamin D that helps regulate calcium homeostasis).

4. pH balance regulation: Kidneys maintain the proper acid-base balance in the body by excreting either hydrogen ions or bicarbonate ions, depending on whether the blood is too acidic or too alkaline.

5. Blood pressure control: The kidneys play a significant role in regulating blood pressure through the renin-angiotensin-aldosterone system (RAAS), which constricts blood vessels and promotes sodium and water retention to increase blood volume and, consequently, blood pressure.

Anatomically, each kidney is approximately 10-12 cm long, 5-7 cm wide, and 3 cm thick, with a weight of about 120-170 grams. They are surrounded by a protective layer of fat and connected to the urinary system through the renal pelvis, ureters, bladder, and urethra.

Cardiology is a branch of medicine that deals with the diagnosis and treatment of diseases and disorders of the heart and blood vessels. It encompasses the study of the normal functioning of the heart, the investigation and diagnosis of heart disease, and the treatment of various cardiovascular conditions through both surgical and non-surgical interventions. Cardiologists are medical professionals who specialize in this field, providing comprehensive care for patients with conditions such as coronary artery disease, congenital heart defects, valvular heart disease, electrophysiology disorders, and hypertension, among others. They work closely with other healthcare providers to manage cardiovascular risk factors, optimize overall cardiovascular health, and improve patients' quality of life.

Vascular resistance is a measure of the opposition to blood flow within a vessel or a group of vessels, typically expressed in units of mmHg/(mL/min) or sometimes as dynes*sec/cm^5. It is determined by the diameter and length of the vessels, as well as the viscosity of the blood flowing through them. In general, a decrease in vessel diameter, an increase in vessel length, or an increase in blood viscosity will result in an increase in vascular resistance, while an increase in vessel diameter, a decrease in vessel length, or a decrease in blood viscosity will result in a decrease in vascular resistance. Vascular resistance is an important concept in the study of circulation and cardiovascular physiology because it plays a key role in determining blood pressure and blood flow within the body.

Renal insufficiency, also known as kidney failure, is a medical condition in which the kidneys are unable to properly filter waste products and excess fluids from the blood. This results in a buildup of these substances in the body, which can cause a variety of symptoms such as weakness, shortness of breath, and fluid retention. Renal insufficiency can be acute, meaning it comes on suddenly, or chronic, meaning it develops over time. It is typically diagnosed through blood tests, urine tests, and imaging studies. Treatment may include medications to control symptoms, dietary changes, and in severe cases, dialysis or a kidney transplant.

"Age factors" refer to the effects, changes, or differences that age can have on various aspects of health, disease, and medical care. These factors can encompass a wide range of issues, including:

1. Physiological changes: As people age, their bodies undergo numerous physical changes that can affect how they respond to medications, illnesses, and medical procedures. For example, older adults may be more sensitive to certain drugs or have weaker immune systems, making them more susceptible to infections.
2. Chronic conditions: Age is a significant risk factor for many chronic diseases, such as heart disease, diabetes, cancer, and arthritis. As a result, age-related medical issues are common and can impact treatment decisions and outcomes.
3. Cognitive decline: Aging can also lead to cognitive changes, including memory loss and decreased decision-making abilities. These changes can affect a person's ability to understand and comply with medical instructions, leading to potential complications in their care.
4. Functional limitations: Older adults may experience physical limitations that impact their mobility, strength, and balance, increasing the risk of falls and other injuries. These limitations can also make it more challenging for them to perform daily activities, such as bathing, dressing, or cooking.
5. Social determinants: Age-related factors, such as social isolation, poverty, and lack of access to transportation, can impact a person's ability to obtain necessary medical care and affect their overall health outcomes.

Understanding age factors is critical for healthcare providers to deliver high-quality, patient-centered care that addresses the unique needs and challenges of older adults. By taking these factors into account, healthcare providers can develop personalized treatment plans that consider a person's age, physical condition, cognitive abilities, and social circumstances.

An implantable defibrillator is a medical device that is surgically placed inside the chest to continuously monitor the heart's rhythm and deliver electrical shocks to restore a normal heartbeat when it detects a life-threatening arrhythmia, such as ventricular fibrillation or ventricular tachycardia.

The device consists of a small generator that is implanted in the upper chest, along with one or more electrode leads that are threaded through veins and positioned in the heart's chambers. The generator contains a battery and a microcomputer that constantly monitors the heart's electrical activity and detects any abnormal rhythms.

When an arrhythmia is detected, the defibrillator delivers an electrical shock to the heart to restore a normal rhythm. This can be done automatically by the device or manually by a healthcare provider using an external programmer.

Implantable defibrillators are typically recommended for people who have a high risk of sudden cardiac death due to a history of heart attacks, heart failure, or inherited heart conditions that affect the heart's electrical system. They can significantly reduce the risk of sudden cardiac death and improve quality of life for those at risk.

Angiotensin II Type 1 Receptor Blockers (ARBs) are a class of medications used to treat hypertension, heart failure, and protect against kidney damage in patients with diabetes. They work by blocking the action of angiotensin II, a hormone that causes blood vessels to constrict and blood pressure to increase, at its type 1 receptor. By blocking this effect, ARBs cause blood vessels to dilate, reducing blood pressure and decreasing the workload on the heart. Examples of ARBs include losartan, valsartan, irbesartan, and candesartan.

A case-control study is an observational research design used to identify risk factors or causes of a disease or health outcome. In this type of study, individuals with the disease or condition (cases) are compared with similar individuals who do not have the disease or condition (controls). The exposure history or other characteristics of interest are then compared between the two groups to determine if there is an association between the exposure and the disease.

Case-control studies are often used when it is not feasible or ethical to conduct a randomized controlled trial, as they can provide valuable insights into potential causes of diseases or health outcomes in a relatively short period of time and at a lower cost than other study designs. However, because case-control studies rely on retrospective data collection, they are subject to biases such as recall bias and selection bias, which can affect the validity of the results. Therefore, it is important to carefully design and conduct case-control studies to minimize these potential sources of bias.

Cardiovascular diseases (CVDs) are a class of diseases that affect the heart and blood vessels. They are the leading cause of death globally, according to the World Health Organization (WHO). The term "cardiovascular disease" refers to a group of conditions that include:

1. Coronary artery disease (CAD): This is the most common type of heart disease and occurs when the arteries that supply blood to the heart become narrowed or blocked due to the buildup of cholesterol, fat, and other substances in the walls of the arteries. This can lead to chest pain, shortness of breath, or a heart attack.
2. Heart failure: This occurs when the heart is unable to pump blood efficiently to meet the body's needs. It can be caused by various conditions, including coronary artery disease, high blood pressure, and cardiomyopathy.
3. Stroke: A stroke occurs when the blood supply to a part of the brain is interrupted or reduced, often due to a clot or a ruptured blood vessel. This can cause brain damage or death.
4. Peripheral artery disease (PAD): This occurs when the arteries that supply blood to the limbs become narrowed or blocked, leading to pain, numbness, or weakness in the legs or arms.
5. Rheumatic heart disease: This is a complication of untreated strep throat and can cause damage to the heart valves, leading to heart failure or other complications.
6. Congenital heart defects: These are structural problems with the heart that are present at birth. They can range from mild to severe and may require medical intervention.
7. Cardiomyopathy: This is a disease of the heart muscle that makes it harder for the heart to pump blood efficiently. It can be caused by various factors, including genetics, infections, and certain medications.
8. Heart arrhythmias: These are abnormal heart rhythms that can cause the heart to beat too fast, too slow, or irregularly. They can lead to symptoms such as palpitations, dizziness, or fainting.
9. Valvular heart disease: This occurs when one or more of the heart valves become damaged or diseased, leading to problems with blood flow through the heart.
10. Aortic aneurysm and dissection: These are conditions that affect the aorta, the largest artery in the body. An aneurysm is a bulge in the aorta, while a dissection is a tear in the inner layer of the aorta. Both can be life-threatening if not treated promptly.

It's important to note that many of these conditions can be managed or treated with medical interventions such as medications, surgery, or lifestyle changes. If you have any concerns about your heart health, it's important to speak with a healthcare provider.

Cardiac catheterization is a medical procedure used to diagnose and treat cardiovascular conditions. In this procedure, a thin, flexible tube called a catheter is inserted into a blood vessel in the arm or leg and threaded up to the heart. The catheter can be used to perform various diagnostic tests, such as measuring the pressure inside the heart chambers and assessing the function of the heart valves.

Cardiac catheterization can also be used to treat certain cardiovascular conditions, such as narrowed or blocked arteries. In these cases, a balloon or stent may be inserted through the catheter to open up the blood vessel and improve blood flow. This procedure is known as angioplasty or percutaneous coronary intervention (PCI).

Cardiac catheterization is typically performed in a hospital cardiac catheterization laboratory by a team of healthcare professionals, including cardiologists, radiologists, and nurses. The procedure may be done under local anesthesia with sedation or general anesthesia, depending on the individual patient's needs and preferences.

Overall, cardiac catheterization is a valuable tool in the diagnosis and treatment of various heart conditions, and it can help improve symptoms, reduce complications, and prolong life for many patients.

Bisoprolol is a beta-blocker medication that is primarily used to treat hypertension (high blood pressure), angina (chest pain), and heart failure. It works by blocking the effects of certain hormones on the heart and blood vessels, which helps to lower heart rate, reduce the force of heart contractions, and decrease blood vessel constriction. This can lead to decreased workload on the heart, improved blood flow, and reduced oxygen demand.

Bisoprolol is available in immediate-release and extended-release forms, and it is typically taken orally once or twice a day. Common side effects of bisoprolol include dizziness, fatigue, and cold hands and feet. It is important to follow the dosage instructions provided by your healthcare provider and to report any bothersome or persistent side effects promptly.

Like all medications, bisoprolol can have potential risks and benefits, and it may not be suitable for everyone. Your healthcare provider will consider your individual medical history and current health status when determining whether bisoprolol is an appropriate treatment option for you.

Cardiovascular models are simplified representations or simulations of the human cardiovascular system used in medical research, education, and training. These models can be physical, computational, or mathematical and are designed to replicate various aspects of the heart, blood vessels, and blood flow. They can help researchers study the structure and function of the cardiovascular system, test new treatments and interventions, and train healthcare professionals in diagnostic and therapeutic techniques.

Physical cardiovascular models may include artificial hearts, blood vessels, or circulation systems made from materials such as plastic, rubber, or silicone. These models can be used to study the mechanics of heart valves, the effects of different surgical procedures, or the impact of various medical devices on blood flow.

Computational and mathematical cardiovascular models use algorithms and equations to simulate the behavior of the cardiovascular system. These models may range from simple representations of a single heart chamber to complex simulations of the entire circulatory system. They can be used to study the electrical activity of the heart, the biomechanics of blood flow, or the distribution of drugs in the body.

Overall, cardiovascular models play an essential role in advancing our understanding of the human body and improving patient care.

Calcium is an essential mineral that is vital for various physiological processes in the human body. The medical definition of calcium is as follows:

Calcium (Ca2+) is a crucial cation and the most abundant mineral in the human body, with approximately 99% of it found in bones and teeth. It plays a vital role in maintaining structural integrity, nerve impulse transmission, muscle contraction, hormonal secretion, blood coagulation, and enzyme activation.

Calcium homeostasis is tightly regulated through the interplay of several hormones, including parathyroid hormone (PTH), calcitonin, and vitamin D. Dietary calcium intake, absorption, and excretion are also critical factors in maintaining optimal calcium levels in the body.

Hypocalcemia refers to low serum calcium levels, while hypercalcemia indicates high serum calcium levels. Both conditions can have detrimental effects on various organ systems and require medical intervention to correct.

Furosemide is a loop diuretic medication that is primarily used to treat edema (fluid retention) associated with various medical conditions such as heart failure, liver cirrhosis, and kidney disease. It works by inhibiting the sodium-potassium-chloride cotransporter in the ascending loop of Henle in the kidneys, thereby promoting the excretion of water, sodium, and chloride ions. This increased urine output helps reduce fluid accumulation in the body and lower blood pressure.

Furosemide is also known by its brand names Lasix and Frusid. It can be administered orally or intravenously, depending on the patient's condition and the desired rate of diuresis. Common side effects include dehydration, electrolyte imbalances, hearing loss (in high doses), and increased blood sugar levels.

It is essential to monitor kidney function, electrolyte levels, and fluid balance while using furosemide to minimize potential adverse effects and ensure appropriate treatment.

A dose-response relationship in the context of drugs refers to the changes in the effects or symptoms that occur as the dose of a drug is increased or decreased. Generally, as the dose of a drug is increased, the severity or intensity of its effects also increases. Conversely, as the dose is decreased, the effects of the drug become less severe or may disappear altogether.

The dose-response relationship is an important concept in pharmacology and toxicology because it helps to establish the safe and effective dosage range for a drug. By understanding how changes in the dose of a drug affect its therapeutic and adverse effects, healthcare providers can optimize treatment plans for their patients while minimizing the risk of harm.

The dose-response relationship is typically depicted as a curve that shows the relationship between the dose of a drug and its effect. The shape of the curve may vary depending on the drug and the specific effect being measured. Some drugs may have a steep dose-response curve, meaning that small changes in the dose can result in large differences in the effect. Other drugs may have a more gradual dose-response curve, where larger changes in the dose are needed to produce significant effects.

In addition to helping establish safe and effective dosages, the dose-response relationship is also used to evaluate the potential therapeutic benefits and risks of new drugs during clinical trials. By systematically testing different doses of a drug in controlled studies, researchers can identify the optimal dosage range for the drug and assess its safety and efficacy.

Multiple Organ Failure (MOF) is a severe condition characterized by the dysfunction or failure of more than one organ system in the body. It often occurs as a result of serious illness, trauma, or infection, such as sepsis. The organs that commonly fail include the lungs, kidneys, liver, and heart. This condition can lead to significant morbidity and mortality if not promptly diagnosed and treated.

The definition of MOF has evolved over time, but a widely accepted one is the "Sequential Organ Failure Assessment" (SOFA) score, which evaluates six organ systems: respiratory, coagulation, liver, cardiovascular, renal, and neurologic. A SOFA score of 10 or more indicates MOF, and a higher score is associated with worse outcomes.

MOF can be classified as primary or secondary. Primary MOF occurs when the initial insult directly causes organ dysfunction, such as in severe trauma or septic shock. Secondary MOF occurs when the initial injury or illness has been controlled, but organ dysfunction develops later due to ongoing inflammation and other factors.

Early recognition and aggressive management of MOF are crucial for improving outcomes. Treatment typically involves supportive care, such as mechanical ventilation, dialysis, and medication to support cardiovascular function. In some cases, surgery or other interventions may be necessary to address the underlying cause of organ dysfunction.

Liver failure is a serious condition in which the liver is no longer able to perform its normal functions, such as removing toxins and waste products from the blood, producing bile to help digest food, and regulating blood clotting. This can lead to a buildup of toxins in the body, jaundice (yellowing of the skin and eyes), fluid accumulation in the abdomen, and an increased risk of bleeding. Liver failure can be acute (sudden) or chronic (developing over time). Acute liver failure is often caused by medication toxicity, viral hepatitis, or other sudden illnesses. Chronic liver failure is most commonly caused by long-term damage from conditions such as cirrhosis, hepatitis, alcohol abuse, and non-alcoholic fatty liver disease.

It's important to note that Liver Failure is a life threatening condition and need immediate medical attention.

Tetrazoles are a class of heterocyclic aromatic organic compounds that contain a five-membered ring with four nitrogen atoms and one carbon atom. They have the chemical formula of C2H2N4. Tetrazoles are stable under normal conditions, but can decompose explosively when heated or subjected to strong shock.

In the context of medicinal chemistry, tetrazoles are sometimes used as bioisosteres for carboxylic acids, as they can mimic some of their chemical and biological properties. This has led to the development of several drugs that contain tetrazole rings, such as the antiviral drug tenofovir and the anti-inflammatory drug celecoxib.

However, it's important to note that 'tetrazoles' is not a medical term per se, but rather a chemical term that can be used in the context of medicinal chemistry or pharmacology.

I apologize for any confusion, but "Pyridazines" is not a medical term. It is a chemical term that refers to a class of heterocyclic organic compounds which contain a six-membered ring with two nitrogen atoms. These types of compounds are often used in the synthesis of various pharmaceuticals and agrochemicals, but "Pyridazines" itself is not a medical concept or diagnosis. If you have any questions related to medicine or health, I would be happy to try to help answer those for you.

Mitral valve insufficiency, also known as mitral regurgitation, is a cardiac condition in which the mitral valve located between the left atrium and left ventricle of the heart does not close properly, causing blood to flow backward into the atrium during contraction of the ventricle. This leads to an increased volume load on the left heart chamber and can result in symptoms such as shortness of breath, fatigue, and fluid retention. The condition can be caused by various factors including valve damage due to degenerative changes, infective endocarditis, rheumatic heart disease, or trauma. Treatment options include medication, mitral valve repair, or replacement surgery depending on the severity and underlying cause of the insufficiency.

Adrenergic beta-agonists are a class of medications that bind to and activate beta-adrenergic receptors, which are found in various tissues throughout the body. These receptors are part of the sympathetic nervous system and mediate the effects of the neurotransmitter norepinephrine (also called noradrenaline) and the hormone epinephrine (also called adrenaline).

When beta-agonists bind to these receptors, they stimulate a range of physiological responses, including relaxation of smooth muscle in the airways, increased heart rate and contractility, and increased metabolic rate. As a result, adrenergic beta-agonists are often used to treat conditions such as asthma, chronic obstructive pulmonary disease (COPD), and bronchitis, as they can help to dilate the airways and improve breathing.

There are several different types of beta-agonists, including short-acting and long-acting formulations. Short-acting beta-agonists (SABAs) are typically used for quick relief of symptoms, while long-acting beta-agonists (LABAs) are used for more sustained symptom control. Examples of adrenergic beta-agonists include albuterol (also known as salbutamol), terbutaline, formoterol, and salmeterol.

It's worth noting that while adrenergic beta-agonists can be very effective in treating respiratory conditions, they can also have side effects, particularly if used in high doses or for prolonged periods of time. These may include tremors, anxiety, palpitations, and increased blood pressure. As with any medication, it's important to use adrenergic beta-agonists only as directed by a healthcare professional.

Multivariate analysis is a statistical method used to examine the relationship between multiple independent variables and a dependent variable. It allows for the simultaneous examination of the effects of two or more independent variables on an outcome, while controlling for the effects of other variables in the model. This technique can be used to identify patterns, associations, and interactions among multiple variables, and is commonly used in medical research to understand complex health outcomes and disease processes. Examples of multivariate analysis methods include multiple regression, factor analysis, cluster analysis, and discriminant analysis.

Enalapril is a medication that belongs to a class of drugs called angiotensin-converting enzyme (ACE) inhibitors. It works by blocking the action of a hormone in the body called angiotensin II, which causes blood vessels to narrow and tighten. By blocking this hormone, Enalapril helps relax and widen blood vessels, making it easier for the heart to pump blood and reducing the workload on the heart.

Enalapril is commonly used to treat high blood pressure (hypertension), congestive heart failure, and to improve survival after a heart attack. It may also be used to treat other conditions as determined by your doctor.

The medication comes in the form of tablets or capsules that are taken orally, usually once or twice a day with or without food. The dosage will depend on various factors such as the patient's age, weight, and medical condition. It is important to follow the instructions of your healthcare provider when taking Enalapril.

Like all medications, Enalapril can cause side effects, including dry cough, dizziness, headache, fatigue, and nausea. More serious side effects may include allergic reactions, kidney problems, and low blood pressure. If you experience any concerning symptoms while taking Enalapril, it is important to contact your healthcare provider right away.

Antihypertensive agents are a class of medications used to treat high blood pressure (hypertension). They work by reducing the force and rate of heart contractions, dilating blood vessels, or altering neurohormonal activation to lower blood pressure. Examples include diuretics, beta blockers, ACE inhibitors, ARBs, calcium channel blockers, and direct vasodilators. These medications may be used alone or in combination to achieve optimal blood pressure control.

Exercise is defined in the medical context as a physical activity that is planned, structured, and repetitive, with the primary aim of improving or maintaining one or more components of physical fitness. Components of physical fitness include cardiorespiratory endurance, muscular strength, muscular endurance, flexibility, and body composition. Exercise can be classified based on its intensity (light, moderate, or vigorous), duration (length of time), and frequency (number of times per week). Common types of exercise include aerobic exercises, such as walking, jogging, cycling, and swimming; resistance exercises, such as weightlifting; flexibility exercises, such as stretching; and balance exercises. Exercise has numerous health benefits, including reducing the risk of chronic diseases, improving mental health, and enhancing overall quality of life.

Equipment failure is a term used in the medical field to describe the malfunction or breakdown of medical equipment, devices, or systems that are essential for patient care. This can include simple devices like syringes and thermometers, as well as complex machines such as ventilators, infusion pumps, and imaging equipment.

Equipment failure can have serious consequences for patients, including delayed or inappropriate treatment, injury, or even death. It is therefore essential that medical equipment is properly maintained, tested, and repaired to ensure its safe and effective operation.

There are many potential causes of equipment failure, including:

* Wear and tear from frequent use
* Inadequate cleaning or disinfection
* Improper handling or storage
* Power supply issues
* Software glitches or bugs
* Mechanical failures or defects
* Human error or misuse

To prevent equipment failure, healthcare facilities should have established policies and procedures for the acquisition, maintenance, and disposal of medical equipment. Staff should be trained in the proper use and handling of equipment, and regular inspections and testing should be performed to identify and address any potential issues before they lead to failure.

Isosorbide dinitrate is a medication that belongs to a class of drugs called nitrates. It is primarily used in the prevention and treatment of angina pectoris, which is chest pain caused by reduced blood flow to the heart muscle.

The medical definition of Isosorbide dinitrate is:

A soluble nitrate ester used in the prevention and treatment of anginal attacks. It acts by dilating coronary and peripheral arteries and veins, thereby reducing cardiac workload and increasing oxygen delivery to the heart muscle. Its therapeutic effects are attributed to its conversion to nitric oxide, a potent vasodilator, in the body. Isosorbide dinitrate is available in various forms, including tablets, capsules, and oral solutions, and is typically taken 2-3 times daily for optimal effect.

Ambulatory electrocardiography, also known as ambulatory ECG or Holter monitoring, is a non-invasive method of recording the electrical activity of the heart over an extended period of time (typically 24 hours or more) while the patient goes about their daily activities. The device used to record the ECG is called a Holter monitor, which consists of a small, portable recorder that is attached to the patient's chest with electrodes.

The recorded data provides information on any abnormalities in the heart's rhythm or electrical activity during different stages of activity and rest, allowing healthcare providers to diagnose and evaluate various cardiac conditions such as arrhythmias, ischemia, and infarction. The ability to monitor the heart's activity over an extended period while the patient performs their normal activities provides valuable information that may not be captured during a standard ECG, which only records the heart's electrical activity for a few seconds.

In summary, ambulatory electrocardiography is a diagnostic tool used to evaluate the electrical activity of the heart over an extended period, allowing healthcare providers to diagnose and manage various cardiac conditions.

Hydralazine is an antihypertensive medication, which means it is used to treat high blood pressure. It works by relaxing and widening the blood vessels, making it easier for the heart to pump blood through the body. This can help reduce the workload on the heart and lower blood pressure. Hydralazine is available in oral tablet form and is typically prescribed to be taken several times a day.

Hydralazine belongs to a class of medications called vasodilators, which work by relaxing the muscle in the walls of the blood vessels, causing them to widen. This increases the amount of blood that can flow through the blood vessels and reduces the pressure within them. Hydralazine is often used in combination with other medications to treat high blood pressure.

It's important to note that hydralazine should be used under the close supervision of a healthcare provider, as it can cause side effects such as headache, dizziness, and rapid heartbeat. It may also interact with certain other medications, so it is important to inform your doctor of all medications you are taking before starting hydralazine.

Reference values, also known as reference ranges or reference intervals, are the set of values that are considered normal or typical for a particular population or group of people. These values are often used in laboratory tests to help interpret test results and determine whether a patient's value falls within the expected range.

The process of establishing reference values typically involves measuring a particular biomarker or parameter in a large, healthy population and then calculating the mean and standard deviation of the measurements. Based on these statistics, a range is established that includes a certain percentage of the population (often 95%) and excludes extreme outliers.

It's important to note that reference values can vary depending on factors such as age, sex, race, and other demographic characteristics. Therefore, it's essential to use reference values that are specific to the relevant population when interpreting laboratory test results. Additionally, reference values may change over time due to advances in measurement technology or changes in the population being studied.

A peptide fragment is a short chain of amino acids that is derived from a larger peptide or protein through various biological or chemical processes. These fragments can result from the natural breakdown of proteins in the body during regular physiological processes, such as digestion, or they can be produced experimentally in a laboratory setting for research or therapeutic purposes.

Peptide fragments are often used in research to map the structure and function of larger peptides and proteins, as well as to study their interactions with other molecules. In some cases, peptide fragments may also have biological activity of their own and can be developed into drugs or diagnostic tools. For example, certain peptide fragments derived from hormones or neurotransmitters may bind to receptors in the body and mimic or block the effects of the full-length molecule.

A randomized controlled trial (RCT) is a type of clinical study in which participants are randomly assigned to receive either the experimental intervention or the control condition, which may be a standard of care, placebo, or no treatment. The goal of an RCT is to minimize bias and ensure that the results are due to the intervention being tested rather than other factors. This design allows for a comparison between the two groups to determine if there is a significant difference in outcomes. RCTs are often considered the gold standard for evaluating the safety and efficacy of medical interventions, as they provide a high level of evidence for causal relationships between the intervention and health outcomes.

Quality of Life (QOL) is a broad, multidimensional concept that usually includes an individual's physical health, psychological state, level of independence, social relationships, personal beliefs, and their relationship to salient features of their environment. It reflects the impact of disease and treatment on a patient's overall well-being and ability to function in daily life.

The World Health Organization (WHO) defines QOL as "an individual's perception of their position in life in the context of the culture and value systems in which they live and in relation to their goals, expectations, standards and concerns." It is a subjective concept, meaning it can vary greatly from person to person.

In healthcare, QOL is often used as an outcome measure in clinical trials and other research studies to assess the impact of interventions or treatments on overall patient well-being.

Isoproterenol is a medication that belongs to a class of drugs called beta-adrenergic agonists. Medically, it is defined as a synthetic catecholamine with both alpha and beta adrenergic receptor stimulating properties. It is primarily used as a bronchodilator to treat conditions such as asthma and chronic obstructive pulmonary disease (COPD) by relaxing the smooth muscles in the airways, thereby improving breathing.

Isoproterenol can also be used in the treatment of bradycardia (abnormally slow heart rate), cardiac arrest, and heart blocks by increasing the heart rate and contractility. However, due to its non-selective beta-agonist activity, it may cause various side effects such as tremors, palpitations, and increased blood pressure. Its use is now limited due to the availability of more selective and safer medications.

Right ventricular dysfunction is a condition characterized by the impaired ability of the right ventricle (one of the two pumping chambers in the heart) to fill with blood during the diastolic phase or eject blood during the systolic phase. This results in reduced cardiac output from the right ventricle, which can lead to various complications such as fluid accumulation in the body, particularly in the abdomen and lower extremities, and ultimately congestive heart failure if left untreated.

Right ventricular dysfunction can be caused by various factors, including damage to the heart muscle due to a heart attack, high blood pressure in the lungs (pulmonary hypertension), chronic lung diseases, congenital heart defects, viral infections, and certain medications. Symptoms of right ventricular dysfunction may include shortness of breath, fatigue, swelling in the legs, ankles, or abdomen, and a decreased tolerance for physical activity.

Diagnosis of right ventricular dysfunction typically involves a combination of medical history, physical examination, imaging tests such as echocardiography, cardiac MRI, or CT scan, and other diagnostic procedures such as electrocardiogram (ECG) or cardiac catheterization. Treatment options depend on the underlying cause but may include medications to reduce fluid buildup, improve heart function, and manage symptoms, as well as lifestyle modifications such as reducing salt intake and increasing physical activity levels. In severe cases, more invasive treatments such as surgery or implantable devices like pacemakers or ventricular assist devices may be necessary.

Captopril is a medication that belongs to a class of drugs called ACE (angiotensin-converting enzyme) inhibitors. It works by blocking the action of a chemical in the body called angiotensin II, which causes blood vessels to narrow and release hormones that can increase blood pressure. By blocking the action of angiotensin II, captopril helps relax and widen blood vessels, which lowers blood pressure and improves blood flow.

Captopril is used to treat high blood pressure (hypertension), congestive heart failure, and to improve survival after a heart attack. It may also be used to protect the kidneys from damage due to diabetes or high blood pressure. The medication comes in the form of tablets that are taken by mouth, usually two to three times per day.

Common side effects of captopril include cough, dizziness, headache, and skin rash. More serious side effects may include allergic reactions, kidney problems, and changes in blood cell counts. It is important for patients taking captopril to follow their doctor's instructions carefully and report any unusual symptoms or side effects promptly.

An artificial heart is a mechanical device designed to replace the function of one or both ventricles of the natural human heart. It can be used as a temporary or permanent solution for patients with end-stage heart failure who are not candidates for heart transplantation. There are different types of artificial hearts, such as total artificial hearts and ventricular assist devices (VADs), which can help to pump blood throughout the body. These devices are typically composed of titanium and polyurethane materials and are powered by external electrical systems. They are designed to mimic the natural heart's action, helping to maintain adequate blood flow and oxygenation to vital organs.

Angiotensin receptor antagonists (ARAs), also known as angiotensin II receptor blockers (ARBs), are a class of medications used to treat hypertension, heart failure, and protect against kidney damage in patients with diabetes. They work by blocking the action of angiotensin II, a potent vasoconstrictor and hormone that increases blood pressure and promotes tissue fibrosis. By blocking the binding of angiotensin II to its receptors, ARAs cause relaxation of blood vessels, decreased sodium and water retention, and reduced cardiac remodeling, ultimately leading to improved cardiovascular function and reduced risk of organ damage. Examples of ARAs include losartan, valsartan, irbesartan, and candesartan.

Cardiac volume refers to the amount of blood contained within the heart chambers at any given point in time. It is a measure of the volume of blood that is being moved by the heart during each cardiac cycle, which includes both systole (contraction) and diastole (relaxation) phases.

There are several types of cardiac volumes that are commonly measured or estimated using medical imaging techniques such as echocardiography or cardiac magnetic resonance imaging (MRI). These include:

1. End-diastolic volume (EDV): This is the volume of blood in the heart chambers at the end of diastole, when the heart chambers are fully filled with blood.
2. End-systolic volume (ESV): This is the volume of blood in the heart chambers at the end of systole, when the heart chambers have contracted and ejected most of the blood.
3. Stroke volume (SV): This is the difference between the EDV and ESV, and represents the amount of blood that is pumped out of the heart with each beat.
4. Cardiac output (CO): This is the product of the stroke volume and heart rate, and represents the total amount of blood that is pumped by the heart in one minute.

Abnormalities in cardiac volumes can indicate various heart conditions such as heart failure, valvular heart disease, or cardiomyopathy.

A heart valve prosthesis is a medical device that is implanted in the heart to replace a damaged or malfunctioning heart valve. The prosthetic valve can be made of biological tissue (such as from a pig or cow) or artificial materials (such as carbon or polyester). Its function is to allow for the proper directional flow of blood through the heart, opening and closing with each heartbeat to prevent backflow of blood.

There are several types of heart valve prostheses, including:

1. Mechanical valves: These are made entirely of artificial materials and have a longer lifespan than biological valves. However, they require the patient to take blood-thinning medication for the rest of their life to prevent blood clots from forming on the valve.
2. Bioprosthetic valves: These are made of biological tissue and typically last 10-15 years before needing replacement. They do not require the patient to take blood-thinning medication, but there is a higher risk of reoperation due to degeneration of the tissue over time.
3. Homografts or allografts: These are human heart valves that have been donated and preserved for transplantation. They have similar longevity to bioprosthetic valves and do not require blood-thinning medication.
4. Autografts: In this case, the patient's own pulmonary valve is removed and used to replace the damaged aortic valve. This procedure is called the Ross procedure and has excellent long-term results, but it requires advanced surgical skills and is not widely available.

The choice of heart valve prosthesis depends on various factors, including the patient's age, overall health, lifestyle, and personal preferences.

The Autonomic Nervous System (ANS) is a part of the peripheral nervous system that operates largely below the level of consciousness and controls visceral functions. It is divided into two main subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.

The Sympathetic Nervous System (SNS) prepares the body for stressful or emergency situations, often referred to as the "fight or flight" response. It increases heart rate, blood pressure, respiratory rate, and metabolic rate, while also decreasing digestive activity. This response helps the body respond quickly to perceived threats.

The Parasympathetic Nervous System (PNS), on the other hand, promotes the "rest and digest" state, allowing the body to conserve energy and restore itself after the stress response has subsided. It decreases heart rate, blood pressure, and respiratory rate, while increasing digestive activity and promoting relaxation.

These two systems work together to maintain balance in the body by adjusting various functions based on internal and external demands. Disorders of the Autonomic Nervous System can lead to a variety of symptoms, such as orthostatic hypotension, gastroparesis, and cardiac arrhythmias, among others.

The Chi-square distribution is a continuous probability distribution that is often used in statistical hypothesis testing. It is the distribution of a sum of squares of k independent standard normal random variables. The resulting quantity follows a chi-square distribution with k degrees of freedom, denoted as χ²(k).

The probability density function (pdf) of the Chi-square distribution with k degrees of freedom is given by:

f(x; k) = (1/ (2^(k/2) * Γ(k/2))) \* x^((k/2)-1) \* e^(-x/2), for x > 0 and 0, otherwise.

Where Γ(k/2) is the gamma function evaluated at k/2. The mean and variance of a Chi-square distribution with k degrees of freedom are k and 2k, respectively.

The Chi-square distribution has various applications in statistical inference, including testing goodness-of-fit, homogeneity of variances, and independence in contingency tables.

Milrinone is a type of medication known as an inotrope and vasodilator. It works by increasing the force of heart muscle contractions and relaxing the blood vessels, which leads to improved pumping ability of the heart and increased blood flow. Milrinone is primarily used in the treatment of heart failure, either in the hospital setting or after discharge, to improve symptoms and help the heart work more efficiently. It is given intravenously (through an IV) and its effects are closely monitored by healthcare professionals due to the potential for serious side effects such as irregular heart rhythms.

Central sleep apnea (CSA) is a type of sleep-disordered breathing characterized by repeated cessations in breathing during sleep due to the brain's failure to transmit signals to the respiratory muscles that control breathing. Unlike obstructive sleep apnea (OSA), which results from airway obstruction, CSA occurs when the brain fails to send the necessary signals to the diaphragm and intercostal muscles to initiate or maintain respiratory efforts during sleep.

Central sleep apneas are usually associated with decreased oxygen saturation levels and can lead to frequent arousals from sleep, causing excessive daytime sleepiness, fatigue, and impaired cognitive function. CSA is often related to underlying medical conditions such as heart failure, stroke, or brainstem injury, and it may also be caused by the use of certain medications, including opioids.

There are several types of central sleep apnea, including:

1. Primary Central Sleep Apnea: This type occurs without any underlying medical condition or medication use.
2. Cheyne-Stokes Breathing: A pattern of central sleep apnea commonly seen in individuals with heart failure or stroke. It is characterized by a crescendo-decrescendo pattern of breathing, with periods of hyperventilation followed by hypoventilation and apnea.
3. High-Altitude Periodic Breathing: This type occurs at high altitudes due to the reduced oxygen levels and is usually reversible upon returning to lower altitudes.
4. Complex or Mixed Sleep Apnea: A combination of both central and obstructive sleep apneas, often observed in patients with OSA who are treated with continuous positive airway pressure (CPAP) therapy. In some cases, the central component may resolve over time with continued CPAP use.

Diagnosis of CSA typically involves a sleep study (polysomnography), which monitors various physiological parameters during sleep, such as brain waves, eye movements, muscle activity, heart rate, and breathing patterns. Treatment options for central sleep apnea depend on the underlying cause and may include medications, adjustments in medication dosages, or the use of devices that assist with breathing, such as adaptive servo-ventilation (ASV) or bilevel positive airway pressure (BiPAP) therapy.

Rheumatic Heart Disease (RHD) is defined as a chronic heart condition caused by damage to the heart valves due to untreated or inadequately treated streptococcal throat infection (strep throat). The immune system's response to this infection can mistakenly attack and damage the heart tissue, leading to inflammation and scarring of the heart valves. This damage can result in narrowing, leakage, or abnormal functioning of the heart valves, which can further lead to complications such as heart failure, stroke, or infective endocarditis.

RHD is a preventable and treatable condition if detected early and managed effectively. It primarily affects children and young adults in developing countries where access to healthcare and antibiotics for strep throat infections may be limited. Long-term management of RHD typically involves medications, regular monitoring, and sometimes surgical intervention to repair or replace damaged heart valves.

Impedance cardiography is a non-invasive method to measure cardiac output and systemic vascular resistance. It uses low-frequency electrical currents passed through the thorax to measure changes in impedance or resistance to flow during each heartbeat. This allows for the calculation of stroke volume and cardiac output. Impedance cardiography can provide continuous, real-time monitoring of cardiovascular function, making it useful in critical care settings and for tracking changes in patients with heart failure or other cardiovascular conditions.

Acute kidney injury (AKI), also known as acute renal failure, is a rapid loss of kidney function that occurs over a few hours or days. It is defined as an increase in the serum creatinine level by 0.3 mg/dL within 48 hours or an increase in the creatinine level to more than 1.5 times baseline, which is known or presumed to have occurred within the prior 7 days, or a urine volume of less than 0.5 mL/kg per hour for six hours.

AKI can be caused by a variety of conditions, including decreased blood flow to the kidneys, obstruction of the urinary tract, exposure to toxic substances, and certain medications. Symptoms of AKI may include decreased urine output, fluid retention, electrolyte imbalances, and metabolic acidosis. Treatment typically involves addressing the underlying cause of the injury and providing supportive care, such as dialysis, to help maintain kidney function until the injury resolves.

Endomyocardial fibrosis is a rare heart condition characterized by the thickening and scarring (fibrosis) of the inner layer of the heart muscle (endocardium) and the muscular walls of the lower chambers of the heart (ventricles). This process can restrict the heart's ability to fill properly with blood, leading to symptoms such as shortness of breath, fatigue, and fluid retention. The exact cause of endomyocardial fibrosis is not fully understood, but it is believed to involve an abnormal immune response or inflammation. It is more commonly found in tropical regions of Africa and Asia. Treatment typically involves medications to manage symptoms and improve heart function, as well as potentially surgical interventions to remove the scar tissue and restore normal heart function.

Prevalence, in medical terms, refers to the total number of people in a given population who have a particular disease or condition at a specific point in time, or over a specified period. It is typically expressed as a percentage or a ratio of the number of cases to the size of the population. Prevalence differs from incidence, which measures the number of new cases that develop during a certain period.

The Renin-Angiotensin System (RAS) is a complex hormonal system that regulates blood pressure, fluid and electrolyte balance, and vascular resistance. It plays a crucial role in the pathophysiology of hypertension, heart failure, and kidney diseases.

Here's a brief overview of how it works:

1. Renin is an enzyme that is released by the juxtaglomerular cells in the kidneys in response to decreased blood pressure or reduced salt delivery to the distal tubules.
2. Renin acts on a protein called angiotensinogen, which is produced by the liver, converting it into angiotensin I.
3. Angiotensin-converting enzyme (ACE), found in the lungs and other tissues, then converts angiotensin I into angiotensin II, a potent vasoconstrictor that narrows blood vessels and increases blood pressure.
4. Angiotensin II also stimulates the release of aldosterone from the adrenal glands, which promotes sodium and water reabsorption in the kidneys, further increasing blood volume and blood pressure.
5. Additionally, angiotensin II has direct effects on the heart, promoting hypertrophy and remodeling, which can contribute to heart failure.
6. The RAS can be modulated by various medications, such as ACE inhibitors, angiotensin receptor blockers (ARBs), and aldosterone antagonists, which are commonly used to treat hypertension, heart failure, and kidney diseases.

Hospital mortality is a term used to describe the number or rate of deaths that occur in a hospital setting during a specific period. It is often used as a measure of the quality of healthcare provided by a hospital, as a higher hospital mortality rate may indicate poorer care or more complex cases being treated. However, it's important to note that hospital mortality rates can be influenced by many factors, including the severity of illness of the patients being treated, patient demographics, and the availability of resources and specialized care. Therefore, hospital mortality rates should be interpreted with caution and in the context of other quality metrics.

The American Heart Association (AHA) is a non-profit organization in the United States that aims to reduce disability and death from cardiovascular diseases and stroke, including heart disease and stroke. The AHA was founded in 1924 and is one of the oldest and largest voluntary organizations dedicated to fighting cardiovascular disease.

The AHA provides a range of services, including:

* Funding research into the causes, prevention, and treatment of heart disease and stroke
* Providing educational resources for healthcare professionals, patients, and the general public
* Advocating for policies that promote heart health and prevent heart disease and stroke
* Developing guidelines and standards for the diagnosis, treatment, and prevention of cardiovascular diseases

The AHA is funded through donations from individuals, corporations, and foundations. It operates with a volunteer board of directors and a professional staff. The organization has more than 3,400 volunteers and 70 local offices across the United States.

Hypertension is a medical term used to describe abnormally high blood pressure in the arteries, often defined as consistently having systolic blood pressure (the top number in a blood pressure reading) over 130 mmHg and/or diastolic blood pressure (the bottom number) over 80 mmHg. It is also commonly referred to as high blood pressure.

Hypertension can be classified into two types: primary or essential hypertension, which has no identifiable cause and accounts for about 95% of cases, and secondary hypertension, which is caused by underlying medical conditions such as kidney disease, hormonal disorders, or use of certain medications.

If left untreated, hypertension can lead to serious health complications such as heart attack, stroke, heart failure, and chronic kidney disease. Therefore, it is important for individuals with hypertension to manage their condition through lifestyle modifications (such as healthy diet, regular exercise, stress management) and medication if necessary, under the guidance of a healthcare professional.

Skeletal muscle, also known as striated or voluntary muscle, is a type of muscle that is attached to bones by tendons or aponeuroses and functions to produce movements and support the posture of the body. It is composed of long, multinucleated fibers that are arranged in parallel bundles and are characterized by alternating light and dark bands, giving them a striped appearance under a microscope. Skeletal muscle is under voluntary control, meaning that it is consciously activated through signals from the nervous system. It is responsible for activities such as walking, running, jumping, and lifting objects.

Tachycardia is a medical term that refers to an abnormally rapid heart rate, often defined as a heart rate greater than 100 beats per minute in adults. It can occur in either the atria (upper chambers) or ventricles (lower chambers) of the heart. Different types of tachycardia include supraventricular tachycardia (SVT), atrial fibrillation, atrial flutter, and ventricular tachycardia.

Tachycardia can cause various symptoms such as palpitations, shortness of breath, dizziness, lightheadedness, chest discomfort, or syncope (fainting). In some cases, tachycardia may not cause any symptoms and may only be detected during a routine physical examination or medical test.

The underlying causes of tachycardia can vary widely, including heart disease, electrolyte imbalances, medications, illicit drug use, alcohol abuse, smoking, stress, anxiety, and other medical conditions. In some cases, the cause may be unknown. Treatment for tachycardia depends on the underlying cause, type, severity, and duration of the arrhythmia.

The baroreflex is a physiological mechanism that helps regulate blood pressure and heart rate in response to changes in stretch of the arterial walls. It is mediated by baroreceptors, which are specialized sensory nerve endings located in the carotid sinus and aortic arch. These receptors detect changes in blood pressure and send signals to the brainstem via the glossopharyngeal (cranial nerve IX) and vagus nerves (cranial nerve X), respectively.

In response to an increase in arterial pressure, the baroreceptors are stimulated, leading to increased firing of afferent neurons that signal the brainstem. This results in a reflexive decrease in heart rate and cardiac output, as well as vasodilation of peripheral blood vessels, which collectively work to reduce blood pressure back towards its normal level. Conversely, if arterial pressure decreases, the baroreceptors are less stimulated, leading to an increase in heart rate and cardiac output, as well as vasoconstriction of peripheral blood vessels, which helps restore blood pressure.

Overall, the baroreflex is a crucial homeostatic mechanism that helps maintain stable blood pressure and ensure adequate perfusion of vital organs.

Messenger RNA (mRNA) is a type of RNA (ribonucleic acid) that carries genetic information copied from DNA in the form of a series of three-base code "words," each of which specifies a particular amino acid. This information is used by the cell's machinery to construct proteins, a process known as translation. After being transcribed from DNA, mRNA travels out of the nucleus to the ribosomes in the cytoplasm where protein synthesis occurs. Once the protein has been synthesized, the mRNA may be degraded and recycled. Post-transcriptional modifications can also occur to mRNA, such as alternative splicing and addition of a 5' cap and a poly(A) tail, which can affect its stability, localization, and translation efficiency.

The "cause of death" is a medical determination of the disease, injury, or event that directly results in a person's death. This information is typically documented on a death certificate and may be used for public health surveillance, research, and legal purposes. The cause of death is usually determined by a physician based on their clinical judgment and any available medical evidence, such as laboratory test results, autopsy findings, or eyewitness accounts. In some cases, the cause of death may be uncertain or unknown, and the death may be classified as "natural," "accidental," "homicide," or "suicide" based on the available information.

Regression analysis is a statistical technique used in medicine, as well as in other fields, to examine the relationship between one or more independent variables (predictors) and a dependent variable (outcome). It allows for the estimation of the average change in the outcome variable associated with a one-unit change in an independent variable, while controlling for the effects of other independent variables. This technique is often used to identify risk factors for diseases or to evaluate the effectiveness of medical interventions. In medical research, regression analysis can be used to adjust for potential confounding variables and to quantify the relationship between exposures and health outcomes. It can also be used in predictive modeling to estimate the probability of a particular outcome based on multiple predictors.

Aldosterone is a hormone produced by the adrenal gland. It plays a key role in regulating sodium and potassium balance and maintaining blood pressure through its effects on the kidneys. Aldosterone promotes the reabsorption of sodium ions and the excretion of potassium ions in the distal tubules and collecting ducts of the nephrons in the kidneys. This increases the osmotic pressure in the blood, which in turn leads to water retention and an increase in blood volume and blood pressure.

Aldosterone is released from the adrenal gland in response to a variety of stimuli, including angiotensin II (a peptide hormone produced as part of the renin-angiotensin-aldosterone system), potassium ions, and adrenocorticotropic hormone (ACTH) from the pituitary gland. The production of aldosterone is regulated by a negative feedback mechanism involving sodium levels in the blood. High sodium levels inhibit the release of aldosterone, while low sodium levels stimulate its release.

In addition to its role in maintaining fluid and electrolyte balance and blood pressure, aldosterone has been implicated in various pathological conditions, including hypertension, heart failure, and primary hyperaldosteronism (a condition characterized by excessive production of aldosterone).

3-Iodobenzylguanidine (3-IBG) is a radioactive tracer drug that is used in nuclear medicine to help diagnose and evaluate pheochromocytomas and paragangliomas, which are rare tumors of the adrenal glands or nearby nerve tissue. It works by accumulating in the cells of these tumors, allowing them to be detected through imaging techniques such as single-photon emission computed tomography (SPECT) scans.

The drug contains a radioactive isotope of iodine (I-123 or I-131) that emits gamma rays, which can be detected by a gamma camera during the imaging procedure. The 3-IBG molecule also includes a guanidine group, which selectively binds to the norepinephrine transporter (NET) on the surface of the tumor cells, allowing the drug to accumulate within the tumor tissue.

It is important to note that the use of 3-IBG should be under the supervision of a qualified healthcare professional, as it involves exposure to radiation and may have potential side effects.

Respiratory insufficiency is a condition characterized by the inability of the respiratory system to maintain adequate gas exchange, resulting in an inadequate supply of oxygen and/or removal of carbon dioxide from the body. This can occur due to various causes, such as lung diseases (e.g., chronic obstructive pulmonary disease, pneumonia), neuromuscular disorders (e.g., muscular dystrophy, spinal cord injury), or other medical conditions that affect breathing mechanics and/or gas exchange.

Respiratory insufficiency can manifest as hypoxemia (low oxygen levels in the blood) and/or hypercapnia (high carbon dioxide levels in the blood). Symptoms of respiratory insufficiency may include shortness of breath, rapid breathing, fatigue, confusion, and in severe cases, loss of consciousness or even death. Treatment depends on the underlying cause and severity of the condition and may include oxygen therapy, mechanical ventilation, medications, and/or other supportive measures.

Xamoterol is not generally considered to have a medical definition, as it is not an approved or commonly used medication in clinical practice. However, it is a chemical compound that has been studied in the past for its potential therapeutic effects.

Xamoterol is a beta-adrenergic receptor agonist, which means that it binds to and activates certain types of receptors found on cells throughout the body. Specifically, xamoterol is a partial agonist of both beta-1 and beta-2 adrenergic receptors, which are involved in various physiological processes such as heart rate, contractility, and bronchodilation.

In clinical trials, xamoterol was investigated for its potential to improve cardiac function and exercise capacity in patients with chronic heart failure. However, the drug was found to have only modest benefits and was associated with an increased risk of serious arrhythmias, which ultimately led to its discontinuation in further development and use.

Therefore, while xamoterol may have a chemical definition as a beta-adrenergic receptor agonist, it is not commonly used or recognized as a medical term in clinical practice.

The heart septum is the thick, muscular wall that divides the right and left sides of the heart. It consists of two main parts: the atrial septum, which separates the right and left atria (the upper chambers of the heart), and the ventricular septum, which separates the right and left ventricles (the lower chambers of the heart). A normal heart septum ensures that oxygen-rich blood from the lungs does not mix with oxygen-poor blood from the body. Any defect or abnormality in the heart septum is called a septal defect, which can lead to various congenital heart diseases.

Creatinine is a waste product that's produced by your muscles and removed from your body by your kidneys. Creatinine is a breakdown product of creatine, a compound found in meat and fish, as well as in the muscles of vertebrates, including humans.

In healthy individuals, the kidneys filter out most of the creatinine and eliminate it through urine. However, when the kidneys are not functioning properly, creatinine levels in the blood can rise. Therefore, measuring the amount of creatinine in the blood or urine is a common way to test how well the kidneys are working. High creatinine levels in the blood may indicate kidney damage or kidney disease.

Sodium-potassium-chloride symporters, also known as sodium-potassium-chloride cotransporters or NKCCs, are a type of membrane transport protein that facilitates the movement of ions across the cell membrane. Specifically, they mediate the simultaneous transport of sodium (Na+), potassium (K+), and chloride (Cl-) ions into cells.

Sodium-potassium-chloride symporter inhibitors are pharmacological agents that block the activity of these transporters, thereby preventing the uptake of these ions into cells. These drugs have been used in various clinical settings to treat or manage conditions such as hypertension, edema, and certain types of epilepsy.

Examples of sodium-potassium-chloride symporter inhibitors include loop diuretics such as furosemide, bumetanide, and torasemide, which target the NKCC2 transporter in the thick ascending limb of the loop of Henle in the kidney. By blocking this transporter, these drugs increase sodium and water excretion, reducing blood volume and lowering blood pressure.

It's worth noting that while "sodium-potassium-chloride symporter inhibitors" is a valid term, it may be less commonly used than more specific terms such as "loop diuretics."

Combination drug therapy is a treatment approach that involves the use of multiple medications with different mechanisms of action to achieve better therapeutic outcomes. This approach is often used in the management of complex medical conditions such as cancer, HIV/AIDS, and cardiovascular diseases. The goal of combination drug therapy is to improve efficacy, reduce the risk of drug resistance, decrease the likelihood of adverse effects, and enhance the overall quality of life for patients.

In combining drugs, healthcare providers aim to target various pathways involved in the disease process, which may help to:

1. Increase the effectiveness of treatment by attacking the disease from multiple angles.
2. Decrease the dosage of individual medications, reducing the risk and severity of side effects.
3. Slow down or prevent the development of drug resistance, a common problem in chronic diseases like HIV/AIDS and cancer.
4. Improve patient compliance by simplifying dosing schedules and reducing pill burden.

Examples of combination drug therapy include:

1. Antiretroviral therapy (ART) for HIV treatment, which typically involves three or more drugs from different classes to suppress viral replication and prevent the development of drug resistance.
2. Chemotherapy regimens for cancer treatment, where multiple cytotoxic agents are used to target various stages of the cell cycle and reduce the likelihood of tumor cells developing resistance.
3. Cardiovascular disease management, which may involve combining medications such as angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, diuretics, and statins to control blood pressure, heart rate, fluid balance, and cholesterol levels.
4. Treatment of tuberculosis, which often involves a combination of several antibiotics to target different aspects of the bacterial life cycle and prevent the development of drug-resistant strains.

When prescribing combination drug therapy, healthcare providers must carefully consider factors such as potential drug interactions, dosing schedules, adverse effects, and contraindications to ensure safe and effective treatment. Regular monitoring of patients is essential to assess treatment response, manage side effects, and adjust the treatment plan as needed.

Myocardial reperfusion injury is a pathological process that occurs when blood flow is restored to the heart muscle (myocardium) after a period of ischemia or reduced oxygen supply, such as during a myocardial infarction (heart attack). The restoration of blood flow, although necessary to salvage the dying tissue, can itself cause further damage to the heart muscle. This paradoxical phenomenon is known as myocardial reperfusion injury.

The mechanisms behind myocardial reperfusion injury are complex and involve several processes, including:

1. Oxidative stress: The sudden influx of oxygen into the previously ischemic tissue leads to an overproduction of reactive oxygen species (ROS), which can damage cellular structures, such as proteins, lipids, and DNA.
2. Calcium overload: During reperfusion, there is an increase in calcium influx into the cardiomyocytes (heart muscle cells). This elevated intracellular calcium level can disrupt normal cellular functions, leading to further damage.
3. Inflammation: Reperfusion triggers an immune response, with the recruitment of inflammatory cells, such as neutrophils and monocytes, to the site of injury. These cells release cytokines and other mediators that can exacerbate tissue damage.
4. Mitochondrial dysfunction: The restoration of blood flow can cause mitochondria, the powerhouses of the cell, to malfunction, leading to the release of pro-apoptotic factors and contributing to cell death.
5. Vasoconstriction and microvascular obstruction: During reperfusion, there may be vasoconstriction of the small blood vessels (microvasculature) in the heart, which can further limit blood flow and contribute to tissue damage.

Myocardial reperfusion injury is a significant concern because it can negate some of the benefits of early reperfusion therapy, such as thrombolysis or primary percutaneous coronary intervention (PCI), used to treat acute myocardial infarction. Strategies to minimize myocardial reperfusion injury are an area of active research and include pharmacological interventions, ischemic preconditioning, and remote ischemic conditioning.

Amiodarone is a Class III antiarrhythmic medication used to treat and prevent various types of irregular heart rhythms (arrhythmias). It works by stabilizing the electrical activity of the heart and slowing down the nerve impulses in the heart tissue. Amiodarone is available in oral tablet and injection forms.

The medical definition of 'Amiodarone' is:

A benzofuran derivative with Class III antiarrhythmic properties, used for the treatment of ventricular arrhythmias. It has a relatively slow onset of action and is therefore not useful in acute situations. Additionally, it has negative inotropic effects and may exacerbate heart failure. The most serious adverse effect is pulmonary fibrosis, which occurs in approximately 1-2% of patients. Other important side effects include corneal microdeposits, hepatotoxicity, thyroid dysfunction, and photosensitivity. Amiodarone has a very long half-life (approximately 50 days) due to its extensive tissue distribution. It is metabolized by the liver and excreted in bile and urine.

Sources:

1. UpToDate - Amiodarone use in adults: Indications, dosing, and adverse effects.
2. Micromedex - Amiodarone.
3. Drugs.com - Amiodarone.

Right Ventricular Function refers to the ability of the right ventricle (RV) of the heart to receive and eject blood during the cardiac cycle. The right ventricle is one of the four chambers of the heart and is responsible for pumping deoxygenated blood from the body to the lungs for re-oxygenation.

Right ventricular function can be assessed by measuring various parameters such as:

1. Right Ventricular Ejection Fraction (RVEF): It is the percentage of blood that is ejected from the right ventricle during each heartbeat. A normal RVEF ranges from 45-75%.
2. Right Ventricular Systolic Function: It refers to the ability of the right ventricle to contract and eject blood during systole (contraction phase). This can be assessed by measuring the tricuspid annular plane systolic excursion (TAPSE) or tissue Doppler imaging.
3. Right Ventricular Diastolic Function: It refers to the ability of the right ventricle to relax and fill with blood during diastole (relaxation phase). This can be assessed by measuring the right ventricular inflow pattern, tricuspid valve E/A ratio, or deceleration time.
4. Right Ventricular Afterload: It refers to the pressure that the right ventricle must overcome to eject blood into the pulmonary artery. Increased afterload can impair right ventricular function.

Abnormalities in right ventricular function can lead to various cardiovascular conditions such as pulmonary hypertension, heart failure, and arrhythmias.

The sarcoplasmic reticulum (SR) is a specialized type of smooth endoplasmic reticulum found in muscle cells, particularly in striated muscles such as skeletal and cardiac muscles. It is a complex network of tubules that surrounds the myofibrils, the contractile elements of the muscle fiber.

The primary function of the sarcoplasmic reticulum is to store calcium ions (Ca2+) and regulate their release during muscle contraction and uptake during muscle relaxation. The SR contains a high concentration of calcium-binding proteins, such as calsequestrin, which help to maintain this storage.

The release of calcium ions from the sarcoplasmic reticulum is triggered by an action potential that travels along the muscle fiber's sarcolemma and into the muscle fiber's interior (the sarcoplasm). This action potential causes the voltage-gated calcium channels in the SR membrane, known as ryanodine receptors, to open, releasing Ca2+ ions into the sarcoplasm.

The increased concentration of Ca2+ ions in the sarcoplasm triggers muscle contraction by binding to troponin, a protein associated with actin filaments, causing a conformational change that exposes the active sites on actin for myosin heads to bind and generate force.

After muscle contraction, the calcium ions must be actively transported back into the sarcoplasmic reticulum by Ca2+ ATPase pumps, also known as sarco(endo)plasmic reticulum calcium ATPases (SERCAs). This process helps to lower the concentration of Ca2+ in the sarcoplasm and allows the muscle fiber to relax.

Overall, the sarcoplasmic reticulum plays a crucial role in excitation-contraction coupling, the process by which action potentials trigger muscle contraction.

Perfusion, in medical terms, refers to the process of circulating blood through the body's organs and tissues to deliver oxygen and nutrients and remove waste products. It is a measure of the delivery of adequate blood flow to specific areas or tissues in the body. Perfusion can be assessed using various methods, including imaging techniques like computed tomography (CT) scans, magnetic resonance imaging (MRI), and perfusion scintigraphy.

Perfusion is critical for maintaining proper organ function and overall health. When perfusion is impaired or inadequate, it can lead to tissue hypoxia, acidosis, and cell death, which can result in organ dysfunction or failure. Conditions that can affect perfusion include cardiovascular disease, shock, trauma, and certain surgical procedures.

Dobutamine is a synthetic catecholamine used in medical treatment, specifically as a positive inotrope and vasodilator. It works by stimulating the beta-1 adrenergic receptors of the heart, thereby increasing its contractility and stroke volume. This results in an improved cardiac output, making dobutamine beneficial in treating heart failure, cardiogenic shock, and other conditions where heart function is compromised.

It's important to note that dobutamine should be administered under strict medical supervision due to its potential to cause adverse effects such as arrhythmias, hypotension, or hypertension. The dosage, frequency, and duration of administration are determined by the patient's specific condition and response to treatment.

Reproducibility of results in a medical context refers to the ability to obtain consistent and comparable findings when a particular experiment or study is repeated, either by the same researcher or by different researchers, following the same experimental protocol. It is an essential principle in scientific research that helps to ensure the validity and reliability of research findings.

In medical research, reproducibility of results is crucial for establishing the effectiveness and safety of new treatments, interventions, or diagnostic tools. It involves conducting well-designed studies with adequate sample sizes, appropriate statistical analyses, and transparent reporting of methods and findings to allow other researchers to replicate the study and confirm or refute the results.

The lack of reproducibility in medical research has become a significant concern in recent years, as several high-profile studies have failed to produce consistent findings when replicated by other researchers. This has led to increased scrutiny of research practices and a call for greater transparency, rigor, and standardization in the conduct and reporting of medical research.

Cardiac arrest, also known as heart arrest, is a medical condition where the heart suddenly stops beating or functioning properly. This results in the cessation of blood flow to the rest of the body, including the brain, leading to loss of consciousness and pulse. Cardiac arrest is often caused by electrical disturbances in the heart that disrupt its normal rhythm, known as arrhythmias. If not treated immediately with cardiopulmonary resuscitation (CPR) and defibrillation, it can lead to death or permanent brain damage due to lack of oxygen supply. It's important to note that a heart attack is different from cardiac arrest; a heart attack occurs when blood flow to a part of the heart is blocked, often by a clot, causing damage to the heart muscle, but the heart continues to beat. However, a heart attack can sometimes trigger a cardiac arrest.

Signal transduction is the process by which a cell converts an extracellular signal, such as a hormone or neurotransmitter, into an intracellular response. This involves a series of molecular events that transmit the signal from the cell surface to the interior of the cell, ultimately resulting in changes in gene expression, protein activity, or metabolism.

The process typically begins with the binding of the extracellular signal to a receptor located on the cell membrane. This binding event activates the receptor, which then triggers a cascade of intracellular signaling molecules, such as second messengers, protein kinases, and ion channels. These molecules amplify and propagate the signal, ultimately leading to the activation or inhibition of specific cellular responses.

Signal transduction pathways are highly regulated and can be modulated by various factors, including other signaling molecules, post-translational modifications, and feedback mechanisms. Dysregulation of these pathways has been implicated in a variety of diseases, including cancer, diabetes, and neurological disorders.

Heart injuries, also known as cardiac injuries, refer to any damage or harm caused to the heart muscle, valves, or surrounding structures. This can result from various causes such as blunt trauma (e.g., car accidents, falls), penetrating trauma (e.g., gunshot wounds, stabbing), or medical conditions like heart attacks (myocardial infarction) and infections (e.g., myocarditis, endocarditis).

Some common types of heart injuries include:

1. Contusions: Bruising of the heart muscle due to blunt trauma.
2. Myocardial infarctions: Damage to the heart muscle caused by insufficient blood supply, often due to blocked coronary arteries.
3. Cardiac rupture: A rare but life-threatening condition where the heart muscle tears or breaks open, usually resulting from severe trauma or complications from a myocardial infarction.
4. Valvular damage: Disruption of the heart valves' function due to injury or infection, leading to leakage (regurgitation) or narrowing (stenosis).
5. Pericardial injuries: Damage to the pericardium, the sac surrounding the heart, which can result in fluid accumulation (pericardial effusion), inflammation (pericarditis), or tamponade (compression of the heart by excess fluid).
6. Arrhythmias: Irregular heart rhythms caused by damage to the heart's electrical conduction system.

Timely diagnosis and appropriate treatment are crucial for managing heart injuries, as they can lead to severe complications or even be fatal if left untreated.

Beta-1 adrenergic receptors (also known as β1-adrenergic receptors) are a type of G protein-coupled receptor found in the cell membrane. They are activated by the catecholamines, particularly noradrenaline (norepinephrine) and adrenaline (epinephrine), which are released by the sympathetic nervous system as part of the "fight or flight" response.

When a catecholamine binds to a β1-adrenergic receptor, it triggers a series of intracellular signaling events that ultimately lead to an increase in the rate and force of heart contractions, as well as an increase in renin secretion from the kidneys. These effects help to prepare the body for physical activity by increasing blood flow to the muscles and improving the efficiency of the cardiovascular system.

In addition to their role in the regulation of cardiovascular function, β1-adrenergic receptors have been implicated in a variety of physiological processes, including lipolysis (the breakdown of fat), glucose metabolism, and the regulation of mood and cognition.

Dysregulation of β1-adrenergic receptor signaling has been linked to several pathological conditions, including heart failure, hypertension, and anxiety disorders. As a result, β1-adrenergic receptors are an important target for the development of therapeutics used in the treatment of these conditions.

Cardiac surgical procedures are operations that are performed on the heart or great vessels (the aorta and vena cava) by cardiothoracic surgeons. These surgeries are often complex and require a high level of skill and expertise. Some common reasons for cardiac surgical procedures include:

1. Coronary artery bypass grafting (CABG): This is a surgery to improve blood flow to the heart in patients with coronary artery disease. During the procedure, a healthy blood vessel from another part of the body is used to create a detour around the blocked or narrowed portion of the coronary artery.
2. Valve repair or replacement: The heart has four valves that control blood flow through and out of the heart. If one or more of these valves become damaged or diseased, they may need to be repaired or replaced. This can be done using artificial valves or valves from animal or human donors.
3. Aneurysm repair: An aneurysm is a weakened area in the wall of an artery that can bulge out and potentially rupture. If an aneurysm occurs in the aorta, it may require surgical repair to prevent rupture.
4. Heart transplantation: In some cases, heart failure may be so severe that a heart transplant is necessary. This involves removing the diseased heart and replacing it with a healthy donor heart.
5. Arrhythmia surgery: Certain types of abnormal heart rhythms (arrhythmias) may require surgical treatment. One such procedure is called the Maze procedure, which involves creating a pattern of scar tissue in the heart to disrupt the abnormal electrical signals that cause the arrhythmia.
6. Congenital heart defect repair: Some people are born with structural problems in their hearts that require surgical correction. These may include holes between the chambers of the heart or abnormal blood vessels.

Cardiac surgical procedures carry risks, including bleeding, infection, stroke, and death. However, for many patients, these surgeries can significantly improve their quality of life and longevity.

A "knockout" mouse is a genetically engineered mouse in which one or more genes have been deleted or "knocked out" using molecular biology techniques. This allows researchers to study the function of specific genes and their role in various biological processes, as well as potential associations with human diseases. The mice are generated by introducing targeted DNA modifications into embryonic stem cells, which are then used to create a live animal. Knockout mice have been widely used in biomedical research to investigate gene function, disease mechanisms, and potential therapeutic targets.

Glomerular filtration rate (GFR) is a test used to check how well the kidneys are working. Specifically, it estimates how much blood passes through the glomeruli each minute. The glomeruli are the tiny fibers in the kidneys that filter waste from the blood. A lower GFR number means that the kidneys aren't working properly and may indicate kidney disease.

The GFR is typically calculated using a formula that takes into account the patient's serum creatinine level, age, sex, and race. The most commonly used formula is the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) equation. A normal GFR is usually above 90 mL/min/1.73m2, but this can vary depending on the individual's age and other factors.

Endothelin-1 is a small peptide (21 amino acids) and a potent vasoconstrictor, which means it narrows blood vessels. It is primarily produced by the endothelial cells that line the interior surface of blood vessels. Endothelin-1 plays a crucial role in regulating vascular tone, cell growth, and inflammation. Its dysregulation has been implicated in various cardiovascular diseases, such as hypertension and heart failure. It exerts its effects by binding to specific G protein-coupled receptors (ETA and ETB) on the surface of target cells.

C57BL/6 (C57 Black 6) is an inbred strain of laboratory mouse that is widely used in biomedical research. The term "inbred" refers to a strain of animals where matings have been carried out between siblings or other closely related individuals for many generations, resulting in a population that is highly homozygous at most genetic loci.

The C57BL/6 strain was established in 1920 by crossing a female mouse from the dilute brown (DBA) strain with a male mouse from the black strain. The resulting offspring were then interbred for many generations to create the inbred C57BL/6 strain.

C57BL/6 mice are known for their robust health, longevity, and ease of handling, making them a popular choice for researchers. They have been used in a wide range of biomedical research areas, including studies of cancer, immunology, neuroscience, cardiovascular disease, and metabolism.

One of the most notable features of the C57BL/6 strain is its sensitivity to certain genetic modifications, such as the introduction of mutations that lead to obesity or impaired glucose tolerance. This has made it a valuable tool for studying the genetic basis of complex diseases and traits.

Overall, the C57BL/6 inbred mouse strain is an important model organism in biomedical research, providing a valuable resource for understanding the genetic and molecular mechanisms underlying human health and disease.

Sensitivity and specificity are statistical measures used to describe the performance of a diagnostic test or screening tool in identifying true positive and true negative results.

* Sensitivity refers to the proportion of people who have a particular condition (true positives) who are correctly identified by the test. It is also known as the "true positive rate" or "recall." A highly sensitive test will identify most or all of the people with the condition, but may also produce more false positives.
* Specificity refers to the proportion of people who do not have a particular condition (true negatives) who are correctly identified by the test. It is also known as the "true negative rate." A highly specific test will identify most or all of the people without the condition, but may also produce more false negatives.

In medical testing, both sensitivity and specificity are important considerations when evaluating a diagnostic test. High sensitivity is desirable for screening tests that aim to identify as many cases of a condition as possible, while high specificity is desirable for confirmatory tests that aim to rule out the condition in people who do not have it.

It's worth noting that sensitivity and specificity are often influenced by factors such as the prevalence of the condition in the population being tested, the threshold used to define a positive result, and the reliability and validity of the test itself. Therefore, it's important to consider these factors when interpreting the results of a diagnostic test.

Digitalis glycosides are a type of cardiac glycoside that are derived from the foxglove plant (Digitalis purpurea) and related species. These compounds have a steroidal structure with a lactone ring attached to the molecule, which is responsible for their positive inotropic effects on the heart.

The two main digitalis glycosides used clinically are digoxin and digitoxin. They work by inhibiting the sodium-potassium pump in cardiac muscle cells, leading to an increase in intracellular calcium levels and a subsequent enhancement of myocardial contractility. This makes them useful in the treatment of heart failure and atrial arrhythmias such as atrial fibrillation.

However, digitalis glycosides have a narrow therapeutic index, meaning that there is only a small difference between their therapeutic and toxic doses. Therefore, they must be administered with caution and patients should be closely monitored for signs of toxicity such as nausea, vomiting, visual disturbances, and cardiac arrhythmias.

Regional blood flow (RBF) refers to the rate at which blood flows through a specific region or organ in the body, typically expressed in milliliters per minute per 100 grams of tissue (ml/min/100g). It is an essential physiological parameter that reflects the delivery of oxygen and nutrients to tissues while removing waste products. RBF can be affected by various factors such as metabolic demands, neural regulation, hormonal influences, and changes in blood pressure or vascular resistance. Measuring RBF is crucial for understanding organ function, diagnosing diseases, and evaluating the effectiveness of treatments.

Analysis of Variance (ANOVA) is a statistical technique used to compare the means of two or more groups and determine whether there are any significant differences between them. It is a way to analyze the variance in a dataset to determine whether the variability between groups is greater than the variability within groups, which can indicate that the groups are significantly different from one another.

ANOVA is based on the concept of partitioning the total variance in a dataset into two components: variance due to differences between group means (also known as "between-group variance") and variance due to differences within each group (also known as "within-group variance"). By comparing these two sources of variance, ANOVA can help researchers determine whether any observed differences between groups are statistically significant, or whether they could have occurred by chance.

ANOVA is a widely used technique in many areas of research, including biology, psychology, engineering, and business. It is often used to compare the means of two or more experimental groups, such as a treatment group and a control group, to determine whether the treatment had a significant effect. ANOVA can also be used to compare the means of different populations or subgroups within a population, to identify any differences that may exist between them.

Logistic models, specifically logistic regression models, are a type of statistical analysis used in medical and epidemiological research to identify the relationship between the risk of a certain health outcome or disease (dependent variable) and one or more independent variables, such as demographic factors, exposure variables, or other clinical measurements.

In contrast to linear regression models, logistic regression models are used when the dependent variable is binary or dichotomous in nature, meaning it can only take on two values, such as "disease present" or "disease absent." The model uses a logistic function to estimate the probability of the outcome based on the independent variables.

Logistic regression models are useful for identifying risk factors and estimating the strength of associations between exposures and health outcomes, adjusting for potential confounders, and predicting the probability of an outcome given certain values of the independent variables. They can also be used to develop clinical prediction rules or scores that can aid in decision-making and patient care.

Ventricular Tachycardia (VT) is a rapid heart rhythm that originates from the ventricles, the lower chambers of the heart. It is defined as three or more consecutive ventricular beats at a rate of 120 beats per minute or greater in a resting adult. This abnormal heart rhythm can cause the heart to pump less effectively, leading to inadequate blood flow to the body and potentially life-threatening conditions such as hypotension, shock, or cardiac arrest.

VT can be classified into three types based on its duration, hemodynamic stability, and response to treatment:

1. Non-sustained VT (NSVT): It lasts for less than 30 seconds and is usually well tolerated without causing significant symptoms or hemodynamic instability.
2. Sustained VT (SVT): It lasts for more than 30 seconds, causes symptoms such as palpitations, dizziness, shortness of breath, or chest pain, and may lead to hemodynamic instability.
3. Pulseless VT: It is a type of sustained VT that does not produce a pulse, blood pressure, or adequate cardiac output, requiring immediate electrical cardioversion or defibrillation to restore a normal heart rhythm.

VT can occur in people with various underlying heart conditions such as coronary artery disease, cardiomyopathy, valvular heart disease, congenital heart defects, and electrolyte imbalances. It can also be triggered by certain medications, substance abuse, or electrical abnormalities in the heart. Prompt diagnosis and treatment of VT are crucial to prevent complications and improve outcomes.

Oxidative stress is defined as an imbalance between the production of reactive oxygen species (free radicals) and the body's ability to detoxify them or repair the damage they cause. This imbalance can lead to cellular damage, oxidation of proteins, lipids, and DNA, disruption of cellular functions, and activation of inflammatory responses. Prolonged or excessive oxidative stress has been linked to various health conditions, including cancer, cardiovascular diseases, neurodegenerative disorders, and aging-related diseases.

'Rats, Inbred Dahl' are a strain of laboratory rats that have been selectively bred for research purposes. They were first developed by Dr. Lewis L. Dahl in the 1960s at the University of Colorado School of Medicine. These rats are known for their susceptibility to develop high blood pressure (hypertension) and related cardiovascular diseases, making them a valuable model for studying hypertension and its complications.

Inbred Dahl rats are typically divided into two main strains: the Dahl Salt-Sensitive (SS/JrHsdMcwi or SS) rat and the Dahl Salt-Resistant (SR/JrHsdMcwi or SR) rat. When fed a high-salt diet, the SS rats develop severe hypertension, kidney damage, and cardiac hypertrophy, while the SR rats are relatively resistant to these effects.

The Inbred Dahl rats have contributed significantly to our understanding of the genetic and environmental factors that contribute to the development of hypertension and related disorders. They continue to be widely used in biomedical research today.

Prosthesis failure is a term used to describe a situation where a prosthetic device, such as an artificial joint or limb, has stopped functioning or failed to meet its intended purpose. This can be due to various reasons, including mechanical failure, infection, loosening of the device, or a reaction to the materials used in the prosthesis.

Mechanical failure can occur due to wear and tear, manufacturing defects, or improper use of the prosthetic device. Infection can also lead to prosthesis failure, particularly in cases where the prosthesis is implanted inside the body. The immune system may react to the presence of the foreign material, leading to inflammation and infection.

Loosening of the prosthesis can also cause it to fail over time, as the device becomes less stable and eventually stops working properly. Additionally, some people may have a reaction to the materials used in the prosthesis, leading to tissue damage or other complications that can result in prosthesis failure.

In general, prosthesis failure can lead to decreased mobility, pain, and the need for additional surgeries or treatments to correct the problem. It is important for individuals with prosthetic devices to follow their healthcare provider's instructions carefully to minimize the risk of prosthesis failure and ensure that the device continues to function properly over time.

"Sex factors" is a term used in medicine and epidemiology to refer to the differences in disease incidence, prevalence, or response to treatment that are observed between males and females. These differences can be attributed to biological differences such as genetics, hormones, and anatomy, as well as social and cultural factors related to gender.

For example, some conditions such as autoimmune diseases, depression, and osteoporosis are more common in women, while others such as cardiovascular disease and certain types of cancer are more prevalent in men. Additionally, sex differences have been observed in the effectiveness and side effects of various medications and treatments.

It is important to consider sex factors in medical research and clinical practice to ensure that patients receive appropriate and effective care.

Renin is a medically recognized term and it is defined as:

"A protein (enzyme) that is produced and released by specialized cells (juxtaglomerular cells) in the kidney. Renin is a key component of the renin-angiotensin-aldosterone system (RAAS), which helps regulate blood pressure and fluid balance in the body.

When the kidney detects a decrease in blood pressure or a reduction in sodium levels, it releases renin into the bloodstream. Renin then acts on a protein called angiotensinogen, converting it to angiotensin I. Angiotensin-converting enzyme (ACE) subsequently converts angiotensin I to angiotensin II, which is a potent vasoconstrictor that narrows blood vessels and increases blood pressure.

Additionally, angiotensin II stimulates the adrenal glands to release aldosterone, a hormone that promotes sodium reabsorption in the kidneys and increases water retention, further raising blood pressure.

Therefore, renin plays a critical role in maintaining proper blood pressure and electrolyte balance in the body."

Medical Definition of Respiration:

Respiration, in physiology, is the process by which an organism takes in oxygen and gives out carbon dioxide. It's also known as breathing. This process is essential for most forms of life because it provides the necessary oxygen for cellular respiration, where the cells convert biochemical energy from nutrients into adenosine triphosphate (ATP), and releases waste products, primarily carbon dioxide.

In humans and other mammals, respiration is a two-stage process:

1. Breathing (or external respiration): This involves the exchange of gases with the environment. Air enters the lungs through the mouth or nose, then passes through the pharynx, larynx, trachea, and bronchi, finally reaching the alveoli where the actual gas exchange occurs. Oxygen from the inhaled air diffuses into the blood, while carbon dioxide, a waste product of metabolism, diffuses from the blood into the alveoli to be exhaled.

2. Cellular respiration (or internal respiration): This is the process by which cells convert glucose and other nutrients into ATP, water, and carbon dioxide in the presence of oxygen. The carbon dioxide produced during this process then diffuses out of the cells and into the bloodstream to be exhaled during breathing.

In summary, respiration is a vital physiological function that enables organisms to obtain the necessary oxygen for cellular metabolism while eliminating waste products like carbon dioxide.

A Receiver Operating Characteristic (ROC) curve is a graphical representation used in medical decision-making and statistical analysis to illustrate the performance of a binary classifier system, such as a diagnostic test or a machine learning algorithm. It's a plot that shows the tradeoff between the true positive rate (sensitivity) and the false positive rate (1 - specificity) for different threshold settings.

The x-axis of an ROC curve represents the false positive rate (the proportion of negative cases incorrectly classified as positive), while the y-axis represents the true positive rate (the proportion of positive cases correctly classified as positive). Each point on the curve corresponds to a specific decision threshold, with higher points indicating better performance.

The area under the ROC curve (AUC) is a commonly used summary measure that reflects the overall performance of the classifier. An AUC value of 1 indicates perfect discrimination between positive and negative cases, while an AUC value of 0.5 suggests that the classifier performs no better than chance.

ROC curves are widely used in healthcare to evaluate diagnostic tests, predictive models, and screening tools for various medical conditions, helping clinicians make informed decisions about patient care based on the balance between sensitivity and specificity.

Excitation-contraction coupling is a process in muscle physiology that describes how an electrical signal, the action potential, triggers the contraction of a muscle fiber. This process involves several steps:

1. The action potential travels along the sarcolemma (the muscle fiber's plasma membrane) and activates voltage-gated calcium channels in the T-tubules (invaginations of the sarcolemma).
2. The influx of calcium ions into the sarcoplasm (the intracellular fluid of the muscle fiber) triggers the release of calcium ions from the sarcoplasmic reticulum, a specialized endoplasmic reticulum found in muscle fibers, through ryanodine receptors.
3. The increased concentration of calcium ions in the sarcoplasm leads to the binding of calcium ions to troponin C, a protein associated with actin filaments in the myofibrils (the contractile units of muscle fibers).
4. This binding causes a conformational change in the tropomyosin-troponin complex, exposing the binding sites on actin for myosin heads.
5. The myosin heads then bind to actin and form cross-bridges, leading to the sliding of actin filaments relative to myosin filaments and muscle contraction.

Excitation-contraction coupling is a fundamental process in muscle physiology that allows for the rapid and coordinated contraction of muscles in response to electrical signals.

Angiotensin II is a potent vasoactive peptide hormone that plays a critical role in the renin-angiotensin-aldosterone system (RAAS), which is a crucial regulator of blood pressure and fluid balance in the body. It is formed from angiotensin I through the action of an enzyme called angiotensin-converting enzyme (ACE).

Angiotensin II has several physiological effects on various organs, including:

1. Vasoconstriction: Angiotensin II causes contraction of vascular smooth muscle, leading to an increase in peripheral vascular resistance and blood pressure.
2. Aldosterone release: Angiotensin II stimulates the adrenal glands to release aldosterone, a hormone that promotes sodium reabsorption and potassium excretion in the kidneys, thereby increasing water retention and blood volume.
3. Sympathetic nervous system activation: Angiotensin II activates the sympathetic nervous system, leading to increased heart rate and contractility, further contributing to an increase in blood pressure.
4. Thirst regulation: Angiotensin II stimulates the hypothalamus to increase thirst, promoting water intake and helping to maintain intravascular volume.
5. Cell growth and fibrosis: Angiotensin II has been implicated in various pathological processes, such as cell growth, proliferation, and fibrosis, which can contribute to the development of cardiovascular and renal diseases.

Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are two classes of medications commonly used in clinical practice to target the RAAS by blocking the formation or action of angiotensin II, respectively. These drugs have been shown to be effective in managing hypertension, heart failure, and chronic kidney disease.

Cardiac resynchronization therapy (CRT) devices are medical implants used to treat heart failure by helping the heart's lower chambers (ventricles) contract more efficiently and in a coordinated manner. These devices combine the functions of a pacemaker and an implantable cardioverter-defibrillator (ICD).

A CRT device has three leads: one that is placed in the right atrium, another in the right ventricle, and a third in the left ventricle through the coronary sinus vein. This configuration allows for simultaneous or near-simultaneous electrical activation of both ventricles, which can improve the heart's pumping efficiency and reduce symptoms associated with heart failure.

There are two main types of CRT devices:

1. Cardiac Resynchronization Therapy-Pacemaker (CRT-P): This device is primarily used to coordinate the contractions of both ventricles through electrical stimulation, using pacing therapy. It is appropriate for patients who do not require defibrillation therapy.
2. Cardiac Resynchronization Therapy-Defibrillator (CRT-D): This device combines the functions of a CRT-P and an ICD, providing both coordinated electrical stimulation and protection against life-threatening ventricular arrhythmias that can lead to sudden cardiac death.

The selection of a CRT device depends on the individual patient's needs and medical history. The primary goal of CRT devices is to improve heart function, reduce symptoms, enhance quality of life, and potentially increase survival in select patients with heart failure.

Nonparametric statistics is a branch of statistics that does not rely on assumptions about the distribution of variables in the population from which the sample is drawn. In contrast to parametric methods, nonparametric techniques make fewer assumptions about the data and are therefore more flexible in their application. Nonparametric tests are often used when the data do not meet the assumptions required for parametric tests, such as normality or equal variances.

Nonparametric statistical methods include tests such as the Wilcoxon rank-sum test (also known as the Mann-Whitney U test) for comparing two independent groups, the Wilcoxon signed-rank test for comparing two related groups, and the Kruskal-Wallis test for comparing more than two independent groups. These tests use the ranks of the data rather than the actual values to make comparisons, which allows them to be used with ordinal or continuous data that do not meet the assumptions of parametric tests.

Overall, nonparametric statistics provide a useful set of tools for analyzing data in situations where the assumptions of parametric methods are not met, and can help researchers draw valid conclusions from their data even when the data are not normally distributed or have other characteristics that violate the assumptions of parametric tests.

Postoperative complications refer to any unfavorable condition or event that occurs during the recovery period after a surgical procedure. These complications can vary in severity and may include, but are not limited to:

1. Infection: This can occur at the site of the incision or inside the body, such as pneumonia or urinary tract infection.
2. Bleeding: Excessive bleeding (hemorrhage) can lead to a drop in blood pressure and may require further surgical intervention.
3. Blood clots: These can form in the deep veins of the legs (deep vein thrombosis) and can potentially travel to the lungs (pulmonary embolism).
4. Wound dehiscence: This is when the surgical wound opens up, which can lead to infection and further complications.
5. Pulmonary issues: These include atelectasis (collapsed lung), pneumonia, or respiratory failure.
6. Cardiovascular problems: These include abnormal heart rhythms (arrhythmias), heart attack, or stroke.
7. Renal failure: This can occur due to various reasons such as dehydration, blood loss, or the use of certain medications.
8. Pain management issues: Inadequate pain control can lead to increased stress, anxiety, and decreased mobility.
9. Nausea and vomiting: These can be caused by anesthesia, opioid pain medication, or other factors.
10. Delirium: This is a state of confusion and disorientation that can occur in the elderly or those with certain medical conditions.

Prompt identification and management of these complications are crucial to ensure the best possible outcome for the patient.

A fatal outcome is a term used in medical context to describe a situation where a disease, injury, or illness results in the death of an individual. It is the most severe and unfortunate possible outcome of any medical condition, and is often used as a measure of the severity and prognosis of various diseases and injuries. In clinical trials and research, fatal outcome may be used as an endpoint to evaluate the effectiveness and safety of different treatments or interventions.

Practice guidelines, also known as clinical practice guidelines, are systematically developed statements that aim to assist healthcare professionals and patients in making informed decisions about appropriate health care for specific clinical circumstances. They are based on a thorough evaluation of the available scientific evidence, consensus of expert opinion, and consideration of patient preferences. Practice guidelines can cover a wide range of topics, including diagnosis, management, prevention, and treatment options for various medical conditions. They are intended to improve the quality and consistency of care, reduce unnecessary variations in practice, and promote evidence-based medicine. However, they should not replace clinical judgment or individualized patient care.

An animal model in medicine refers to the use of non-human animals in experiments to understand, predict, and test responses and effects of various biological and chemical interactions that may also occur in humans. These models are used when studying complex systems or processes that cannot be easily replicated or studied in human subjects, such as genetic manipulation or exposure to harmful substances. The choice of animal model depends on the specific research question being asked and the similarities between the animal's and human's biological and physiological responses. Examples of commonly used animal models include mice, rats, rabbits, guinea pigs, and non-human primates.

Intravenous (IV) infusion is a medical procedure in which liquids, such as medications, nutrients, or fluids, are delivered directly into a patient's vein through a needle or a catheter. This route of administration allows for rapid absorption and distribution of the infused substance throughout the body. IV infusions can be used for various purposes, including resuscitation, hydration, nutrition support, medication delivery, and blood product transfusion. The rate and volume of the infusion are carefully controlled to ensure patient safety and efficacy of treatment.

Pulmonary edema is a medical condition characterized by the accumulation of fluid in the alveoli (air sacs) and interstitial spaces (the area surrounding the alveoli) within the lungs. This buildup of fluid can lead to impaired gas exchange, resulting in shortness of breath, coughing, and difficulty breathing, especially when lying down. Pulmonary edema is often a complication of heart failure, but it can also be caused by other conditions such as pneumonia, trauma, or exposure to certain toxins.

In the early stages of pulmonary edema, patients may experience mild symptoms such as shortness of breath during physical activity. However, as the condition progresses, symptoms can become more severe and include:

* Severe shortness of breath, even at rest
* Wheezing or coughing up pink, frothy sputum
* Rapid breathing and heart rate
* Anxiety or restlessness
* Bluish discoloration of the skin (cyanosis) due to lack of oxygen

Pulmonary edema can be diagnosed through a combination of physical examination, medical history, chest X-ray, and other diagnostic tests such as echocardiography or CT scan. Treatment typically involves addressing the underlying cause of the condition, as well as providing supportive care such as supplemental oxygen, diuretics to help remove excess fluid from the body, and medications to help reduce anxiety and improve breathing. In severe cases, mechanical ventilation may be necessary to support respiratory function.

The forearm is the region of the upper limb between the elbow and the wrist. It consists of two bones, the radius and ulna, which are located side by side and run parallel to each other. The forearm is responsible for movements such as flexion, extension, supination, and pronation of the hand and wrist.

I believe there may be some confusion in your question. "Rabbits" is a common name used to refer to the Lagomorpha species, particularly members of the family Leporidae. They are small mammals known for their long ears, strong legs, and quick reproduction.

However, if you're referring to "rabbits" in a medical context, there is a term called "rabbit syndrome," which is a rare movement disorder characterized by repetitive, involuntary movements of the fingers, resembling those of a rabbit chewing. It is also known as "finger-chewing chorea." This condition is usually associated with certain medications, particularly antipsychotics, and typically resolves when the medication is stopped or adjusted.

Diabetes complications refer to a range of health issues that can develop as a result of poorly managed diabetes over time. These complications can affect various parts of the body and can be classified into two main categories: macrovascular and microvascular.

Macrovascular complications include:

* Cardiovascular disease (CVD): People with diabetes are at an increased risk of developing CVD, including coronary artery disease, peripheral artery disease, and stroke.
* Peripheral arterial disease (PAD): This condition affects the blood vessels that supply oxygen and nutrients to the limbs, particularly the legs. PAD can cause pain, numbness, or weakness in the legs and may increase the risk of amputation.

Microvascular complications include:

* Diabetic neuropathy: This is a type of nerve damage that can occur due to prolonged high blood sugar levels. It commonly affects the feet and legs, causing symptoms such as numbness, tingling, or pain.
* Diabetic retinopathy: This condition affects the blood vessels in the eye and can cause vision loss or blindness if left untreated.
* Diabetic nephropathy: This is a type of kidney damage that can occur due to diabetes. It can lead to kidney failure if not managed properly.

Other complications of diabetes include:

* Increased risk of infections, particularly skin and urinary tract infections.
* Slow healing of wounds, which can increase the risk of infection and amputation.
* Gum disease and other oral health problems.
* Hearing impairment.
* Sexual dysfunction.

Preventing or managing diabetes complications involves maintaining good blood sugar control, regular monitoring of blood glucose levels, following a healthy lifestyle, and receiving routine medical care.

"Cells, cultured" is a medical term that refers to cells that have been removed from an organism and grown in controlled laboratory conditions outside of the body. This process is called cell culture and it allows scientists to study cells in a more controlled and accessible environment than they would have inside the body. Cultured cells can be derived from a variety of sources, including tissues, organs, or fluids from humans, animals, or cell lines that have been previously established in the laboratory.

Cell culture involves several steps, including isolation of the cells from the tissue, purification and characterization of the cells, and maintenance of the cells in appropriate growth conditions. The cells are typically grown in specialized media that contain nutrients, growth factors, and other components necessary for their survival and proliferation. Cultured cells can be used for a variety of purposes, including basic research, drug development and testing, and production of biological products such as vaccines and gene therapies.

It is important to note that cultured cells may behave differently than they do in the body, and results obtained from cell culture studies may not always translate directly to human physiology or disease. Therefore, it is essential to validate findings from cell culture experiments using additional models and ultimately in clinical trials involving human subjects.

A single-blind method in medical research is a study design where the participants are unaware of the group or intervention they have been assigned to, but the researchers conducting the study know which participant belongs to which group. This is done to prevent bias from the participants' expectations or knowledge of their assignment, while still allowing the researchers to control the study conditions and collect data.

In a single-blind trial, the participants do not know whether they are receiving the active treatment or a placebo (a sham treatment that looks like the real thing but has no therapeutic effect), whereas the researcher knows which participant is receiving which intervention. This design helps to ensure that the participants' responses and outcomes are not influenced by their knowledge of the treatment assignment, while still allowing the researchers to assess the effectiveness or safety of the intervention being studied.

Single-blind methods are commonly used in clinical trials and other medical research studies where it is important to minimize bias and control for confounding variables that could affect the study results.

Exercise therapy is a type of medical treatment that uses physical movement and exercise to improve a patient's physical functioning, mobility, and overall health. It is often used as a component of rehabilitation programs for individuals who have experienced injuries, illnesses, or surgeries that have impaired their ability to move and function normally.

Exercise therapy may involve a range of activities, including stretching, strengthening, balance training, aerobic exercise, and functional training. The specific exercises used will depend on the individual's needs, goals, and medical condition.

The benefits of exercise therapy include:

* Improved strength and flexibility
* Increased endurance and stamina
* Enhanced balance and coordination
* Reduced pain and inflammation
* Improved cardiovascular health
* Increased range of motion and joint mobility
* Better overall physical functioning and quality of life.

Exercise therapy is typically prescribed and supervised by a healthcare professional, such as a physical therapist or exercise physiologist, who has experience working with individuals with similar medical conditions. The healthcare professional will create an individualized exercise program based on the patient's needs and goals, and will provide guidance and support to ensure that the exercises are performed safely and effectively.

Hypertrophic cardiomyopathy (HCM) is a genetic disorder characterized by the thickening of the heart muscle, specifically the ventricles (the lower chambers of the heart that pump blood out to the body). This thickening can make it harder for the heart to pump blood effectively, which can lead to symptoms such as shortness of breath, chest pain, and fatigue. In some cases, HCM can also cause abnormal heart rhythms (arrhythmias) and may increase the risk of sudden cardiac death.

The thickening of the heart muscle in HCM is caused by an overgrowth of the cells that make up the heart muscle, known as cardiomyocytes. This overgrowth can be caused by mutations in any one of several genes that encode proteins involved in the structure and function of the heart muscle. These genetic mutations are usually inherited from a parent, but they can also occur spontaneously in an individual with no family history of the disorder.

HCM is typically diagnosed using echocardiography (a type of ultrasound that uses sound waves to create images of the heart) and other diagnostic tests such as electrocardiogram (ECG) and cardiac magnetic resonance imaging (MRI). Treatment for HCM may include medications to help manage symptoms, lifestyle modifications, and in some cases, surgical procedures or implantable devices to help prevent or treat arrhythmias.

The endocardium is the innermost layer of tissue that lines the chambers of the heart and the valves between them. It is a thin, smooth membrane that is in contact with the blood within the heart. This layer helps to maintain the heart's internal environment, facilitates the smooth movement of blood through the heart, and provides a protective barrier against infection and other harmful substances. The endocardium is composed of simple squamous epithelial cells called endothelial cells, which are supported by a thin layer of connective tissue.

Adrenomedullin is a hormone that is produced and released by the adrenal glands, specifically from the chromaffin cells in the adrenal medulla. It is a small peptide made up of 52 amino acids and has various physiological functions, including vasodilation, bronchodilation, and inhibition of cell growth.

Adrenomedullin acts as a potent vasodilator by binding to specific G protein-coupled receptors in the vascular smooth muscle cells, leading to relaxation of the blood vessels. It also has a role in regulating blood pressure and fluid balance in the body.

In addition to its effects on the cardiovascular system, adrenomedullin has been shown to have anti-inflammatory and neuroprotective properties. It is involved in various physiological processes such as wound healing, tissue repair, and angiogenesis (the formation of new blood vessels).

Abnormal levels of adrenomedullin have been implicated in several disease states, including hypertension, heart failure, sepsis, and cancer. Therefore, measuring adrenomedullin levels in the body can provide valuable diagnostic and prognostic information for these conditions.

Heart neoplasms are abnormal growths or tumors that develop within the heart tissue. They can be benign (noncancerous) or malignant (cancerous). Benign tumors, such as myxomas and rhabdomyomas, are typically slower growing and less likely to spread, but they can still cause serious complications if they obstruct blood flow or damage heart valves. Malignant tumors, such as angiosarcomas and rhabdomyosarcomas, are fast-growing and have a higher risk of spreading to other parts of the body. Symptoms of heart neoplasms can include shortness of breath, chest pain, fatigue, and irregular heart rhythms. Treatment options depend on the type, size, and location of the tumor, and may include surgery, radiation therapy, or chemotherapy.

Kidney disease, also known as nephropathy or renal disease, refers to any functional or structural damage to the kidneys that impairs their ability to filter blood, regulate electrolytes, produce hormones, and maintain fluid balance. This damage can result from a wide range of causes, including diabetes, hypertension, glomerulonephritis, polycystic kidney disease, lupus, infections, drugs, toxins, and congenital or inherited disorders.

Depending on the severity and progression of the kidney damage, kidney diseases can be classified into two main categories: acute kidney injury (AKI) and chronic kidney disease (CKD). AKI is a sudden and often reversible loss of kidney function that occurs over hours to days, while CKD is a progressive and irreversible decline in kidney function that develops over months or years.

Symptoms of kidney diseases may include edema, proteinuria, hematuria, hypertension, electrolyte imbalances, metabolic acidosis, anemia, and decreased urine output. Treatment options depend on the underlying cause and severity of the disease and may include medications, dietary modifications, dialysis, or kidney transplantation.

Energy metabolism is the process by which living organisms produce and consume energy to maintain life. It involves a series of chemical reactions that convert nutrients from food, such as carbohydrates, fats, and proteins, into energy in the form of adenosine triphosphate (ATP).

The process of energy metabolism can be divided into two main categories: catabolism and anabolism. Catabolism is the breakdown of nutrients to release energy, while anabolism is the synthesis of complex molecules from simpler ones using energy.

There are three main stages of energy metabolism: glycolysis, the citric acid cycle (also known as the Krebs cycle), and oxidative phosphorylation. Glycolysis occurs in the cytoplasm of the cell and involves the breakdown of glucose into pyruvate, producing a small amount of ATP and nicotinamide adenine dinucleotide (NADH). The citric acid cycle takes place in the mitochondria and involves the further breakdown of pyruvate to produce more ATP, NADH, and carbon dioxide. Oxidative phosphorylation is the final stage of energy metabolism and occurs in the inner mitochondrial membrane. It involves the transfer of electrons from NADH and other electron carriers to oxygen, which generates a proton gradient across the membrane. This gradient drives the synthesis of ATP, producing the majority of the cell's energy.

Overall, energy metabolism is a complex and essential process that allows organisms to grow, reproduce, and maintain their bodily functions. Disruptions in energy metabolism can lead to various diseases, including diabetes, obesity, and neurodegenerative disorders.

Myosin Heavy Chains are the large, essential components of myosin molecules, which are responsible for the molecular motility in muscle cells. These heavy chains have a molecular weight of approximately 200 kDa and form the motor domain of myosin, which binds to actin filaments and hydrolyzes ATP to generate force and movement during muscle contraction. There are several different types of myosin heavy chains, each with specific roles in various tissues and cellular functions. In skeletal and cardiac muscles, for example, myosin heavy chains have distinct isoforms that contribute to the contractile properties of these tissues.

A sodium-calcium exchanger (NCX) is a type of ion transport protein found in the membranes of cells, including those of the heart and brain. It plays a crucial role in regulating intracellular calcium concentrations by facilitating the exchange of sodium ions for calcium ions across the cell membrane.

During each heartbeat, calcium ions enter the cardiac muscle cells to trigger contraction. After the contraction, the sodium-calcium exchanger helps remove excess calcium from the cell by exchanging it for sodium ions. This process is essential for maintaining normal calcium levels within the cell and allowing the heart muscle to relax between beats.

There are three main isoforms of the sodium-calcium exchanger (NCX1, NCX2, and NCX3) with different tissue distributions and functions. Dysfunction in sodium-calcium exchangers has been implicated in various pathological conditions such as heart failure, hypertension, and neurological disorders.

"Recovery of function" is a term used in medical rehabilitation to describe the process in which an individual regains the ability to perform activities or tasks that were previously difficult or impossible due to injury, illness, or disability. This can involve both physical and cognitive functions. The goal of recovery of function is to help the person return to their prior level of independence and participation in daily activities, work, and social roles as much as possible.

Recovery of function may be achieved through various interventions such as physical therapy, occupational therapy, speech-language therapy, and other rehabilitation strategies. The specific approach used will depend on the individual's needs and the nature of their impairment. Recovery of function can occur spontaneously as the body heals, or it may require targeted interventions to help facilitate the process.

It is important to note that recovery of function does not always mean a full return to pre-injury or pre-illness levels of ability. Instead, it often refers to the person's ability to adapt and compensate for any remaining impairments, allowing them to achieve their maximum level of functional independence and quality of life.

Clinical trials are research studies that involve human participants and are designed to evaluate the safety and efficacy of new medical treatments, drugs, devices, or behavioral interventions. The purpose of clinical trials is to determine whether a new intervention is safe, effective, and beneficial for patients, as well as to compare it with currently available treatments. Clinical trials follow a series of phases, each with specific goals and criteria, before a new intervention can be approved by regulatory authorities for widespread use.

Clinical trials are conducted according to a protocol, which is a detailed plan that outlines the study's objectives, design, methodology, statistical analysis, and ethical considerations. The protocol is developed and reviewed by a team of medical experts, statisticians, and ethicists, and it must be approved by an institutional review board (IRB) before the trial can begin.

Participation in clinical trials is voluntary, and participants must provide informed consent before enrolling in the study. Informed consent involves providing potential participants with detailed information about the study's purpose, procedures, risks, benefits, and alternatives, as well as their rights as research subjects. Participants can withdraw from the study at any time without penalty or loss of benefits to which they are entitled.

Clinical trials are essential for advancing medical knowledge and improving patient care. They help researchers identify new treatments, diagnostic tools, and prevention strategies that can benefit patients and improve public health. However, clinical trials also pose potential risks to participants, including adverse effects from experimental interventions, time commitment, and inconvenience. Therefore, it is important for researchers to carefully design and conduct clinical trials to minimize risks and ensure that the benefits outweigh the risks.

Muscle cells, also known as muscle fibers, are specialized cells that have the ability to contract and generate force, allowing for movement of the body and various internal organ functions. There are three main types of muscle tissue: skeletal, cardiac, and smooth.

Skeletal muscle cells are voluntary striated muscles attached to bones, enabling body movements and posture. They are multinucleated, with numerous nuclei located at the periphery of the cell. These cells are often called muscle fibers and can be quite large, extending the entire length of the muscle.

Cardiac muscle cells form the contractile tissue of the heart. They are also striated but have a single nucleus per cell and are interconnected by specialized junctions called intercalated discs, which help coordinate contraction throughout the heart.

Smooth muscle cells are found in various internal organs such as the digestive, respiratory, and urinary tracts, blood vessels, and the reproductive system. They are involuntary, non-striated muscles that control the internal organ functions. Smooth muscle cells have a single nucleus per cell and can either be spindle-shaped or stellate (star-shaped).

In summary, muscle cells are specialized contractile cells responsible for movement and various internal organ functions in the human body. They can be categorized into three types: skeletal, cardiac, and smooth, based on their structure, location, and function.

Anemia is a medical condition characterized by a lower than normal number of red blood cells or lower than normal levels of hemoglobin in the blood. Hemoglobin is an important protein in red blood cells that carries oxygen from the lungs to the rest of the body. Anemia can cause fatigue, weakness, shortness of breath, and a pale complexion because the body's tissues are not getting enough oxygen.

Anemia can be caused by various factors, including nutritional deficiencies (such as iron, vitamin B12, or folate deficiency), blood loss, chronic diseases (such as kidney disease or rheumatoid arthritis), inherited genetic disorders (such as sickle cell anemia or thalassemia), and certain medications.

There are different types of anemia, classified based on the underlying cause, size and shape of red blood cells, and the level of hemoglobin in the blood. Treatment for anemia depends on the underlying cause and may include dietary changes, supplements, medication, or blood transfusions.

In the context of medicine, risk is the probability or likelihood of an adverse health effect or the occurrence of a negative event related to treatment or exposure to certain hazards. It is usually expressed as a ratio or percentage and can be influenced by various factors such as age, gender, lifestyle, genetics, and environmental conditions. Risk assessment involves identifying, quantifying, and prioritizing risks to make informed decisions about prevention, mitigation, or treatment strategies.

Troponin T is a subunit of the troponin complex, which is a protein complex that plays a crucial role in muscle contraction. In particular, Troponin T is responsible for binding the troponin complex to tropomyosin, another protein that helps regulate muscle contraction.

In the context of medical diagnostics, Troponin T is often measured as a biomarker for heart damage. When heart muscle cells are damaged or die, such as in a myocardial infarction (heart attack), troponin T is released into the bloodstream. Therefore, measuring the levels of Troponin T in the blood can help diagnose and assess the severity of heart damage.

It's important to note that Troponin T is specific to cardiac muscle cells, which makes it a more reliable biomarker for heart damage than other markers that may also be found in skeletal muscle cells. However, it's worth noting that Troponin T levels can also be elevated in conditions other than heart attacks, such as heart failure, myocarditis, and pulmonary embolism, so clinical context is important when interpreting test results.

Benzazepines are a class of heterocyclic compounds that contain a benzene fused to a diazepine ring. In the context of pharmaceuticals, benzazepines refer to a group of drugs with various therapeutic uses, such as antipsychotics and antidepressants. Some examples of benzazepine-derived drugs include clozapine, olanzapine, and loxoprofen. These drugs have complex mechanisms of action, often involving multiple receptor systems in the brain.

Blood flow velocity is the speed at which blood travels through a specific part of the vascular system. It is typically measured in units of distance per time, such as centimeters per second (cm/s) or meters per second (m/s). Blood flow velocity can be affected by various factors, including cardiac output, vessel diameter, and viscosity of the blood. Measuring blood flow velocity is important in diagnosing and monitoring various medical conditions, such as heart disease, stroke, and peripheral vascular disease.

A registry in the context of medicine is a collection or database of standardized information about individuals who share a certain condition or attribute, such as a disease, treatment, exposure, or demographic group. These registries are used for various purposes, including:

* Monitoring and tracking the natural history of diseases and conditions
* Evaluating the safety and effectiveness of medical treatments and interventions
* Conducting research and generating hypotheses for further study
* Providing information to patients, clinicians, and researchers
* Informing public health policy and decision-making

Registries can be established for a wide range of purposes, including disease-specific registries (such as cancer or diabetes registries), procedure-specific registries (such as joint replacement or cardiac surgery registries), and population-based registries (such as birth defects or cancer registries). Data collected in registries may include demographic information, clinical data, laboratory results, treatment details, and outcomes.

Registries can be maintained by a variety of organizations, including hospitals, clinics, academic medical centers, professional societies, government agencies, and industry. Participation in registries is often voluntary, although some registries may require informed consent from participants. Data collected in registries are typically de-identified to protect the privacy of individuals.

I'm sorry for any confusion, but "Linear Models" is actually a term from the field of statistics and machine learning, rather than medicine. A linear model is a type of statistical model that is used to analyze the relationship between two or more variables. In a linear model, the relationship between the dependent variable (the outcome or result) and the independent variable(s) (the factors being studied) is assumed to be linear, meaning that it can be described by a straight line on a graph.

The equation for a simple linear model with one independent variable (x) and one dependent variable (y) looks like this:

y = β0 + β1*x + ε

In this equation, β0 is the y-intercept or the value of y when x equals zero, β1 is the slope or the change in y for each unit increase in x, and ε is the error term or the difference between the actual values of y and the predicted values of y based on the linear model.

Linear models are widely used in medical research to study the relationship between various factors (such as exposure to a risk factor or treatment) and health outcomes (such as disease incidence or mortality). They can also be used to adjust for confounding variables, which are factors that may influence both the independent variable and the dependent variable, and thus affect the observed relationship between them.

Radionuclide ventriculography (RVG), also known as multiple-gated acquisition scan (MUGA) or nuclear ventriculography, is a non-invasive diagnostic test used to evaluate the function and pumping efficiency of the heart's lower chambers (ventricles). The test involves the use of radioactive tracers (radionuclides) that are injected into the patient's bloodstream. A specialized camera then captures images of the distribution of the radionuclide within the heart, which allows for the measurement of ventricular volumes and ejection fraction (EF), an important indicator of cardiac function.

During the test, the patient lies on a table while the camera takes pictures of their heart as it beats. The images are captured in "gates" or intervals, corresponding to different phases of the cardiac cycle. This allows for the calculation of ventricular volumes and EF at each phase of the cycle, providing detailed information about the heart's pumping ability.

RVG is commonly used to assess patients with known or suspected heart disease, including those who have had a heart attack, heart failure, valvular heart disease, or cardiomyopathy. It can also be used to monitor the effectiveness of treatment and to evaluate changes in cardiac function over time.

Gene expression is the process by which the information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. This process involves several steps: transcription, RNA processing, and translation. During transcription, the genetic information in DNA is copied into a complementary RNA molecule, known as messenger RNA (mRNA). The mRNA then undergoes RNA processing, which includes adding a cap and tail to the mRNA and splicing out non-coding regions called introns. The resulting mature mRNA is then translated into a protein on ribosomes in the cytoplasm through the process of translation.

The regulation of gene expression is a complex and highly controlled process that allows cells to respond to changes in their environment, such as growth factors, hormones, and stress signals. This regulation can occur at various stages of gene expression, including transcriptional activation or repression, RNA processing, mRNA stability, and translation. Dysregulation of gene expression has been implicated in many diseases, including cancer, genetic disorders, and neurological conditions.

Adrenergic beta-1 receptor antagonists, also known as beta blockers, are a class of medications that block the effects of adrenaline and noradrenaline (also known as epinephrine and norepinephrine) on beta-1 receptors. These receptors are found primarily in the heart and kidneys, where they mediate various physiological responses such as increased heart rate, contractility, and conduction velocity, as well as renin release from the kidneys.

By blocking the action of adrenaline and noradrenaline on these receptors, beta blockers can help to reduce heart rate, lower blood pressure, decrease the force of heart contractions, and improve symptoms of angina (chest pain). They are commonly used to treat a variety of conditions, including hypertension, heart failure, arrhythmias, and certain types of tremors. Examples of beta blockers include metoprolol, atenolol, and propranolol.

Ligation, in the context of medical terminology, refers to the process of tying off a part of the body, usually blood vessels or tissue, with a surgical suture or another device. The goal is to stop the flow of fluids such as blood or other substances within the body. It is commonly used during surgeries to control bleeding or to block the passage of fluids, gases, or solids in various parts of the body.

In medical terms, "outpatients" refers to individuals who receive medical care or treatment at a hospital or clinic without being admitted as inpatients. This means that they do not stay overnight or for an extended period; instead, they visit the healthcare facility for specific services such as consultations, diagnostic tests, treatments, or follow-up appointments and then return home afterward. Outpatient care can include various services like primary care, specialty clinics, dental care, physical therapy, and more. It is often more convenient and cost-effective than inpatient care, as it allows patients to maintain their daily routines while receiving necessary medical attention.

Fetal heart rate (FHR) is the number of times a fetus's heart beats in one minute. It is measured through the use of a fetoscope, Doppler ultrasound device, or cardiotocograph (CTG). A normal FHR ranges from 120 to 160 beats per minute (bpm), although it can vary throughout pregnancy and is usually faster than an adult's heart rate. Changes in the FHR pattern may indicate fetal distress, hypoxia, or other conditions that require medical attention. Regular monitoring of FHR during pregnancy, labor, and delivery helps healthcare providers assess fetal well-being and ensure a safe outcome for both the mother and the baby.

Body weight is the measure of the force exerted on a scale or balance by an object's mass, most commonly expressed in units such as pounds (lb) or kilograms (kg). In the context of medical definitions, body weight typically refers to an individual's total weight, which includes their skeletal muscle, fat, organs, and bodily fluids.

Healthcare professionals often use body weight as a basic indicator of overall health status, as it can provide insights into various aspects of a person's health, such as nutritional status, metabolic function, and risk factors for certain diseases. For example, being significantly underweight or overweight can increase the risk of developing conditions like malnutrition, diabetes, heart disease, and certain types of cancer.

It is important to note that body weight alone may not provide a complete picture of an individual's health, as it does not account for factors such as muscle mass, bone density, or body composition. Therefore, healthcare professionals often use additional measures, such as body mass index (BMI), waist circumference, and blood tests, to assess overall health status more comprehensively.

A cross-over study is a type of experimental design in which participants receive two or more interventions in a specific order. After a washout period, each participant receives the opposite intervention(s). The primary advantage of this design is that it controls for individual variability by allowing each participant to act as their own control.

In medical research, cross-over studies are often used to compare the efficacy or safety of two treatments. For example, a researcher might conduct a cross-over study to compare the effectiveness of two different medications for treating high blood pressure. Half of the participants would be randomly assigned to receive one medication first and then switch to the other medication after a washout period. The other half of the participants would receive the opposite order of treatments.

Cross-over studies can provide valuable insights into the relative merits of different interventions, but they also have some limitations. For example, they may not be suitable for studying conditions that are chronic or irreversible, as it may not be possible to completely reverse the effects of the first intervention before administering the second one. Additionally, carryover effects from the first intervention can confound the results if they persist into the second treatment period.

Overall, cross-over studies are a useful tool in medical research when used appropriately and with careful consideration of their limitations.

Sarcolemma is the medical term for the cell membrane that surrounds a muscle fiber or a skeletal muscle cell. It is responsible for providing protection and structure to the muscle fiber, as well as regulating the movement of ions and other molecules in and out of the cell. The sarcolemma plays a crucial role in the excitation-contraction coupling process that allows muscles to contract and relax.

The sarcolemma is composed of two main layers: the outer plasma membrane, which is similar to the cell membranes of other cells, and the inner basal lamina, which provides structural support and helps to anchor the muscle fiber to surrounding tissues. The sarcolemma also contains various ion channels, receptors, and transporters that are involved in regulating muscle function and communication with other cells.

Damage to the sarcolemma can lead to a variety of muscle disorders, including muscular dystrophy and myasthenia gravis.

Deoxyepinephrine is not a recognized or established medical term or concept in the field of pharmacology, physiology, or clinical medicine. It appears to be a variation or misspelling of "deoxyepinephrines," which refers to a group of biogenic amines that are structurally related to catecholamines (such as epinephrine and norepinephrine) but lack a hydroxyl group (-OH) in the beta-carbon position of their side chain.

Deoxyepinephrines have been studied in laboratory settings for their potential roles in various physiological processes, such as neurotransmission and vasoconstriction, but they are not commonly used or discussed in clinical contexts. Therefore, there is no established medical definition for "deoxyepinephrine" as a standalone term.

A cross-sectional study is a type of observational research design that examines the relationship between variables at one point in time. It provides a snapshot or a "cross-section" of the population at a particular moment, allowing researchers to estimate the prevalence of a disease or condition and identify potential risk factors or associations.

In a cross-sectional study, data is collected from a sample of participants at a single time point, and the variables of interest are measured simultaneously. This design can be used to investigate the association between exposure and outcome, but it cannot establish causality because it does not follow changes over time.

Cross-sectional studies can be conducted using various data collection methods, such as surveys, interviews, or medical examinations. They are often used in epidemiology to estimate the prevalence of a disease or condition in a population and to identify potential risk factors that may contribute to its development. However, because cross-sectional studies only provide a snapshot of the population at one point in time, they cannot account for changes over time or determine whether exposure preceded the outcome.

Therefore, while cross-sectional studies can be useful for generating hypotheses and identifying potential associations between variables, further research using other study designs, such as cohort or case-control studies, is necessary to establish causality and confirm any findings.

Diagnostic techniques in cardiovascular medicine refer to the various tests and methods used to diagnose and evaluate conditions related to the heart and blood vessels. These techniques can be non-invasive or invasive and are designed to provide critical information about a patient's cardiovascular health, such as heart function, blood flow, and the presence of any abnormalities or diseases. Here are some common diagnostic techniques used in cardiovascular medicine:

1. Electrocardiogram (ECG): An ECG is a non-invasive test that records the electrical activity of the heart. It can help detect heart conditions such as arrhythmias, heart attacks, and structural abnormalities.
2. Echocardiogram: This is a non-invasive ultrasound test that produces images of the heart's structures, including the chambers, valves, and major blood vessels. It can help assess heart function, identify damage from heart attacks, and detect various cardiovascular conditions.
3. Stress testing: A stress test involves exercising on a treadmill or stationary bike while being monitored by an ECG to evaluate the heart's response to physical exertion. It can help diagnose coronary artery disease, assess exercise capacity, and determine the need for further testing or treatment.
4. Cardiac catheterization: This is an invasive procedure where a thin, flexible tube (catheter) is inserted into a blood vessel in the arm or leg and guided to the heart. It can help diagnose and treat various cardiovascular conditions, such as blocked arteries, heart valve problems, and congenital heart defects.
5. Coronary angiography: During a cardiac catheterization, a special dye is injected into the coronary arteries to visualize blood flow using X-ray imaging. This can help identify blockages or narrowing in the coronary arteries and guide treatment decisions.
6. Nuclear stress testing: This test combines the use of a radioactive tracer with exercise or pharmacological stress to evaluate heart function and blood flow. It can help diagnose coronary artery disease, assess the effectiveness of treatments, and determine the need for further interventions.
7. Cardiac magnetic resonance imaging (MRI): This non-invasive imaging technique uses a strong magnetic field and radio waves to create detailed images of the heart's structure and function. It can help diagnose various cardiovascular conditions, such as heart muscle disorders, valve problems, and congenital heart defects.
8. Transesophageal echocardiography (TEE): This is a specialized ultrasound technique where a probe is inserted through the esophagus to obtain detailed images of the heart's structure and function. It can help diagnose conditions such as blood clots, valve problems, and infective endocarditis.
9. Positron emission tomography (PET) scanning: This imaging technique uses a small amount of radioactive tracer to evaluate the metabolic activity of the heart. It can help diagnose coronary artery disease, assess the effectiveness of treatments, and determine the need for further interventions.
10. Electrophysiology studies (EPS): These are invasive procedures where catheters are inserted into the heart to study its electrical system. They can help diagnose and treat various arrhythmias, such as atrial fibrillation, ventricular tachycardia, and Wolff-Parkinson-White syndrome.

Benzimidazoles are a class of heterocyclic compounds containing a benzene fused to a imidazole ring. They have a wide range of pharmacological activities and are used in the treatment of various diseases. Some of the benzimidazoles are used as antiparasitics, such as albendazole and mebendazole, which are effective against a variety of worm infestations. Other benzimidazoles have antifungal properties, such as thiabendazole and fuberidazole, and are used to treat fungal infections. Additionally, some benzimidazoles have been found to have anti-cancer properties and are being investigated for their potential use in cancer therapy.

Organ size refers to the volume or physical measurement of an organ in the body of an individual. It can be described in terms of length, width, and height or by using specialized techniques such as imaging studies (like CT scans or MRIs) to determine the volume. The size of an organ can vary depending on factors such as age, sex, body size, and overall health status. Changes in organ size may indicate various medical conditions, including growths, inflammation, or atrophy.

Endothelin receptors are a type of G protein-coupled receptor that bind to endothelin, a potent vasoconstrictor peptide. There are two main types of endothelin receptors: ETA and ETB. ETA receptors are found in vascular smooth muscle cells and activate phospholipase C, leading to an increase in intracellular calcium and subsequent contraction of the smooth muscle. ETB receptors are found in both endothelial cells and vascular smooth muscle cells. In endothelial cells, ETB receptor activation leads to the release of nitric oxide and prostacyclin, which cause vasodilation. In vascular smooth muscle cells, ETB receptor activation causes vasoconstriction through a mechanism that is not fully understood.

Endothelin receptors play important roles in regulating blood flow, vascular remodeling, and the development of cardiovascular diseases such as hypertension and heart failure. They are also involved in the regulation of cell growth, differentiation, and apoptosis in various tissues.

Apoptosis is a programmed and controlled cell death process that occurs in multicellular organisms. It is a natural process that helps maintain tissue homeostasis by eliminating damaged, infected, or unwanted cells. During apoptosis, the cell undergoes a series of morphological changes, including cell shrinkage, chromatin condensation, and fragmentation into membrane-bound vesicles called apoptotic bodies. These bodies are then recognized and engulfed by neighboring cells or phagocytic cells, preventing an inflammatory response. Apoptosis is regulated by a complex network of intracellular signaling pathways that involve proteins such as caspases, Bcl-2 family members, and inhibitors of apoptosis (IAPs).

Enoximone is a medication that belongs to a class of drugs called phosphodiesterase inhibitors. It works by increasing the levels of cyclic adenosine monophosphate (cAMP) in the heart, which leads to relaxation of the heart muscle and improved pumping ability. Enoximone is used to treat chronic heart failure and is often given intravenously in a hospital setting.

The medical definition of 'Enoximone' is:

A selective inhibitor of type III phosphodiesterase, which increases the concentration of cyclic adenosine monophosphate (cAMP) in the heart muscle, leading to vasodilation and positive inotropic effects. Enoximone is used in the treatment of congestive heart failure.

Oxygen is a colorless, odorless, tasteless gas that constitutes about 21% of the earth's atmosphere. It is a crucial element for human and most living organisms as it is vital for respiration. Inhaled oxygen enters the lungs and binds to hemoglobin in red blood cells, which carries it to tissues throughout the body where it is used to convert nutrients into energy and carbon dioxide, a waste product that is exhaled.

Medically, supplemental oxygen therapy may be provided to patients with conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, heart failure, or other medical conditions that impair the body's ability to extract sufficient oxygen from the air. Oxygen can be administered through various devices, including nasal cannulas, face masks, and ventilators.

Enalaprilat is a medication that belongs to a class of drugs called ACE (angiotensin-converting enzyme) inhibitors. It is the active metabolite of Enalapril. Enalaprilat works by blocking the action of angiotensin-converting enzyme, which helps to relax and widen blood vessels, thereby reducing blood pressure and increasing blood flow.

Enalaprilat is primarily used to treat hypertension (high blood pressure), heart failure, and to improve survival after a heart attack. It is administered intravenously in a hospital setting, and its effects are usually seen within 15 minutes of administration. Common side effects of Enalaprilat include hypotension (low blood pressure), dizziness, headache, and nausea.

Heart valve prosthesis implantation is a surgical procedure where an artificial heart valve is inserted to replace a damaged or malfunctioning native heart valve. This can be necessary for patients with valvular heart disease, including stenosis (narrowing) or regurgitation (leaking), who do not respond to medical management and are at risk of heart failure or other complications.

There are two main types of artificial heart valves used in prosthesis implantation: mechanical valves and biological valves. Mechanical valves are made of synthetic materials, such as carbon and metal, and can last a long time but require lifelong anticoagulation therapy to prevent blood clots from forming. Biological valves, on the other hand, are made from animal or human tissue and typically do not require anticoagulation therapy but may have a limited lifespan and may need to be replaced in the future.

The decision to undergo heart valve prosthesis implantation is based on several factors, including the patient's age, overall health, type and severity of valvular disease, and personal preferences. The procedure can be performed through traditional open-heart surgery or minimally invasive techniques, such as robotic-assisted surgery or transcatheter aortic valve replacement (TAVR). Recovery time varies depending on the approach used and individual patient factors.

Epidemiologic methods are systematic approaches used to investigate and understand the distribution, determinants, and outcomes of health-related events or diseases in a population. These methods are applied to study the patterns of disease occurrence and transmission, identify risk factors and causes, and evaluate interventions for prevention and control. The core components of epidemiologic methods include:

1. Descriptive Epidemiology: This involves the systematic collection and analysis of data on the who, what, when, and where of health events to describe their distribution in a population. It includes measures such as incidence, prevalence, mortality, and morbidity rates, as well as geographic and temporal patterns.

2. Analytical Epidemiology: This involves the use of statistical methods to examine associations between potential risk factors and health outcomes. It includes observational studies (cohort, case-control, cross-sectional) and experimental studies (randomized controlled trials). The goal is to identify causal relationships and quantify the strength of associations.

3. Experimental Epidemiology: This involves the design and implementation of interventions or experiments to test hypotheses about disease prevention and control. It includes randomized controlled trials, community trials, and other experimental study designs.

4. Surveillance and Monitoring: This involves ongoing systematic collection, analysis, and interpretation of health-related data for early detection, tracking, and response to health events or diseases.

5. Ethical Considerations: Epidemiologic studies must adhere to ethical principles such as respect for autonomy, beneficence, non-maleficence, and justice. This includes obtaining informed consent, ensuring confidentiality, and minimizing harm to study participants.

Overall, epidemiologic methods provide a framework for investigating and understanding the complex interplay between host, agent, and environmental factors that contribute to the occurrence of health-related events or diseases in populations.

Pulmonary hypertension is a medical condition characterized by increased blood pressure in the pulmonary arteries, which are the blood vessels that carry blood from the right side of the heart to the lungs. This results in higher than normal pressures in the pulmonary circulation and can lead to various symptoms and complications.

Pulmonary hypertension is typically defined as a mean pulmonary artery pressure (mPAP) greater than or equal to 25 mmHg at rest, as measured by right heart catheterization. The World Health Organization (WHO) classifies pulmonary hypertension into five groups based on the underlying cause:

1. Pulmonary arterial hypertension (PAH): This group includes idiopathic PAH, heritable PAH, drug-induced PAH, and associated PAH due to conditions such as connective tissue diseases, HIV infection, portal hypertension, congenital heart disease, and schistosomiasis.
2. Pulmonary hypertension due to left heart disease: This group includes conditions that cause elevated left atrial pressure, such as left ventricular systolic or diastolic dysfunction, valvular heart disease, and congenital cardiovascular shunts.
3. Pulmonary hypertension due to lung diseases and/or hypoxia: This group includes chronic obstructive pulmonary disease (COPD), interstitial lung disease, sleep-disordered breathing, alveolar hypoventilation disorders, and high altitude exposure.
4. Chronic thromboembolic pulmonary hypertension (CTEPH): This group includes persistent obstruction of the pulmonary arteries due to organized thrombi or emboli.
5. Pulmonary hypertension with unclear and/or multifactorial mechanisms: This group includes hematologic disorders, systemic disorders, metabolic disorders, and other conditions that can cause pulmonary hypertension but do not fit into the previous groups.

Symptoms of pulmonary hypertension may include shortness of breath, fatigue, chest pain, lightheadedness, and syncope (fainting). Diagnosis typically involves a combination of medical history, physical examination, imaging studies, and invasive testing such as right heart catheterization. Treatment depends on the underlying cause but may include medications, oxygen therapy, pulmonary rehabilitation, and, in some cases, surgical intervention.

Aging is a complex, progressive and inevitable process of bodily changes over time, characterized by the accumulation of cellular damage and degenerative changes that eventually lead to increased vulnerability to disease and death. It involves various biological, genetic, environmental, and lifestyle factors that contribute to the decline in physical and mental functions. The medical field studies aging through the discipline of gerontology, which aims to understand the underlying mechanisms of aging and develop interventions to promote healthy aging and extend the human healthspan.

"Length of Stay" (LOS) is a term commonly used in healthcare to refer to the amount of time a patient spends receiving care in a hospital, clinic, or other healthcare facility. It is typically measured in hours, days, or weeks and can be used as a metric for various purposes such as resource planning, quality assessment, and reimbursement. The length of stay can vary depending on the type of illness or injury, the severity of the condition, the patient's response to treatment, and other factors. It is an important consideration in healthcare management and can have significant implications for both patients and providers.

Muscle proteins are a type of protein that are found in muscle tissue and are responsible for providing structure, strength, and functionality to muscles. The two major types of muscle proteins are:

1. Contractile proteins: These include actin and myosin, which are responsible for the contraction and relaxation of muscles. They work together to cause muscle movement by sliding along each other and shortening the muscle fibers.
2. Structural proteins: These include titin, nebulin, and desmin, which provide structural support and stability to muscle fibers. Titin is the largest protein in the human body and acts as a molecular spring that helps maintain the integrity of the sarcomere (the basic unit of muscle contraction). Nebulin helps regulate the length of the sarcomere, while desmin forms a network of filaments that connects adjacent muscle fibers together.

Overall, muscle proteins play a critical role in maintaining muscle health and function, and their dysregulation can lead to various muscle-related disorders such as muscular dystrophy, myopathies, and sarcopenia.

Diabetes Mellitus is a chronic metabolic disorder characterized by elevated levels of glucose in the blood (hyperglycemia) due to absolute or relative deficiency in insulin secretion and/or insulin action. There are two main types: Type 1 diabetes, which results from the autoimmune destruction of pancreatic beta cells leading to insulin deficiency, and Type 2 diabetes, which is associated with insulin resistance and relative insulin deficiency.

Type 1 diabetes typically presents in childhood or young adulthood, while Type 2 diabetes tends to occur later in life, often in association with obesity and physical inactivity. Both types of diabetes can lead to long-term complications such as damage to the eyes, kidneys, nerves, and cardiovascular system if left untreated or not well controlled.

The diagnosis of diabetes is usually made based on fasting plasma glucose levels, oral glucose tolerance tests, or hemoglobin A1c (HbA1c) levels. Treatment typically involves lifestyle modifications such as diet and exercise, along with medications to lower blood glucose levels and manage associated conditions.

Lisinopril is an angiotensin-converting enzyme (ACE) inhibitor, which is a type of medication used to treat various cardiovascular conditions. It works by blocking the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor, resulting in relaxation and widening of blood vessels, decreased blood pressure, and increased blood flow.

Lisinopril is primarily used to treat hypertension (high blood pressure), congestive heart failure, and to improve survival after a heart attack. It may also be used to protect the kidneys from damage due to diabetes or high blood pressure. Additionally, it has been shown to reduce proteinuria (excess protein in urine) in patients with diabetic nephropathy.

Common side effects of Lisinopril include dizziness, headache, fatigue, and cough. More serious side effects may include angioedema (rapid swelling of the face, lips, tongue, or throat), hyperkalemia (elevated potassium levels), and impaired kidney function.

It is important to follow the prescribing physician's instructions carefully when taking Lisinopril and to report any unusual symptoms promptly. Regular monitoring of blood pressure, kidney function, and electrolyte levels may be necessary during treatment with this medication.

Transgenic mice are genetically modified rodents that have incorporated foreign DNA (exogenous DNA) into their own genome. This is typically done through the use of recombinant DNA technology, where a specific gene or genetic sequence of interest is isolated and then introduced into the mouse embryo. The resulting transgenic mice can then express the protein encoded by the foreign gene, allowing researchers to study its function in a living organism.

The process of creating transgenic mice usually involves microinjecting the exogenous DNA into the pronucleus of a fertilized egg, which is then implanted into a surrogate mother. The offspring that result from this procedure are screened for the presence of the foreign DNA, and those that carry the desired genetic modification are used to establish a transgenic mouse line.

Transgenic mice have been widely used in biomedical research to model human diseases, study gene function, and test new therapies. They provide a valuable tool for understanding complex biological processes and developing new treatments for a variety of medical conditions.

Electric countershock, also known as defibrillation, is a medical procedure that uses an electric current to restore normal heart rhythm in certain types of cardiac arrhythmias, such as ventricular fibrillation or pulseless ventricular tachycardia. The procedure involves delivering a therapeutic dose of electrical energy to the heart through electrodes placed on the chest wall or directly on the heart. This electric current helps to depolarize a large number of cardiac cells simultaneously, which can help to interrupt the abnormal electrical activity in the heart and allow the normal conduction system to regain control and restore a normal rhythm. Electric countershock is typically delivered using an automated external defibrillator (AED) or a manual defibrillator, and it is a critical component of advanced cardiac life support (ACLS).

Troponin I is a protein that is found in the cardiac muscle cells (myocytes) of the heart. It is a component of the troponin complex, which also includes troponin C and troponin T, that regulates the calcium-mediated interaction between actin and myosin filaments during muscle contraction.

Troponin I is specific to the cardiac muscle tissue, making it a useful biomarker for detecting damage to the heart muscle. When there is injury or damage to the heart muscle cells, such as during a heart attack (myocardial infarction), troponin I is released into the bloodstream.

Measurement of cardiac troponin I levels in the blood is used in the diagnosis and management of acute coronary syndrome (ACS) and other conditions that cause damage to the heart muscle. Elevated levels of troponin I in the blood are indicative of myocardial injury, and the degree of elevation can help determine the severity of the injury.

Cardiomyoplasty is a surgical procedure that involves wrapping skeletal muscle around the heart to help it pump more effectively. In this procedure, the surgeon typically uses the latissimus dorsi muscle, which is a large muscle in the back, and connects it to the heart with a special type of suture called a Dacron mesh.

The skeletal muscle used in cardiomyoplasty can be stimulated to contract using an electrical impulse, which helps to augment the contractions of the heart and improve its overall function. This procedure is typically reserved for patients with severe heart failure who are not candidates for other forms of treatment, such as a heart transplant.

While cardiomyoplasty has shown promise in some studies, it is still considered an experimental procedure and is not widely performed due to the risks involved and the limited number of patients who may benefit from it. Some of the potential complications of this procedure include infection, bleeding, muscle weakness, and damage to the heart or surrounding tissues.

Ventricular Fibrillation (VF) is a type of cardiac arrhythmia, which is an abnormal heart rhythm. In VF, the ventricles, which are the lower chambers of the heart, beat in a rapid and unorganized manner. This results in the heart being unable to pump blood effectively to the rest of the body, leading to immediate circulatory collapse and cardiac arrest if not treated promptly. It is often caused by underlying heart conditions such as coronary artery disease, structural heart problems, or electrolyte imbalances. VF is a medical emergency that requires immediate defibrillation to restore a normal heart rhythm.

The pulmonary artery is a large blood vessel that carries deoxygenated blood from the right ventricle of the heart to the lungs for oxygenation. It divides into two main branches, the right and left pulmonary arteries, which further divide into smaller vessels called arterioles, and then into a vast network of capillaries in the lungs where gas exchange occurs. The thin walls of these capillaries allow oxygen to diffuse into the blood and carbon dioxide to diffuse out, making the blood oxygen-rich before it is pumped back to the left side of the heart through the pulmonary veins. This process is crucial for maintaining proper oxygenation of the body's tissues and organs.

Plethysmography is a non-invasive medical technique used to measure changes in volume or blood flow within an organ or body part, typically in the lungs or extremities. There are several types of plethysmography, including:

1. **Whole Body Plethysmography (WBP):** This type of plethysmography is used to assess lung function and volumes by measuring changes in pressure within a sealed chamber that contains the patient's entire body except for their head. The patient breathes normally while wearing a nose clip, allowing technicians to analyze respiratory patterns, airflow, and lung volume changes.
2. **Segmental or Local Plethysmography:** This technique measures volume or blood flow changes in specific body parts, such as the limbs or digits. It can help diagnose and monitor conditions affecting peripheral circulation, like deep vein thrombosis, arterial occlusive disease, or Raynaud's phenomenon.
3. **Impedance Plethysmography (IPG):** This non-invasive method uses electrical impedance to estimate changes in blood volume within an organ or body part. By applying a small electrical current and measuring the opposition to flow (impedance), technicians can determine variations in blood volume, which can help diagnose conditions like deep vein thrombosis or heart failure.
4. **Optical Plethysmography:** This technique uses light to measure changes in blood volume, typically in the skin or mucous membranes. By shining a light on the area and analyzing the reflected or transmitted light, technicians can detect variations in blood volume related to cardiac output, respiration, or other physiological factors.

Overall, plethysmography is an essential tool for diagnosing and monitoring various medical conditions affecting circulation, respiratory function, and organ volumes.

Western blotting is a laboratory technique used in molecular biology to detect and quantify specific proteins in a mixture of many different proteins. This technique is commonly used to confirm the expression of a protein of interest, determine its size, and investigate its post-translational modifications. The name "Western" blotting distinguishes this technique from Southern blotting (for DNA) and Northern blotting (for RNA).

The Western blotting procedure involves several steps:

1. Protein extraction: The sample containing the proteins of interest is first extracted, often by breaking open cells or tissues and using a buffer to extract the proteins.
2. Separation of proteins by electrophoresis: The extracted proteins are then separated based on their size by loading them onto a polyacrylamide gel and running an electric current through the gel (a process called sodium dodecyl sulfate-polyacrylamide gel electrophoresis or SDS-PAGE). This separates the proteins according to their molecular weight, with smaller proteins migrating faster than larger ones.
3. Transfer of proteins to a membrane: After separation, the proteins are transferred from the gel onto a nitrocellulose or polyvinylidene fluoride (PVDF) membrane using an electric current in a process called blotting. This creates a replica of the protein pattern on the gel but now immobilized on the membrane for further analysis.
4. Blocking: The membrane is then blocked with a blocking agent, such as non-fat dry milk or bovine serum albumin (BSA), to prevent non-specific binding of antibodies in subsequent steps.
5. Primary antibody incubation: A primary antibody that specifically recognizes the protein of interest is added and allowed to bind to its target protein on the membrane. This step may be performed at room temperature or 4°C overnight, depending on the antibody's properties.
6. Washing: The membrane is washed with a buffer to remove unbound primary antibodies.
7. Secondary antibody incubation: A secondary antibody that recognizes the primary antibody (often coupled to an enzyme or fluorophore) is added and allowed to bind to the primary antibody. This step may involve using a horseradish peroxidase (HRP)-conjugated or alkaline phosphatase (AP)-conjugated secondary antibody, depending on the detection method used later.
8. Washing: The membrane is washed again to remove unbound secondary antibodies.
9. Detection: A detection reagent is added to visualize the protein of interest by detecting the signal generated from the enzyme-conjugated or fluorophore-conjugated secondary antibody. This can be done using chemiluminescent, colorimetric, or fluorescent methods.
10. Analysis: The resulting image is analyzed to determine the presence and quantity of the protein of interest in the sample.

Western blotting is a powerful technique for identifying and quantifying specific proteins within complex mixtures. It can be used to study protein expression, post-translational modifications, protein-protein interactions, and more. However, it requires careful optimization and validation to ensure accurate and reproducible results.

A heart septal defect is a type of congenital heart defect, which means it is present at birth. It involves an abnormal opening in the septum, the wall that separates the two sides of the heart. This opening allows oxygen-rich blood to leak into the oxygen-poor blood chambers in the heart.

There are several types of heart septal defects, including:

1. Atrial Septal Defect (ASD): A hole in the atrial septum, the wall between the two upper chambers of the heart (the right and left atria).
2. Ventricular Septal Defect (VSD): A hole in the ventricular septum, the wall between the two lower chambers of the heart (the right and left ventricles).
3. Atrioventricular Septal Defect (AVSD): A combination of an ASD and a VSD, often accompanied by malformation of the mitral and/or tricuspid valves.

The severity of a heart septal defect depends on the size of the opening and its location in the septum. Small defects may cause no symptoms and may close on their own over time. Larger defects can lead to complications, such as heart failure, pulmonary hypertension, or infective endocarditis, and may require medical or surgical intervention.

Cardiac myosins are a type of myosin protein that are specifically expressed in the cardiac muscle cells (or cardiomyocytes) of the heart. These proteins play a crucial role in the contraction and relaxation of heart muscles, which is essential for proper heart function and blood circulation.

Myosins are molecular motors that use chemical energy from ATP to generate force and movement. In the context of cardiac muscle cells, cardiac myosins interact with another protein called actin to form sarcomeres, which are the basic contractile units of muscle fibers. During contraction, the heads of cardiac myosin molecules bind to actin filaments and pull them together, causing the muscle fiber to shorten and generate force.

There are different isoforms of cardiac myosins that can vary in their structure and function. Mutations in the genes encoding these proteins have been linked to various forms of cardiomyopathy, which are diseases of the heart muscle that can lead to heart failure and other complications. Therefore, understanding the structure and function of cardiac myosins is an important area of research for developing therapies and treatments for heart disease.

Echocardiography, Doppler, color is a type of ultrasound test that uses sound waves to create detailed moving images of the heart and its blood vessels. In this technique, color Doppler is used to visualize the direction and speed of blood flow through the heart and great vessels. The movement of the red blood cells causes a change in frequency of the reflected sound waves (Doppler shift), which can be used to calculate the velocity and direction of the blood flow. By adding color to the Doppler image, it becomes easier for the interpreting physician to understand the complex three-dimensional motion of blood through the heart. This test is often used to diagnose and monitor various heart conditions, including valve disorders, congenital heart defects, and cardiac muscle diseases.

Renal dialysis is a medical procedure that is used to artificially remove waste products, toxins, and excess fluids from the blood when the kidneys are no longer able to perform these functions effectively. This process is also known as hemodialysis.

During renal dialysis, the patient's blood is circulated through a special machine called a dialyzer or an artificial kidney, which contains a semi-permeable membrane that filters out waste products and excess fluids from the blood. The cleaned blood is then returned to the patient's body.

Renal dialysis is typically recommended for patients with advanced kidney disease or kidney failure, such as those with end-stage renal disease (ESRD). It is a life-sustaining treatment that helps to maintain the balance of fluids and electrolytes in the body, prevent the buildup of waste products and toxins, and control blood pressure.

There are two main types of renal dialysis: hemodialysis and peritoneal dialysis. Hemodialysis is the most common type and involves using a dialyzer to filter the blood outside the body. Peritoneal dialysis, on the other hand, involves placing a catheter in the abdomen and using the lining of the abdomen (peritoneum) as a natural filter to remove waste products and excess fluids from the body.

Overall, renal dialysis is an essential treatment option for patients with kidney failure, helping them to maintain their quality of life and prolong their survival.

Vasodilation is the widening or increase in diameter of blood vessels, particularly the involuntary relaxation of the smooth muscle in the tunica media (middle layer) of the arteriole walls. This results in an increase in blood flow and a decrease in vascular resistance. Vasodilation can occur due to various physiological and pathophysiological stimuli, such as local metabolic demands, neural signals, or pharmacological agents. It plays a crucial role in regulating blood pressure, tissue perfusion, and thermoregulation.

Sulfones are a group of medications that contain a sulfur atom bonded to two oxygen atoms and one other group, typically a hydrogen or carbon atom. They have various medical uses, including as antibacterial, antifungal, and anti-inflammatory agents. One example of a sulfone is dapsone, which is used to treat bacterial infections such as leprosy and Pneumocystis jirovecii pneumonia (PJP), as well as some inflammatory skin conditions. It's important to note that sulfones can have significant side effects and should only be used under the supervision of a healthcare professional.

The Angiotensin II Receptor Type 1 (AT1 receptor) is a type of G protein-coupled receptor that binds and responds to the hormone angiotensin II, which plays a crucial role in the renin-angiotensin-aldosterone system (RAAS). The RAAS is a vital physiological mechanism that regulates blood pressure, fluid, and electrolyte balance.

The AT1 receptor is found in various tissues throughout the body, including the vascular smooth muscle cells, cardiac myocytes, adrenal glands, kidneys, and brain. When angiotensin II binds to the AT1 receptor, it activates a series of intracellular signaling pathways that lead to vasoconstriction, increased sodium and water reabsorption in the kidneys, and stimulation of aldosterone release from the adrenal glands. These effects ultimately result in an increase in blood pressure and fluid volume.

AT1 receptor antagonists, also known as angiotensin II receptor blockers (ARBs), are a class of drugs used to treat hypertension, heart failure, and other cardiovascular conditions. By blocking the AT1 receptor, these medications prevent angiotensin II from exerting its effects on the cardiovascular system, leading to vasodilation, decreased sodium and water reabsorption in the kidneys, and reduced aldosterone release. These actions ultimately result in a decrease in blood pressure and fluid volume.

Peptidyl-dipeptidase A is more commonly known as angiotensin-converting enzyme (ACE). It is a key enzyme in the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure and fluid balance.

ACE is a membrane-bound enzyme found primarily in the lungs, but also in other tissues such as the heart, kidneys, and blood vessels. It plays a crucial role in converting the inactive decapeptide angiotensin I into the potent vasoconstrictor octapeptide angiotensin II, which constricts blood vessels and increases blood pressure.

ACE also degrades the peptide bradykinin, which is involved in the regulation of blood flow and vascular permeability. By breaking down bradykinin, ACE helps to counteract its vasodilatory effects, thereby maintaining blood pressure homeostasis.

Inhibitors of ACE are widely used as medications for the treatment of hypertension, heart failure, and diabetic kidney disease, among other conditions. These drugs work by blocking the action of ACE, leading to decreased levels of angiotensin II and increased levels of bradykinin, which results in vasodilation, reduced blood pressure, and improved cardiovascular function.

'Gene expression regulation' refers to the processes that control whether, when, and where a particular gene is expressed, meaning the production of a specific protein or functional RNA encoded by that gene. This complex mechanism can be influenced by various factors such as transcription factors, chromatin remodeling, DNA methylation, non-coding RNAs, and post-transcriptional modifications, among others. Proper regulation of gene expression is crucial for normal cellular function, development, and maintaining homeostasis in living organisms. Dysregulation of gene expression can lead to various diseases, including cancer and genetic disorders.

The odds ratio (OR) is a statistical measure used in epidemiology and research to estimate the association between an exposure and an outcome. It represents the odds that an event will occur in one group versus the odds that it will occur in another group, assuming that all other factors are held constant.

In medical research, the odds ratio is often used to quantify the strength of the relationship between a risk factor (exposure) and a disease outcome. An OR of 1 indicates no association between the exposure and the outcome, while an OR greater than 1 suggests that there is a positive association between the two. Conversely, an OR less than 1 implies a negative association.

It's important to note that the odds ratio is not the same as the relative risk (RR), which compares the incidence rates of an outcome in two groups. While the OR can approximate the RR when the outcome is rare, they are not interchangeable and can lead to different conclusions about the association between an exposure and an outcome.

Calcium-transporting ATPases, also known as calcium pumps, are a type of enzyme that use the energy from ATP (adenosine triphosphate) hydrolysis to transport calcium ions across membranes against their concentration gradient. This process helps maintain low intracellular calcium concentrations and is essential for various cellular functions, including muscle contraction, neurotransmitter release, and gene expression.

There are two main types of calcium-transporting ATPases: the sarcoplasmic/endoplasmic reticulum Ca^2+^-ATPase (SERCA) and the plasma membrane Ca^2+^-ATPase (PMCA). SERCA is found in the sarcoplasmic reticulum of muscle cells and endoplasmic reticulum of other cell types, where it pumps calcium ions into these organelles to initiate muscle relaxation or signal transduction. PMCA, on the other hand, is located in the plasma membrane and extrudes calcium ions from the cell to maintain low cytosolic calcium concentrations.

Calcium-transporting ATPases play a crucial role in maintaining calcium homeostasis in cells and are important targets for drug development in various diseases, including heart failure, hypertension, and neurological disorders.

Left atrial function refers to the role and performance of the left atrium in the heart. The left atrium is the upper chamber on the left side of the heart that receives oxygenated blood from the lungs via the pulmonary veins and then contracts to help pump it into the left ventricle, which is the lower chamber that pumps blood out to the rest of the body.

The main functions of the left atrium include:

1. Receiving oxygen-rich blood from the lungs: The left atrium receives oxygenated blood from the pulmonary veins and acts as a reservoir for this blood before it is pumped into the left ventricle.
2. Contracting to help pump blood into the left ventricle: During atrial contraction, also known as atrial kick, the left atrium contracts and helps push blood into the left ventricle, increasing the amount of blood that can be ejected with each heartbeat.
3. Relaxing to receive more blood: Between heartbeats, the left atrium relaxes and fills up with more oxygenated blood from the lungs.
4. Contributing to heart rate regulation: The left atrium contains specialized cells called pacemaker cells that can help regulate the heart rate by initiating electrical impulses that trigger heart contractions.

Left atrial function is crucial for maintaining efficient cardiac output and overall cardiovascular health. Various conditions, such as heart failure, atrial fibrillation, and hypertension, can negatively impact left atrial function and contribute to the development of complications like stroke and reduced exercise tolerance.

Sudden death is a term used to describe a situation where a person dies abruptly and unexpectedly, often within minutes to hours of the onset of symptoms. It is typically caused by cardiac or respiratory arrest, which can be brought on by various medical conditions such as heart disease, stroke, severe infections, drug overdose, or trauma. In some cases, the exact cause of sudden death may remain unknown even after a thorough post-mortem examination.

It is important to note that sudden death should not be confused with "sudden cardiac death," which specifically refers to deaths caused by the abrupt loss of heart function (cardiac arrest). Sudden cardiac death is often related to underlying heart conditions such as coronary artery disease, cardiomyopathy, or electrical abnormalities in the heart.

Ventricular function, in the context of cardiac medicine, refers to the ability of the heart's ventricles (the lower chambers) to fill with blood during the diastole phase and eject blood during the systole phase. The ventricles are primarily responsible for pumping oxygenated blood out to the body (left ventricle) and deoxygenated blood to the lungs (right ventricle).

There are several ways to assess ventricular function, including:

1. Ejection Fraction (EF): This is the most commonly used measure of ventricular function. It represents the percentage of blood that is ejected from the ventricle during each heartbeat. A normal left ventricular ejection fraction is typically between 55% and 70%.
2. Fractional Shortening (FS): This is another measure of ventricular function, which calculates the change in size of the ventricle during contraction as a percentage of the original size. A normal FS for the left ventricle is typically between 25% and 45%.
3. Stroke Volume (SV): This refers to the amount of blood that is pumped out of the ventricle with each heartbeat. SV is calculated by multiplying the ejection fraction by the end-diastolic volume (the amount of blood in the ventricle at the end of diastole).
4. Cardiac Output (CO): This is the total amount of blood that the heart pumps in one minute. It is calculated by multiplying the stroke volume by the heart rate.

Impaired ventricular function can lead to various cardiovascular conditions, such as heart failure, cardiomyopathy, and valvular heart disease. Assessing ventricular function is crucial for diagnosing these conditions, monitoring treatment response, and guiding clinical decision-making.

Patient selection, in the context of medical treatment or clinical research, refers to the process of identifying and choosing appropriate individuals who are most likely to benefit from a particular medical intervention or who meet specific criteria to participate in a study. This decision is based on various factors such as the patient's diagnosis, stage of disease, overall health status, potential risks, and expected benefits. The goal of patient selection is to ensure that the selected individuals will receive the most effective and safe care possible while also contributing to meaningful research outcomes.

The Parasympathetic Nervous System (PNS) is the part of the autonomic nervous system that primarily controls vegetative functions during rest, relaxation, and digestion. It is responsible for the body's "rest and digest" activities including decreasing heart rate, lowering blood pressure, increasing digestive activity, and stimulating sexual arousal. The PNS utilizes acetylcholine as its primary neurotransmitter and acts in opposition to the Sympathetic Nervous System (SNS), which is responsible for the "fight or flight" response.

Pulmonary heart disease, also known as cor pulmonale, is a type of heart disease that occurs as a complication of chronic lung diseases or hypoxia (low oxygen levels in the body). The condition is characterized by enlargement and thickening of the right ventricle of the heart, which results from increased pressure in the pulmonary artery due to damaged or narrowed blood vessels in the lungs. This can lead to symptoms such as shortness of breath, fatigue, swelling in the legs and abdomen, and irregular heart rhythms. The condition can be managed with medications, oxygen therapy, and lifestyle changes, but if left untreated, it can lead to serious complications such as heart failure.

Physiological monitoring is the continuous or intermittent observation and measurement of various body functions or parameters in a patient, with the aim of evaluating their health status, identifying any abnormalities or changes, and guiding clinical decision-making and treatment. This may involve the use of specialized medical equipment, such as cardiac monitors, pulse oximeters, blood pressure monitors, and capnographs, among others. The data collected through physiological monitoring can help healthcare professionals assess the effectiveness of treatments, detect complications early, and make timely adjustments to patient care plans.

Cardiogenic shock is a serious condition characterized by the inability of the heart to pump enough blood to meet the body's needs. It is a type of shock that originates from a primary cardiac dysfunction, such as severe heart muscle damage (myocardial infarction or heart attack), abnormal heart rhythms (arrhythmias), or acute valvular insufficiency.

In cardiogenic shock, the low cardiac output leads to inadequate tissue perfusion and oxygenation, resulting in multiple organ dysfunction and failure. Symptoms of cardiogenic shock include severe hypotension (low blood pressure), cool extremities, decreased urine output, altered mental status, and signs of congestive heart failure such as shortness of breath, cough, and peripheral edema.

Cardiogenic shock is a medical emergency that requires prompt diagnosis and immediate treatment, which may include medications to support blood pressure and heart function, mechanical assist devices, or even emergency heart transplantation in some cases.

I'm sorry for any confusion, but "pilot projects" is not a medical term per se. Instead, it is a general term used in various fields, including healthcare and medicine, to describe a small-scale initiative that is implemented on a temporary basis to evaluate its feasibility, effectiveness, or impact before deciding whether to expand or continue it.

In the context of healthcare, pilot projects might involve testing new treatment protocols, implementing innovative care models, or introducing technology solutions in a limited setting to assess their potential benefits and drawbacks. The results of these projects can help inform decisions about broader implementation and provide valuable insights for improving the quality and efficiency of healthcare services.

A Cardiology Service in a hospital is a specialized department that provides medical care and treatment for patients with conditions related to the heart and cardiovascular system. The service is typically staffed by cardiologists, who are doctors with additional training and expertise in diagnosing and treating heart diseases. They work closely with other healthcare professionals such as nurses, technicians, and support staff to provide comprehensive care to patients with various heart conditions, including coronary artery disease, heart failure, arrhythmias, valvular heart disease, and genetic disorders that affect the heart.

The Cardiology Service may offer a range of diagnostic tests and procedures such as electrocardiograms (ECGs), stress testing, echocardiography, cardiac catheterization, and coronary angioplasty. They may also provide interventional procedures such as implantation of pacemakers or defibrillators, as well as more invasive surgeries like coronary artery bypass grafting (CABG) or valve replacement surgery.

In addition to providing clinical care, Cardiology Services may also be involved in research and education, conducting studies to advance the understanding of heart disease and training medical students, residents, and fellows in the latest diagnostic and treatment techniques.

Catecholamines are a group of hormones and neurotransmitters that are derived from the amino acid tyrosine. The most well-known catecholamines are dopamine, norepinephrine (also known as noradrenaline), and epinephrine (also known as adrenaline). These hormones are produced by the adrenal glands and are released into the bloodstream in response to stress. They play important roles in the "fight or flight" response, increasing heart rate, blood pressure, and alertness. In addition to their role as hormones, catecholamines also function as neurotransmitters, transmitting signals in the nervous system. Disorders of catecholamine regulation can lead to a variety of medical conditions, including hypertension, mood disorders, and neurological disorders.

Sodium is an essential mineral and electrolyte that is necessary for human health. In a medical context, sodium is often discussed in terms of its concentration in the blood, as measured by serum sodium levels. The normal range for serum sodium is typically between 135 and 145 milliequivalents per liter (mEq/L).

Sodium plays a number of important roles in the body, including:

* Regulating fluid balance: Sodium helps to regulate the amount of water in and around your cells, which is important for maintaining normal blood pressure and preventing dehydration.
* Facilitating nerve impulse transmission: Sodium is involved in the generation and transmission of electrical signals in the nervous system, which is necessary for proper muscle function and coordination.
* Assisting with muscle contraction: Sodium helps to regulate muscle contractions by interacting with other minerals such as calcium and potassium.

Low sodium levels (hyponatremia) can cause symptoms such as confusion, seizures, and coma, while high sodium levels (hypernatremia) can lead to symptoms such as weakness, muscle cramps, and seizures. Both conditions require medical treatment to correct.

Bundle-branch block (BBB) is a type of conduction delay or block in the heart's electrical system that affects the way electrical impulses travel through the ventricles (the lower chambers of the heart). In BBB, one of the two main bundle branches that conduct electrical impulses to the ventricles is partially or completely blocked, causing a delay in the contraction of one of the ventricles.

There are two types of bundle-branch block: right bundle-branch block (RBBB) and left bundle-branch block (LBBB). In RBBB, the right bundle branch is affected, while in LBBB, the left bundle branch is affected. The symptoms and severity of BBB can vary depending on the underlying cause and the presence of other heart conditions.

In some cases, BBB may not cause any noticeable symptoms and may only be detected during a routine electrocardiogram (ECG). However, if BBB occurs along with other heart conditions such as coronary artery disease, heart failure, or cardiomyopathy, it can increase the risk of serious complications such as arrhythmias, syncope, and even sudden cardiac death.

Treatment for bundle-branch block depends on the underlying cause and the severity of the condition. In some cases, no treatment may be necessary, while in others, medications, pacemakers, or other treatments may be recommended to manage symptoms and prevent complications.

"Random allocation," also known as "random assignment" or "randomization," is a process used in clinical trials and other research studies to distribute participants into different intervention groups (such as experimental group vs. control group) in a way that minimizes selection bias and ensures the groups are comparable at the start of the study.

In random allocation, each participant has an equal chance of being assigned to any group, and the assignment is typically made using a computer-generated randomization schedule or other objective methods. This process helps to ensure that any differences between the groups are due to the intervention being tested rather than pre-existing differences in the participants' characteristics.

A confidence interval (CI) is a range of values that is likely to contain the true value of a population parameter with a certain level of confidence. It is commonly used in statistical analysis to express the uncertainty associated with estimates derived from sample data.

For example, if we calculate a 95% confidence interval for the mean height of a population based on a sample of individuals, we can say that we are 95% confident that the true population mean height falls within the calculated range. The width of the confidence interval gives us an idea of how precise our estimate is - narrower intervals indicate more precise estimates, while wider intervals suggest greater uncertainty.

Confidence intervals are typically calculated using statistical formulas that take into account the sample size, standard deviation, and level of confidence desired. They can be used to compare different groups or to evaluate the effectiveness of interventions in medical research.

Disease management is a proactive, planned approach to identify and manage patients with chronic medical conditions. It involves a systematic and coordinated method of delivering care to patients with the goal of improving clinical outcomes, enhancing quality of life, and reducing healthcare costs. This approach typically includes elements such as evidence-based care guidelines, patient education, self-management support, regular monitoring and follow-up, and collaboration between healthcare providers and specialists.

The objective of disease management is to improve the overall health and well-being of patients with chronic conditions by providing them with the necessary tools, resources, and support to effectively manage their condition and prevent complications. By implementing a comprehensive and coordinated approach to care, disease management can help reduce hospitalizations, emergency department visits, and other costly healthcare services while improving patient satisfaction and overall health outcomes.

An action potential is a brief electrical signal that travels along the membrane of a nerve cell (neuron) or muscle cell. It is initiated by a rapid, localized change in the permeability of the cell membrane to specific ions, such as sodium and potassium, resulting in a rapid influx of sodium ions and a subsequent efflux of potassium ions. This ion movement causes a brief reversal of the electrical potential across the membrane, which is known as depolarization. The action potential then propagates along the cell membrane as a wave, allowing the electrical signal to be transmitted over long distances within the body. Action potentials play a crucial role in the communication and functioning of the nervous system and muscle tissue.

Patient discharge is a medical term that refers to the point in time when a patient is released from a hospital or other healthcare facility after receiving treatment. This process typically involves the physician or healthcare provider determining that the patient's condition has improved enough to allow them to continue their recovery at home or in another appropriate setting.

The discharge process may include providing the patient with instructions for ongoing care, such as medication regimens, follow-up appointments, and activity restrictions. The healthcare team may also provide educational materials and resources to help patients and their families manage their health conditions and prevent complications.

It is important for patients and their families to understand and follow the discharge instructions carefully to ensure a smooth transition back to home or another care setting and to promote continued recovery and good health.

A newborn infant is a baby who is within the first 28 days of life. This period is also referred to as the neonatal period. Newborns require specialized care and attention due to their immature bodily systems and increased vulnerability to various health issues. They are closely monitored for signs of well-being, growth, and development during this critical time.

Hyperkalemia is a medical condition characterized by an elevated level of potassium (K+) in the blood serum, specifically when the concentration exceeds 5.0-5.5 mEq/L (milliequivalents per liter). Potassium is a crucial intracellular ion that plays a significant role in various physiological processes, including nerve impulse transmission, muscle contraction, and heart rhythm regulation.

Mild to moderate hyperkalemia might not cause noticeable symptoms but can still have harmful effects on the body, particularly on the cardiovascular system. Severe cases of hyperkalemia (potassium levels > 6.5 mEq/L) can lead to potentially life-threatening arrhythmias and heart failure.

Hyperkalemia may result from various factors, such as kidney dysfunction, hormonal imbalances, medication side effects, trauma, or excessive potassium intake. Prompt identification and management of hyperkalemia are essential to prevent severe complications and ensure proper treatment.

Creatine kinase (CK) is a muscle enzyme that is normally present in small amounts in the blood. It is primarily found in tissues that require a lot of energy, such as the heart, brain, and skeletal muscles. When these tissues are damaged or injured, CK is released into the bloodstream, causing the levels to rise.

Creatine kinase exists in several forms, known as isoenzymes, which can be measured in the blood to help identify the location of tissue damage. The three main isoenzymes are:

1. CK-MM: Found primarily in skeletal muscle
2. CK-MB: Found primarily in heart muscle
3. CK-BB: Found primarily in the brain

Elevated levels of creatine kinase, particularly CK-MB, can indicate damage to the heart muscle, such as occurs with a heart attack. Similarly, elevated levels of CK-BB may suggest brain injury or disease. Overall, measuring creatine kinase levels is a useful diagnostic tool for assessing tissue damage and determining the severity of injuries or illnesses.

The Ryanodine Receptor (RyR) is a calcium release channel located on the sarcoplasmic reticulum (SR), a type of endoplasmic reticulum found in muscle cells. It plays a crucial role in excitation-contraction coupling, which is the process by which electrical signals are converted into mechanical responses in muscle fibers.

In more detail, when an action potential reaches the muscle fiber's surface membrane, it triggers the opening of voltage-gated L-type calcium channels (Dihydropyridine Receptors or DHPRs) in the sarcolemma (the cell membrane of muscle fibers). This influx of calcium ions into the cytoplasm causes a conformational change in the RyR, leading to its own opening and the release of stored calcium from the SR into the cytoplasm. The increased cytoplasmic calcium concentration then initiates muscle contraction through interaction with contractile proteins like actin and myosin.

There are three isoforms of RyR: RyR1, RyR2, and RyR3. RyR1 is primarily found in skeletal muscle, while RyR2 is predominantly expressed in cardiac muscle. Both RyR1 and RyR2 are large homotetrameric proteins with a molecular weight of approximately 2.2 million Daltons. They contain multiple domains including an ion channel pore, regulatory domains, and a foot structure that interacts with DHPRs. RyR3 is more widely distributed, being found in various tissues such as the brain, smooth muscle, and some types of neurons.

Dysfunction of these channels has been implicated in several diseases including malignant hyperthermia, central core disease, catecholaminergic polymorphic ventricular tachycardia (CPVT), and certain forms of heart failure.

Telemetry is the automated measurement and wireless transmission of data from remote or inaccessible sources to receiving stations for monitoring and analysis. In a medical context, telemetry is often used to monitor patients' vital signs such as heart rate, blood pressure, oxygen levels, and other important physiological parameters continuously and remotely. This technology allows healthcare providers to track patients' conditions over time, detect any abnormalities or trends, and make informed decisions about their care, even when they are not physically present with the patient. Telemetry is commonly used in hospitals, clinics, and research settings to monitor patients during procedures, after surgery, or during extended stays in intensive care units.

A ventricular septal defect (VSD) is a type of congenital heart defect that involves a hole in the wall separating the two lower chambers of the heart, the ventricles. This defect allows oxygenated blood from the left ventricle to mix with deoxygenated blood in the right ventricle, leading to inefficient oxygenation of the body's tissues. The size and location of the hole can vary, and symptoms may range from none to severe, depending on the size of the defect and the amount of blood that is able to shunt between the ventricles. Small VSDs may close on their own over time, while larger defects usually require medical intervention, such as medication or surgery, to prevent complications like pulmonary hypertension and heart failure.

Death is the cessation of all biological functions that sustain a living organism. It is characterized by the loss of brainstem reflexes, unresponsiveness, and apnea (no breathing). In medical terms, death can be defined as:

1. Cardiopulmonary Death: The irreversible cessation of circulatory and respiratory functions.
2. Brain Death: The irreversible loss of all brain function, including the brainstem. This is often used as a definition of death when performing organ donation.

It's important to note that the exact definition of death can vary somewhat based on cultural, religious, and legal perspectives.

I'm happy to help! However, it seems like there are two terms combined into one request: "Mitochondria" and "Heart." I will provide separate definitions for each.

Mitochondrion (singular) or Mitochondria (plural): These are specialized structures found in the cytoplasm of most eukaryotic cells (cells with a true nucleus), including human cells. They are often referred to as the "powerhouse" of the cell because they generate energy in the form of ATP (adenosine triphosphate) through a process called oxidative phosphorylation. Mitochondria contain their own DNA, which is distinct from the nuclear DNA, and are believed to have originated from ancient bacteria that established a symbiotic relationship with primitive eukaryotic cells.

Heart: In human anatomy, the heart is a muscular organ responsible for pumping blood throughout the body. It is located in the thoracic cavity, slightly left of the center, and is enclosed by the pericardium, a double-walled sac that provides protection and lubrication for the heart's movement. The human heart is divided into four chambers: two atria on the top and two ventricles on the bottom. The right side of the heart receives deoxygenated blood from the body and pumps it to the lungs, while the left side receives oxygenated blood from the lungs and pumps it to the rest of the body. The heart's pumping action is regulated by electrical signals that originate in a group of specialized cardiac muscle cells called the sinoatrial node (SA node).

Restrictive cardiomyopathy (RCM) is a type of heart muscle disorder characterized by impaired relaxation and filling of the lower chambers of the heart (the ventricles), leading to reduced pump function. This is caused by stiffening or rigidity of the heart muscle, often due to fibrosis or scarring. The stiffness prevents the ventricles from filling properly with blood during the diastolic phase, which can result in symptoms such as shortness of breath, fatigue, and fluid retention.

RCM is a less common form of cardiomyopathy compared to dilated or hypertrophic cardiomyopathies. It can be idiopathic (no known cause) or secondary to other conditions like amyloidosis, sarcoidosis, or storage diseases. Diagnosis typically involves a combination of medical history, physical examination, echocardiography, and sometimes cardiac MRI or biopsy. Treatment is focused on managing symptoms and addressing underlying causes when possible.

A phenotype is the physical or biochemical expression of an organism's genes, or the observable traits and characteristics resulting from the interaction of its genetic constitution (genotype) with environmental factors. These characteristics can include appearance, development, behavior, and resistance to disease, among others. Phenotypes can vary widely, even among individuals with identical genotypes, due to differences in environmental influences, gene expression, and genetic interactions.

Hypotension is a medical term that refers to abnormally low blood pressure, usually defined as a systolic blood pressure less than 90 millimeters of mercury (mm Hg) or a diastolic blood pressure less than 60 mm Hg. Blood pressure is the force exerted by the blood against the walls of the blood vessels as the heart pumps blood.

Hypotension can cause symptoms such as dizziness, lightheadedness, weakness, and fainting, especially when standing up suddenly. In severe cases, hypotension can lead to shock, which is a life-threatening condition characterized by multiple organ failure due to inadequate blood flow.

Hypotension can be caused by various factors, including certain medications, medical conditions such as heart disease, endocrine disorders, and dehydration. It is important to seek medical attention if you experience symptoms of hypotension, as it can indicate an underlying health issue that requires treatment.

Recurrence, in a medical context, refers to the return of symptoms or signs of a disease after a period of improvement or remission. It indicates that the condition has not been fully eradicated and may require further treatment. Recurrence is often used to describe situations where a disease such as cancer comes back after initial treatment, but it can also apply to other medical conditions. The likelihood of recurrence varies depending on the type of disease and individual patient factors.

Nitroglycerin, also known as glyceryl trinitrate, is a medication used primarily for the treatment of angina pectoris (chest pain due to coronary artery disease) and hypertensive emergencies (severe high blood pressure). It belongs to a class of drugs called nitrates or organic nitrites.

Nitroglycerin works by relaxing and dilating the smooth muscle in blood vessels, which leads to decreased workload on the heart and increased oxygen delivery to the myocardium (heart muscle). This results in reduced symptoms of angina and improved cardiac function during hypertensive emergencies.

The drug is available in various forms, including sublingual tablets, sprays, transdermal patches, ointments, and intravenous solutions. The choice of formulation depends on the specific clinical situation and patient needs. Common side effects of nitroglycerin include headache, dizziness, and hypotension (low blood pressure).

nitroprusside (ni-troe-rus-ide)

A rapid-acting vasodilator used in the management of severe hypertension, acute heart failure, and to reduce afterload in patients undergoing cardiac surgery. It is a potent arterial and venous dilator that decreases preload and afterload, thereby reducing myocardial oxygen demand. Nitroprusside is metabolized to cyanide, which must be monitored closely during therapy to prevent toxicity.

Pharmacologic class: Peripheral vasodilators

Therapeutic class: Antihypertensives, Vasodilators

Medical Categories: Cardiovascular Drugs, Hypertension Agents

The endothelium is a thin layer of simple squamous epithelial cells that lines the interior surface of blood vessels, lymphatic vessels, and heart chambers. The vascular endothelium, specifically, refers to the endothelial cells that line the blood vessels. These cells play a crucial role in maintaining vascular homeostasis by regulating vasomotor tone, coagulation, platelet activation, inflammation, and permeability of the vessel wall. They also contribute to the growth and repair of the vascular system and are involved in various pathological processes such as atherosclerosis, hypertension, and diabetes.

The sinoatrial (SA) node, also known as the sinus node, is the primary pacemaker of the heart. It is a small bundle of specialized cardiac conduction tissue located in the upper part of the right atrium, near the entrance of the superior vena cava. The SA node generates electrical impulses that initiate each heartbeat, causing the atria to contract and pump blood into the ventricles. This process is called sinus rhythm.

The SA node's electrical activity is regulated by the autonomic nervous system, which can adjust the heart rate in response to changes in the body's needs, such as during exercise or rest. The SA node's rate of firing determines the heart rate, with a normal resting heart rate ranging from 60 to 100 beats per minute.

If the SA node fails to function properly or its electrical impulses are blocked, other secondary pacemakers in the heart may take over, resulting in abnormal heart rhythms called arrhythmias.

I apologize for the confusion, but "physical conditioning" is not a term that is typically used in the context of animals in veterinary medicine or animal sciences. The term "physical conditioning" is more commonly used to describe the process of improving an individual's physical fitness through exercise and training.

However, in animal science, the concept of "training" or "exercising" animals may refer to the process of teaching them specific behaviors or skills, improving their physical abilities, or promoting their overall health and well-being. This might involve activities such as providing opportunities for regular exercise, engaging in play, or using positive reinforcement techniques to teach animals new skills or modify their behavior.

If you have any further questions about animal care or training, I would be happy to try to help!

A reflex is an automatic, involuntary and rapid response to a stimulus that occurs without conscious intention. In the context of physiology and neurology, it's a basic mechanism that involves the transmission of nerve impulses between neurons, resulting in a muscle contraction or glandular secretion.

Reflexes are important for maintaining homeostasis, protecting the body from harm, and coordinating movements. They can be tested clinically to assess the integrity of the nervous system, such as the knee-j jerk reflex, which tests the function of the L3-L4 spinal nerve roots and the sensitivity of the stretch reflex arc.

The Autonomic Nervous System (ANS) is a part of the nervous system that controls involuntary actions, such as heart rate, digestion, respiratory rate, pupillary response, urination, and sexual arousal. It consists of two subdivisions: the sympathetic and parasympathetic nervous systems, which generally have opposing effects and maintain homeostasis in the body.

Autonomic Nervous System Diseases (also known as Autonomic Disorders or Autonomic Neuropathies) refer to a group of conditions that affect the functioning of the autonomic nervous system. These diseases can cause damage to the nerves that control automatic functions, leading to various symptoms and complications.

Autonomic Nervous System Diseases can be classified into two main categories:

1. Primary Autonomic Nervous System Disorders: These are conditions that primarily affect the autonomic nervous system without any underlying cause. Examples include:
* Pure Autonomic Failure (PAF): A rare disorder characterized by progressive loss of autonomic nerve function, leading to symptoms such as orthostatic hypotension, urinary retention, and constipation.
* Multiple System Atrophy (MSA): A degenerative neurological disorder that affects both the autonomic nervous system and movement coordination. Symptoms may include orthostatic hypotension, urinary incontinence, sexual dysfunction, and Parkinsonian features like stiffness and slowness of movements.
* Autonomic Neuropathy associated with Parkinson's Disease: Some individuals with Parkinson's disease develop autonomic symptoms such as orthostatic hypotension, constipation, and urinary dysfunction due to the degeneration of autonomic nerves.
2. Secondary Autonomic Nervous System Disorders: These are conditions that affect the autonomic nervous system as a result of an underlying cause or disease. Examples include:
* Diabetic Autonomic Neuropathy: A complication of diabetes mellitus that affects the autonomic nerves, leading to symptoms such as orthostatic hypotension, gastroparesis (delayed gastric emptying), and sexual dysfunction.
* Autoimmune-mediated Autonomic Neuropathies: Conditions like Guillain-Barré syndrome or autoimmune autonomic ganglionopathy can cause autonomic symptoms due to the immune system attacking the autonomic nerves.
* Infectious Autonomic Neuropathies: Certain infections, such as HIV or Lyme disease, can lead to autonomic dysfunction as a result of nerve damage.
* Toxin-induced Autonomic Neuropathy: Exposure to certain toxins, like heavy metals or organophosphate pesticides, can cause autonomic neuropathy.

Autonomic nervous system disorders can significantly impact a person's quality of life and daily functioning. Proper diagnosis and management are crucial for improving symptoms and preventing complications. Treatment options may include lifestyle modifications, medications, and in some cases, devices or surgical interventions.

Sympatholytics are a class of drugs that block the action of the sympathetic nervous system, which is the part of the autonomic nervous system responsible for preparing the body for the "fight or flight" response. Sympatholytics achieve this effect by binding to and blocking alpha-adrenergic receptors or beta-adrenergic receptors located in various organs throughout the body, including the heart, blood vessels, lungs, gastrointestinal tract, and urinary system.

Examples of sympatholytic drugs include:

* Alpha blockers (e.g., prazosin, doxazosin)
* Beta blockers (e.g., propranolol, metoprolol)
* Centrally acting sympatholytics (e.g., clonidine, methyldopa)

Sympatholytics are used to treat a variety of medical conditions, including hypertension, angina, heart failure, arrhythmias, and certain neurological disorders. They may also be used to manage symptoms associated with anxiety or withdrawal from alcohol or other substances.

Ambulatory care is a type of health care service in which patients are treated on an outpatient basis, meaning they do not stay overnight at the medical facility. This can include a wide range of services such as diagnosis, treatment, and follow-up care for various medical conditions. The goal of ambulatory care is to provide high-quality medical care that is convenient, accessible, and cost-effective for patients.

Examples of ambulatory care settings include physician offices, community health centers, urgent care centers, outpatient surgery centers, and diagnostic imaging facilities. Patients who receive ambulatory care may have a variety of medical needs, such as routine checkups, chronic disease management, minor procedures, or same-day surgeries.

Overall, ambulatory care is an essential component of modern healthcare systems, providing patients with timely and convenient access to medical services without the need for hospitalization.

The aorta is the largest artery in the human body, which originates from the left ventricle of the heart and carries oxygenated blood to the rest of the body. It can be divided into several parts, including the ascending aorta, aortic arch, and descending aorta. The ascending aorta gives rise to the coronary arteries that supply blood to the heart muscle. The aortic arch gives rise to the brachiocephalic, left common carotid, and left subclavian arteries, which supply blood to the head, neck, and upper extremities. The descending aorta travels through the thorax and abdomen, giving rise to various intercostal, visceral, and renal arteries that supply blood to the chest wall, organs, and kidneys.

Immunohistochemistry (IHC) is a technique used in pathology and laboratory medicine to identify specific proteins or antigens in tissue sections. It combines the principles of immunology and histology to detect the presence and location of these target molecules within cells and tissues. This technique utilizes antibodies that are specific to the protein or antigen of interest, which are then tagged with a detection system such as a chromogen or fluorophore. The stained tissue sections can be examined under a microscope, allowing for the visualization and analysis of the distribution and expression patterns of the target molecule in the context of the tissue architecture. Immunohistochemistry is widely used in diagnostic pathology to help identify various diseases, including cancer, infectious diseases, and immune-mediated disorders.

Thiazepines are not a recognized term in medical terminology or pharmacology. It appears that you may have misspelled "thiazepines," which also does not have a specific medical meaning. However, "thiazepine" is a chemical compound with a specific structure, and it is the core structure of some drugs such as thiazepine derivatives. These derivatives are often used for their sedative, hypnotic, anticonvulsant, and muscle relaxant properties.

If you meant to ask about "thiazide" or "thiazide diuretics," I would be happy to provide a definition:

Thiazides are a class of diuretic medications that act on the distal convoluted tubule in the kidney, promoting sodium and chloride excretion. This also leads to increased water excretion (diuresis) and decreased extracellular fluid volume. Thiazide diuretics are primarily used to treat hypertension and edema associated with heart failure or liver cirrhosis. Common thiazide diuretics include hydrochlorothiazide, chlorthalidone, and indapamide.

Nitric oxide (NO) is a molecule made up of one nitrogen atom and one oxygen atom. In the body, it is a crucial signaling molecule involved in various physiological processes such as vasodilation, immune response, neurotransmission, and inhibition of platelet aggregation. It is produced naturally by the enzyme nitric oxide synthase (NOS) from the amino acid L-arginine. Inhaled nitric oxide is used medically to treat pulmonary hypertension in newborns and adults, as it helps to relax and widen blood vessels, improving oxygenation and blood flow.

Pulmonary circulation refers to the process of blood flow through the lungs, where blood picks up oxygen and releases carbon dioxide. This is a vital part of the overall circulatory system, which delivers nutrients and oxygen to the body's cells while removing waste products like carbon dioxide.

In pulmonary circulation, deoxygenated blood from the systemic circulation returns to the right atrium of the heart via the superior and inferior vena cava. The blood then moves into the right ventricle through the tricuspid valve and gets pumped into the pulmonary artery when the right ventricle contracts.

The pulmonary artery divides into smaller vessels called arterioles, which further branch into a vast network of tiny capillaries in the lungs. Here, oxygen from the alveoli diffuses into the blood, binding to hemoglobin in red blood cells, while carbon dioxide leaves the blood and is exhaled through the nose or mouth.

The now oxygenated blood collects in venules, which merge to form pulmonary veins. These veins transport the oxygen-rich blood back to the left atrium of the heart, where it enters the systemic circulation once again. This continuous cycle enables the body's cells to receive the necessary oxygen and nutrients for proper functioning while disposing of waste products.

Self care is a health practice that involves individuals taking responsibility for their own health and well-being by actively seeking out and participating in activities and behaviors that promote healthy living, prevent illness and disease, and manage existing medical conditions. Self care includes a wide range of activities such as:

* Following a healthy diet and exercise routine
* Getting adequate sleep and rest
* Managing stress through relaxation techniques or mindfulness practices
* Practicing good hygiene and grooming habits
* Seeking preventive care through regular check-ups and screenings
* Taking prescribed medications as directed by a healthcare provider
* Monitoring symptoms and seeking medical attention when necessary

Self care is an important part of overall health and wellness, and can help individuals maintain their physical, emotional, and mental health. It is also an essential component of chronic disease management, helping people with ongoing medical conditions to manage their symptoms and improve their quality of life.

A multicenter study is a type of clinical research study that involves multiple centers or institutions. These studies are often conducted to increase the sample size and diversity of the study population, which can improve the generalizability of the study results. In a multicenter study, data is collected from participants at multiple sites and then analyzed together to identify patterns, trends, and relationships in the data. This type of study design can be particularly useful for researching rare diseases or conditions, or for testing new treatments or interventions that require a large number of participants.

Multicenter studies can be either interventional (where participants are randomly assigned to receive different treatments or interventions) or observational (where researchers collect data on participants' characteristics and outcomes without intervening). In both cases, it is important to ensure standardization of data collection and analysis procedures across all study sites to minimize bias and ensure the validity and reliability of the results.

Multicenter studies can provide valuable insights into the effectiveness and safety of new treatments or interventions, as well as contribute to our understanding of disease mechanisms and risk factors. However, they can also be complex and expensive to conduct, requiring careful planning, coordination, and management to ensure their success.

The mitral valve, also known as the bicuspid valve, is a two-leaflet valve located between the left atrium and left ventricle in the heart. Its function is to ensure unidirectional flow of blood from the left atrium into the left ventricle during the cardiac cycle. The mitral valve consists of two leaflets (anterior and posterior), the chordae tendineae, papillary muscles, and the left atrial and ventricular myocardium. Dysfunction of the mitral valve can lead to various heart conditions such as mitral regurgitation or mitral stenosis.

Enzyme inhibitors are substances that bind to an enzyme and decrease its activity, preventing it from catalyzing a chemical reaction in the body. They can work by several mechanisms, including blocking the active site where the substrate binds, or binding to another site on the enzyme to change its shape and prevent substrate binding. Enzyme inhibitors are often used as drugs to treat various medical conditions, such as high blood pressure, abnormal heart rhythms, and bacterial infections. They can also be found naturally in some foods and plants, and can be used in research to understand enzyme function and regulation.

Patients with diastolic heart failure have a preserved ejection fraction, which is a measure of systolic function. Diastolic ... The high blood pressure eventually leads to heart failure, strokes, heart attacks, blindness, kidney failure, loss of libido ... Abnormalities of diastolic function, ranging from asymptomatic heart disease to overt heart failure, are common in hypertensive ... "Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure". Current ...
Increased BNP concentrations have been found in patients who experience diastolic heart failure. Impaired diastolic function ... Examining diastolic function during a cardiac stress test is a good way to test for heart failure with preserved ejection ... "Diagnostic value of BNP in diastolic heart failure". Biochemia Medica: 183-192. doi:10.11613/bm.2008.018. Look up diastole in ... "Pathophysiological rationale and diagnostic targets for diastolic stress testing". Heart. 101 (17): 1355-1360. doi:10.1136/ ...
This results in both systolic and diastolic dysfunction. Eventually, heart failure can result, which carries a 50% mortality ... including risk of cardiac failure manifesting as congestive heart failure (CHF). Published phase II study results have shown ... The most dangerous side effect of doxorubicin is dilated cardiomyopathy, leading to congestive heart failure. The rate of ... Other serious side effects may include allergic reactions such as anaphylaxis, heart damage, tissue damage at the site of ...
"Potential treatment for diastolic dysfunction in heart failure". ScienceDaily. Retrieved 2018-08-19. WO 9743251, "Compounds ... A preclinical study produced early results suggesting the molecule might help with diastolic dysfunction. ITF2357 was ... a measure of electrical conduction in the heart, severe enough to warrant temporary suspension of treatment. Givinostat ...
One may see signs of right heart failure on exam. Pulmonary valve regurgitation presents as a diastolic decrescendo murmur. One ... Heart murmurs are frequently categorized by timing. These include systolic heart murmurs, diastolic heart murmurs, or ... Heart murmurs are unique heart sounds produced when blood flows across a heart valve or blood vessel. This occurs when ... This is also known as an "echo" or ultrasound of the heart. It shows the heart structures and blood flow through the heart. ...
... pulmonary edema in left heart failure, peripheral edema in right heart failure).[citation needed] Diastolic dysfunction can be ... However, the main mechanism by which left-sided heart failure causes right-sided heart failure is actually not well understood ... Heart failure caused by diastolic dysfunction is generally described as the backward failure of the ventricle to adequately ... Over time these increases in workload will produce changes to the heart itself: The heart of a person with heart failure may ...
Diastolic dysfunction must be differentiated from diastolic heart failure. Diastolic dysfunction can be found in elderly and ... Zile MR (May 2003). "Heart failure with preserved ejection fraction: is this diastolic heart failure?". Journal of the American ... Although the term diastolic heart failure is often used when there are signs and symptoms of heart failure with normal left ... systolic heart failure has usually an eccentric hypertrophy. Diastolic failure is characterized by an elevated diastolic ...
... shows promise in correcting diastolic heart failure. Diastolic heart failure is a condition where the heart has ... Haney, S; Sur D; Xu Z (May-June 2005). "Diastolic heart failure: a review and primary care perspective". Journal of the ... and optimal delivery mechanisms before moving on to experimental trials to treat conditions such as diastolic heart failure. ... and congestive heart failure develops. Additionally, the decreased ability of the heart to eject blood leads to perfusion ...
... pathogenic variant leads to cardiomyopathy with heart failure and is unreponsive to standard heart failure therapy". Scientific ... The protein is a key regulator of cardiac diastolic function. Mutations in this gene are a cause of inherited human dilated ... Mutations in this gene are a cause of inherited human dilated cardiomyopathy with refractory congestive heart failure. ... "Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban". Science. 299 (5611): 1410-3. doi:10.1126/ ...
This has led to the concept of "pure diastolic heart failure" being discarded. The preferred term is now heart failure with ... of the total heart failure population. The prognosis of HFPEF is the same as for heart failure with dilated hearts. Pulsed-wave ... This led to the concept of pure "diastolic heart failure". However, In hypertrophic left ventricles with small cavity size, the ... or heart failure with preserved ejection fraction (HFPEF). This is common and is often seen in hypertensive heart disease, ...
... diastolic function, and plasma neurohormones in Maine Coon cats with familial hypertrophic cardiomyopathy without heart failure ... Cats with severe HCM often develop left heart failure (pulmonary edema; pleural effusion) because of severe diastolic ... a Heart Failure Society of America practice guideline". Journal of Cardiac Failure. 15 (2): 83-97. doi:10.1016/j.cardfail. ... Complications may include heart failure, an irregular heartbeat, and sudden cardiac death. HCM is most commonly inherited in an ...
After that the same neurologist diagnosed him with diastolic heart failure. In February 2001, he had another stroke. The ...
... is a treatment for both systolic and diastolic heart failure. Systolic heart failure is characterized by impaired ... June 2009). "Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, ... a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial". American Heart Journal. 157 (6 ... Diastolic dysfunction is defined by defective ventricular filling, caused by the heart's inability to properly relax between ...
Prevalence and treatment patterns of diastolic filling abnormalities in the elderly. Journal of Heart Failure 1997; 4(1): 110. ... Cost-effectiveness of nurse-led disease management for heart failure in a racially diverse urban community. Annals of Internal ... American Heart Association, NYC Board American Heart Association, Board of Directors, Northeast Region July 2008 - present ... Why men's hearts break: cardiovascular effects of sex steroids. Endocrinol Metab Clin North Am. 2007 June;36(2):365-77. PMID ...
Poor diastolic function, typically Grade III - IV Diastolic heart failure. Those affected by RCM will experience decreased ... In time, restrictive cardiomyopathy patients develop diastolic dysfunction and eventually heart failure. Diagnosis is typically ... "Worsening of congestive heart failure in amyloid heart disease treated by calcium channel-blocking agents". American Journal of ... Heart failure resulting from restrictive cardiomyopathy will usually eventually have to be treated by cardiac transplantation ...
... diastolic dysfunction congestive heart failure arrythmia cardiac nervous conduction block fatigue dyspnea Amyloid proteins are ... This can lead to a variety of cardiac issues, such as congestive heart failure, atrial arrythmia, ventricular arrythmia, and ... Amyloid cardiomyopathy (stiff heart syndrome) is a condition resulting in the death of part of the myocardium (heart muscle). ... Electrocardiography can be used to identify low voltage and patterns similar to those of a heart attack. Cardiac MRI can be ...
Chagas cardiomyopathy thus represents a unique method of study of diastolic heart failure. It may be addressed by removal of a ... Tønnessen T, Knudsen CW (August 2005). "Surgical left ventricular remodeling in heart failure". Eur. J. Heart Fail. 7 (5): 704- ... Most hospitals in the US have abandoned this operation and it is no longer included in heart failure guidelines. "Pioneers of ... Chapter 69: Nontransplant Surgical Options for Heart Failure by Martinus T. Spoor and Steven F. Bolling in Cardiac Surgery in ...
Amyloid deposition in the heart can cause both diastolic and systolic heart failure. EKG changes may be present, showing low ... AA amyloidosis usually spares the heart. Cardiac amyloidosis can present with symptoms of heart failure including shortness of ... ATTR is found in 13-19% of people experiencing heart failure with preserved ejection fraction, making it a very common form of ... Studies showed tafamidis reduced mortality and hospitalization due to heart failure. Previously, for variant ATTR amyloidosis, ...
Due to the epidemic of heart failure, particularly the cases determined as diastolic heart failure, it is increasingly urgent ... "Understanding the Epidemic of Heart Failure: Past, Present, and Future". Current Heart Failure Reports. 11 (4): 404-415. doi: ... In clinical cardiology the term "diastolic function" is most commonly referred as how the heart fills. Parallel to "diastolic ... "Volumetric load in the diagnosis of early right-ventricular heart failure in patients with alcoholic heart damage". ...
Angina pectoris Heart failure: Exercise intolerance is a primary symptom of chronic diastolic heart failure. Cardiac arrhythmia ... Chronic heart failure Spinal muscular atrophy: symptoms include exercise intolerance, cognitive impairment and fatigue. ... These conditions include:[citation needed] Decompensated heart failure Recent myocardial infarction Hypertrophic cardiomyopathy ... In individuals with heart failure and normal EF (ejection fraction), including aortic distensibility, blood pressure, LV ...
Patients with acute decompensated heart failure have diminished left ventricular systolic and/or diastolic functioning. ... Improves Left Ventricular Systolic and Diastolic Function in Dogs with Advanced Heart Failure". Circulation. 120: S582. Lancel ... CXL 1020 is an experimental drug that is being investigated as a treatment for acute decompensated heart failure. CXL 1020 ... Nitroxyl is capable of enhancing left ventricular contractility without increasing heart rate by modifying normal Ca2+ cycling ...
Amyloid deposition in the heart causes restrictive diastolic heart failure that progresses to systolic heart failure. Cardiac ... The majority of treatment is aimed at preserving heart function and treating heart failure symptoms. Light chain (AL-CM) ... Right heart catheterization is the test used to test for elevated diastolic ventricular pressures. This test is more invasive ... New treatment methods are actively being researched in regards to the treatment of heart failure and specific cardiac ...
... two trials being conducted by Spotnitz investigates the use of biventricular pacing in patients who develop acute heart failure ... Diastolic properties predict short-term postoperative risk and duration of pleural effusions after the fontan operation. ... Am J Physiol Heart Circ Physiol 2009 Dec; 297(6): H2220-6. Spotnitz HM. Ventricular function in surgery for congenital Heart ... Spotnitz has been awarded a five-year grant from the National Heart, Lung, and Blood Institute to study the effects of ...
Aug 1993). "Sustained cardiac diastolic changes elicited by ultrafiltration in patients with moderate congestive heart failure ... "ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure" (PDF). Eur Heart J. 10 (10): 933-89. doi: ... Congestive heart failure is the most common reason for fluid overload. Blood containing excess salt and water is withdrawn from ... 2009). "2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in ...
... right heart failure. A diastolic decrescendo murmur can sometimes be identified,( heard best) over the left lower sternal ... Prosthetic heart valve The pathophysiology is due to diastolic pressure variations between the pulmonary artery and right ... "Pulmonary regurgitation in congenital heart disease". Heart. 93 (7): 880-889. doi:10.1136/hrt.2005.075234. ISSN 1355-6037. PMC ... Auscultation Skills: Breath & Heart Sounds. Lippincott Williams & Wilkins. 2009-10-01. p. 83. ISBN 9781605474540. "Pulmonic ...
Severe forms of calciphylaxis may cause diastolic heart failure from cardiac calcification, called heart of stone. Widespread ... ISBN 978-0-07-179302-5. Tom, Cindy W.; Talreja, Deepak R. (March 2006). "Heart of Stone". Mayo Clinic Proceedings. 81 (3): 335 ... the disease is not limited to patients with kidney failure. The current belief is that in end-stage kidney disease, abnormal ... since morphine breakdown produces active metabolites that accumulate in the body of patients with kidney failure. Adjunct ...
If the pulse pressure is extremely low, i.e. 25 mmHg or less, it may indicate low stroke volume, as in congestive heart failure ... with lower diastolic levels. This suggests that interventions that lower diastolic pressure without also lowering systolic ... Pulse pressures of 50 mmHg or more can increase your risk of heart disease, heart rhythm disorders, stroke and more. Higher ... A very low pulse pressure can be a symptom of disorders such as congestive heart failure. Pulse pressure is calculated as the ...
"Angiotensin-converting enzyme 2 as a therapeutic target for heart failure". Current Heart Failure Reports. Springer Science and ... rhACE2 has anti-fibrotic properties and can attenuate effect on systolic and diastolic dysfunction, presumably via Ang-II ... "Angiotensin-converting enzyme 2 as a therapeutic target for heart failure". Current Heart Failure Reports. Springer Science and ... March 2020). "Angiotensin II and angiotensin 1-7: which is their role in atrial fibrillation?". Heart Failure Reviews. Springer ...
"Myocardial Fibrosis Detected by Cardiac Magnetic Resonance Imaging in Heart Failure: Impact on Remodeling, Diastolic Function ... "CORONARY HEART DISEASE". Merriam-Webster. Retrieved 2020-03-23. CDC (2019-11-22). "What are Congenital Heart Defects? , CDC". ... European Journal of Heart Failure. 9 (4): 370-376. doi:10.1016/j.ejheart.2006.09.010. PMID 17140850. S2CID 2118209. Richardson ... Fibrosis in the heart is often hard to detect because fibromas, scar tissue or small tumors formed in one cell line, are often ...
... in the treatment of elderly patients with diastolic heart failure". Journal of Cardiac Failure. 11 (3): 191-195. doi:10.1016/j. ... effective in reducing systolic blood pressure and providing therapeutic benefit for patients with diastolic heart failure. AGEs ...
New research uncovers what causes diastolic heart failure and how it can be treated. ... How the Enzyme Lipoxygenase Drives Heart Failure After Heart Attacks. May 31, 2019 Heart failure after a heart attack is a ... Study suggests how to treat diastolic heart failure. Research shows magnesium improves a form of heart failure previously ... "It eliminated the poor heart relaxation that causes diastolic heart failure.". Obesity and diabetes are known risk factors for ...
... blocks the action of a key hormone did not significantly improve a set of cardiovascular outcomes for patients with diastolic ... Diastolic heart failure, also known as heart failure with preserved systolic function, is a common heart condition accounting ... "Heart failure is the most common reason for hospital admissions in the Medicare population, and diastolic heart failure ... in which the heart muscles pumping ability is reduced. There is no specific therapy for diastolic heart failure. ...
At the Ohio State University Wexner Medical Center clinical researchers have begun studying a new treatment for diastolic heart ... InterAtrial Shunt Device Tested for Diastolic Heart Failure. February 25th, 2016 Medgadget Editors Cardiology, Radiology ... This relieves the intraatrial blood backup and should help with the symptoms that cascade from the congestive heart failure.. ... State University Wexner Medical Center clinical researchers have begun studying a new treatment for diastolic heart failure, an ...
How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ... Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007; ... Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. T. Bitter, N. Westerheide, L. Faber, D. ... Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. T. Bitter, N. Westerheide, L. Faber, D. ...
Diastolic heart failure (right-sided heart failure): The second type of heart failure is diastolic heart failure, characterized ... between systolic and diastolic types of heart failure. *Blood tests such as BNP. (beta naturetic peptide) suggest heart failure ... This is why diastolic heart failure is sometimes referred to as heart failure with preserved ejection fraction (PEF), or right- ... Can heart failure be prevented?. *The best way to prevent heart failure is to never have a heart attack, but if you do, there ...
Abstract: Diastolic heart failure (DHF) is estimated to occur in 40% to 50% of patients with heart failure. Evidence suggests ... Heart and Lung. Language: English. Date: 2008. Keywords. diastolic heart failure, aging, hypertension, diabetes, obesity, ... Diastolic heart failure. UNCG Author/Contributor (non-UNCG co-authors, if there are any, appear on document). Leslie L Davis, ... Diastolic heart failure. PDF (Portable Document Format). 147 KB. Created on 10/25/2017. Views: 647 ...
Congestive heart failure in the fetus, or hydrops, can be detected by performing fetal echocardiography. ... The most likely causes of pediatric congestive heart failure depend on the age of the child. ... Diastolic dysfunction. Diastolic dysfunction results from decreased ventricular compliance, necessitating an increase in venous ... Acute heart failure. During acute congestive heart failure, the sympathetic nervous system and renin-angiotensin system act to ...
It happens when the heart cannot pump blood properly. Learn more. ... Systolic heart failure affects the left side of the heart. ... diastolic heart failure. Systolic and diastolic heart failure can occur on either side of the heart, but this article focuses ... Systolic heart failure is left-sided heart failure or left-ventricle heart failure. Systolic heart failure means the heart does ... Types of heart failure. (2017).. https://www.heart.org/en/health-topics/heart-failure/what-is-heart-failure/types-of-heart- ...
BACKGROUND: To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure (DHF), left ... N2 - BACKGROUND: To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure (DHF), ... AB - BACKGROUND: To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure (DHF), ... abstract = "BACKGROUND: To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure ( ...
Leave a Comment on Systolic VS Diastolic Heart Failure. Introduction. Heart failure is considered to be a global public health ... In this case the heart muscle becomes weak.. Diastolic Failure (Heart Failure, in which the Ejection Fraction is taken care of) ... Among the Elderly, Heart Failure remains the main cause of hospitalization.. Heart Failure is a condition in which heart will ... Causes for Systolic Heart Failure. Heart Failure occurs mainly due to heart conditions or illness. ...
1999). Relation of atrial natriuretic pepitdes to left ventricular systolic and diastolic function in heart failure. European ... Relation of atrial natriuretic pepitdes to left ventricular systolic and diastolic function in heart failure. In: European ... Relation of atrial natriuretic pepitdes to left ventricular systolic and diastolic function in heart failure. European Journal ... Relation of atrial natriuretic pepitdes to left ventricular systolic and diastolic function in heart failure. / Wijbenga, JAM ( ...
Sometimes though the ability of the heart to pump blood in systole remains ... Heart failure with preserved ejection fraction is known as diastolic heart failure. ... Diastolic Heart Failure Prognosis Score. Heart failure with preserved ejection fraction is known as diastolic heart failure. ... This is termed diastolic heart failure. Its prognosis can be quantified using the MAGGIC risk score. ...
Access this presentation on ESC 365 from ESC Congress 2016 on Diastolic dysfunction by Professor A. Chilingaryan (Armenia,AM) ... Predictors of transition of preclinical diastolic dysfunction to heart failure with preserved ejection fraction in patients ... Poster session 1 - Heart failure LV dysfunction. Speakers: Professor A. Chilingaryan, Assistant Professor A. Kovacs, Doctor A. ... One year hemodynamics and long-term survival after heart transplantation. Speaker: Associate Professor E. Bollano (Gothenburg, ...
Heart failure and cardiomyopathy. Diastolic filling pattern and left ventricular diameter predict response and prognosis after ... Diastolic filling pattern and left ventricular diameter predict response and prognosis after cardiac resynchronisation therapy ...
... heart attack and stroke leap to mind. Were less likely to think of heart failure, though it affects more than 2.5 million ... Heart failure affects increasing numbers of older women, but its becoming easier to prevent and treat.When we think about ... Types of heart failure: Diastolic and systolic. In diastolic heart failure (left), the heart muscle stiffens and thickens, ... Symptoms of heart failure. Heart failure usually develops gradually, so its signs are much less dramatic than those of heart ...
Patients with diastolic heart failure have a preserved ejection fraction, which is a measure of systolic function. Diastolic ... The high blood pressure eventually leads to heart failure, strokes, heart attacks, blindness, kidney failure, loss of libido ... Abnormalities of diastolic function, ranging from asymptomatic heart disease to overt heart failure, are common in hypertensive ... "Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure". Current ...
Diastolic heart failure BMJ 2003; 327 :1181 (Published 20 November 2003) *PDF ... Antiretroviral therapy increases risk of heart attack BMJ 2003; 327 :1186 (Published 20 November 2003) ...
1. Shammas RL, Khan NUA, Nekkanti R, Movahed A. Diastolic heart failure and left ventricular diastolic dysfunction: What we ... Arterial Stiffening as a Possible Risk Factor for Both Atherosclerosis and Diastolic Heart Failure. Hypertension Research. 2004 ... The cardiac mortality and morbidity were increased in heart failure patients with left ventricular diastolic dysfunction (LVDD ... European journal of heart failure. 2004;6:567-9 23. Abhayaratna WP, Marwick TH, Smith WT, Becker NG. Characteristics of left ...
An estimated half of all heart failure (HF) populations has been categorized to have diastolic HF (DHF), but sparse data are ... Etiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart Failure. ... Etiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart ... renal failure (OR 1.21, 95% CI 1.17 to 1.25, p peripheral vascular disease (OR 1.05, 95% CI 1.02 to 1.09, p = 0.002), anemia ( ...
Diastolic heart failure. Wheeldon NM, Clarkson P, MacDonald TM. Wheeldon NM, et al. Among authors: macdonald tm. Eur Heart J. ... Allopurinol versus usual care in UK patients with ischaemic heart disease (ALL-HEART): a multicentre, prospective, randomised, ... doi: 10.1093/oxfordjournals.eurheartj.a060453. Eur Heart J. 1994. PMID: 7698140 Review. ... ALL-HEART Study Group. Mackenzie IS, et al. Among authors: macdonald tm. Lancet. 2022 Oct 8;400(10359):1195-1205. doi: 10.1016/ ...
We have recently demonstrated diastolic ventricular interaction in some patients with chronic heart failure as evidenced by ... Some heart failure patients develop attenuated vasoconstriction or paradoxical vasodilation. The mechanism for this is unknown ... Diastolic ventricular interaction: A possible mechanism for abnormal vascular responses during volume unloading in heart ... Baroreflex dysfunction is common in chronic heart failure and contributes to the associated sympathoexcitation. Baroreceptor ...
Ventricular Stroke Work Index is Inversely Related to Renal Function in Patients with Left Ventricular Diastolic Heart Failure ...
A Reversible Model of Early Heart Failure? Holloway CJ., Murray AJ., Cochlin L., Emmanuel Y., Levett DH., Rider OJ., Tyler DJ ... Abnormal Cardiac High Energy Phosphate Metabolism and Impaired Diastolic Function after Mt Everest: A Reversible Model of Early ... Abnormal Cardiac High Energy Phosphate Metabolism and Impaired Diastolic Function after Mt Everest: ...
The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ... The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ... title = "The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with ... The interplay between metabolic alterations, diastolic strain rate and exercise capacity in mild heart failure with preserved ...
Valvular Heart Disease. *Diastolic Dysfunction. *Congestive Heart Failure. Pulmonary Hypertension Owing to Chronic Lung Disease ... COVID-19 Memory Heart sculpture at Emory University Hospital Midtown focuses on remembrance and reflection A public art ... as his struggling heart healed from infection. Thankfully, he had the lifesaving support of a full team at Emory -- doctors, ... sculpture in the shape of a heart stands in the historic Orr Building courtyard at Emory University Hospital Midtown as a ...
The presence of heart failure can be confirmed by an echocardiogram. Heart failure is highly unlikely in the absence of dyspnea ... Patients with confirmed heart failure should undergo additional testing, including a more detailed history and physical ... Radionuclide angiography or contrast cineangiography may be necessary when clinical suspicion for heart failure is high and the ... The evaluation of symptomatic patients with suspected heart failure is directed at confirming the diagnosis, determining the ...
Blood pressure is a measurement of the force exerted against the walls of your arteries as your heart pumps blood to your body ... Blood pressure is a measurement of the force exerted against the walls of your arteries as your heart pumps blood to your body ... High blood pressure increases your chance of having a stroke, heart attack, heart failure, kidney disease, or early death. ... Bottom number (diastolic pressure) of 80 or more. If you have diabetes, heart problems, or a history of a stroke, medicines may ...
  • We've found that cardiac mitochondrial oxidative stress can cause diastolic dysfunction. (sciencedaily.com)
  • The main pathophysiological correlate is impaired left ventricular filling, resulting in diastolic dysfunction with increased end-diastolic left ventricular pressure ( P LV,ED ), with consequent pulmonary congestion, increased stimulation of pulmonary vagal irritant receptors (J-receptors) and enhanced chemosensitivity of central and peripheral carbon dioxide receptors. (ersjournals.com)
  • In this case, congestive heart failure may represent underlying anemia (eg, Rh sensitization, fetal-maternal transfusion), arrhythmias (usually supraventricular tachycardia), or myocardial dysfunction (myocarditis or cardiomyopathy). (medscape.com)
  • Diastolic dysfunction results from decreased ventricular compliance, necessitating an increase in venous pressure to maintain adequate ventricular filling. (medscape.com)
  • Causes of primary diastolic dysfunction include an anatomic obstruction that prevents ventricular filling (eg, pulmonary venous obstruction), a primary reduction in ventricular compliance (eg, cardiomyopathy, transplant rejection), external constraints (eg, pericardial effusion), and poor hemodynamics after the Fontan procedure (eg, elevated pulmonary vascular resistance). (medscape.com)
  • Predictors of transition of preclinical diastolic dysfunction to heart failure with preserved ejection fraction in patients with metabolic syndrome. (escardio.org)
  • Hypertensive heart disease is the result of structural and functional adaptations leading to left ventricular hypertrophy, diastolic dysfunction, CHF (Congestive Heart Failure), abnormalities of blood flow due to atherosclerotic coronary artery disease and microvascular disease, and cardiac arrhythmias. (wikipedia.org)
  • Diastolic dysfunction is an early consequence of hypertension-related heart disease and is exacerbated by left ventricular hypertrophy and ischemia. (wikipedia.org)
  • The association between increased arterial stiffness and left ventricular diastolic dysfunction (LVDD) may be influenced by left ventricular performance. (medsci.org)
  • brachial-ankle pulse wave velocity, P wave dispersion, left ventricular diastolic dysfunction. (medsci.org)
  • The cardiac mortality and morbidity were increased in heart failure patients with left ventricular diastolic dysfunction (LVDD) [ 1 , 2 ]. (medsci.org)
  • Baroreflex dysfunction is common in chronic heart failure and contributes to the associated sympathoexcitation. (uea.ac.uk)
  • 50%, evidence of mild diastolic dysfunction and evidence of exercise limitation as assessed by cardiopulmonary exercise test) and 14 controls underwent 1H-cardiovascular magnetic resonance spectroscopy (1H-CMRS) to measure MTG (lipid/water, %), 31P-CMRS to measure myocardial energetics (phosphocreatine-to-adenosine triphosphate - PCr/ATP) and feature-tracking cardiovascular magnetic resonance (CMR) imaging for diastolic strain rate. (uea.ac.uk)
  • Dependent edema and pulmonary rales are of limited value in diagnosing heart failure resulting from left ventricular dysfunction. (aafp.org)
  • This results from diastolic dysfunction, the principal pathophysiologic consequence of a wide range of heart muscle disorders, most prominent of which are hypertrophic cardiomyopathy or restrictive cardiomyopathy. (vin.com)
  • Diastolic dysfunction is the principal pathophysiologic consequence of a wide range of phenotypically heterogeneous myocardial disorders. (vin.com)
  • These alterations promote ventricular stiffness and loss of compliance (diastolic dysfunction). (vin.com)
  • Coronary Microvascular Dysfunction and Heart Failure With Preserved Ejection Fraction as Female-pattern Cardiovascular Disease: The Chicken or the Egg? (medscape.com)
  • A variety of observations suggest that coronary microvascular dysfunction (CMD) is related to the pathogenesis of cardiovascular disease, including myocardial ischaemia and heart failure. (medscape.com)
  • Specifically, does primary CMD lead to ventricular remodelling/diastolic dysfunction and HFpEF or do alterations in myocardial remodelling/diastolic dysfunction observed in HFpEF lead to secondary CMD, i.e. the chicken or the egg? (medscape.com)
  • This is consistent with a growing body of work from our group showing that women with CMD often have left ventricular (LV) diastolic dysfunction, [ 5 , 11 , 12 ] and are at increased risk of developing HFpEF. (medscape.com)
  • The exact mechanism(s) contributing to CMD-related diastolic dysfunction, however, remains incompletely understood. (medscape.com)
  • A high prevalence of nocturnal Cheyne-Stokes respiration (CSR) has been documented in patients with heart failure with normal left ventricular ejection fraction (HFNEF). (ersjournals.com)
  • Heart failure with normal left ventricular ejection fraction (HFNEF) is a clinical entity that embodies symptoms of heart failure in the presence of preserved systolic function of the left ventricle. (ersjournals.com)
  • In patients aged ≥60 yrs, its prevalence reaches that of heart failure with reduced left ventricular ejection fraction (HFREF), and, by the eighth decade, it is more frequent than HFREF. (ersjournals.com)
  • Systolic heart failure is also called heart failure with reduced ejection fraction. (medicalnewstoday.com)
  • Ejection fraction measures how well the left part of the heart is pumping blood. (medicalnewstoday.com)
  • A healthy heart pumps blood at an ejection fraction of 55-70% . (medicalnewstoday.com)
  • An ejection fraction of 50-55% is heart failure with preserved ejection fraction. (medicalnewstoday.com)
  • An ejection fraction of 40-49% is heart failure with mildly reduced ejection fraction. (medicalnewstoday.com)
  • Ejection Fraction is one of the most important measures to know the functioning and pumping of the heart. (indexofsciences.com)
  • The Ejection fraction of the heart should be 50 or higher, with every beat higher than half of the blood that fills the ventricle is pushed out with every beat. (indexofsciences.com)
  • Sometimes, even though the ejection fraction is normal but the muscles of the heart gets stiff majorly from hypertension or other conditions. (indexofsciences.com)
  • Heart failure with preserved ejection fraction is known as diastolic heart failure. (theheartandlungclinic.com)
  • Sometimes though the ability of the heart to pump blood in systole remains normal (preserved ejection fraction), its ability to relax in diastole and allow blood to fill its chambers during diastole is impaired. (theheartandlungclinic.com)
  • Patients with diastolic heart failure have a preserved ejection fraction, which is a measure of systolic function. (wikipedia.org)
  • Assessment of left ventricular diastolic function is useful in risk stratification for patients with cardiovascular disease and can provide a diagnostic clue for heart failure with preserved ejection fraction. (medsci.org)
  • We hypothesized the existence of distinct phenotype-based groups within the very heterogeneous population of patients of heart failure with preserved ejection fraction (HFpEF) and using an unsupervised hierarchical clustering applied to plasma concentration of various biomarkers. (karger.com)
  • The pathophysiological mechanisms underlying preserved left ventricular (LV) ejection fraction (EF) in patients with heart failure and preserved ejection fraction (HFpEF) remain incompletely understood. (frontiersin.org)
  • Heart failure with preserved ejection fraction (HFpEF) was a common clinical disease, with an incidence rate as high as 50% in all heart failure cases [ 10 - 12 ]. (hindawi.com)
  • According to what I was taught at Uni, the right side HF is aka Cor Pulmonale (1 type) and there are 2 types of left side HF which are HF with preserved ejection fraction (aka diastolic HF) and HF with reduced ejection fraction (aka systolic HF). (khanacademy.org)
  • [ 3 ] While termed ischaemia with no obstructive CAD (INOCA) and myocardial infarction with no obstructive CAD (MINOCA), [ 3 ] it is also sometimes called 'female-pattern' cardiovascular disease along with heart failure with preserved ejection fraction (HFpEF) because these occur more commonly in women, and the relative paucity of studies of women has resulted in therapeutic deserts for these conditions. (medscape.com)
  • BACKGROUND: To support the clinical distinction between systolic heart failure (SHF) and diastolic heart failure (DHF), left ventricular (LV) myocardial structure and function were compared in LV endomyocardial biopsy samples of patients with systolic and diastolic heart failure. (amsterdamumc.org)
  • In conditions such as left ventricular heart failure, the heart's left side has to pump harder to supply an equal amount of blood. (indexofsciences.com)
  • Two types of Left-sided Ventricular Failure and the treatment for them is also different. (indexofsciences.com)
  • This study is designed to compare left ventricular diastolic function among patients divided by brachial-ankle pulse wave velocity (baPWV) and corrected P wave dispersion (PWDC) and assess whether the combination of baPWV and PWDC can predict LVDD more accurately. (medsci.org)
  • We have recently demonstrated diastolic ventricular interaction in some patients with chronic heart failure as evidenced by increases in left ventricular (LV) end-diastolic volume in association with decreases in right ventricular (RV) volume during volume unloading. (uea.ac.uk)
  • With further study, RDN has been found to have significant therapeutic effects on other cardiovascular diseases, such as atrial fibrillation (AF), heart failure, and ventricular arrhythmia [ 4 - 9 ]. (hindawi.com)
  • AF could lead to the loss of atrial systolic function and ventricular irregular contraction and then promote the decline of cardiac diastolic function. (hindawi.com)
  • The left ventricular assist device, or LVAD, is a mechanical pump that is implanted inside a person's chest to help a weakened heart ventricle pump blood throughout the body. (medicinenet.com)
  • Hearts from cats with ventricular hypertrophy (HCM), and restrictive cardiomyopathy (RCM) are affected by complex intrinsic and extrinsic factors that affect left ventricular diastolic performance. (vin.com)
  • When alterations in diastolic function lead to increased left ventricular filling pressure and mean left atrial pressure, congestive heart failure may result. (vin.com)
  • The left ventricular hypertrophy is the most common type of hypertrophic heart disease. (antiessays.com)
  • This relieves the intraatrial blood backup and should help with the symptoms that cascade from the congestive heart failure. (medgadget.com)
  • Medications can help reduce the symptoms of congestive heart failure ( CHF ) and improve heart muscle function. (hdkino.org)
  • The most likely causes of pediatric congestive heart failure depend on the age of the child. (medscape.com)
  • Congestive heart failure in the fetus, or hydrops , can be detected by performing fetal echocardiography. (medscape.com)
  • Curiously, structural heart disease is rarely a cause of congestive heart failure in the fetus, although it does occur. (medscape.com)
  • Neonates and infants younger than age 2 months are the most likely group to present with congestive heart failure related to structural heart disease. (medscape.com)
  • therefore, an increased suspicion of drug use is warranted in unexplained congestive heart failure. (medscape.com)
  • Although congestive heart failure in adolescents can be related to structural heart disease (including complications after surgical palliation or repair), it is usually associated with chronic arrhythmia or acquired heart disease, such as cardiomyopathy. (medscape.com)
  • For patient education information, see the Heart Health Center , as well as Congestive Heart Failure . (medscape.com)
  • Congestive heart failure occurs when the heart can no longer meet the metabolic demands of the body at normal physiologic venous pressures. (medscape.com)
  • As the demands on the heart outstrip the normal range of physiologic compensatory mechanisms, signs of congestive heart failure occur. (medscape.com)
  • Chest radiograph shows signs of congestive heart failure (CHF). (medscape.com)
  • Learn about the symptoms of congestive heart failure. (medicalnewstoday.com)
  • What Are the Symptoms of Congestive Heart Failure? (healthline.com)
  • Congestive heart failure (CHF) affects your heart's ability to pump enough blood to effectively meet your body's needs. (healthline.com)
  • Learn more about congestive heart failure. (healthline.com)
  • Managing congestive heart failure symptoms usually starts with making several key lifestyle changes to support better heart function. (healthline.com)
  • It may also benefit people with congestive heart failure. (consumerlab.com)
  • Heart failure (congestive) is caused by many conditions including coronary artery disease, heart attack, cardiomyopathy, and conditions that overwork the heart. (medicinenet.com)
  • Treatment, prognosis, and life-expectancy for a person with congestive heart failure depends upon the stage of the disease. (medicinenet.com)
  • This occurs when the heart becomes weakened and enlarged, and congestive heart failure follow quickly. (antiessays.com)
  • Increasing body mass index, neck circumference, Epworth Sleepiness Scale score, hypertension, congestive heart failure, and type 2 diabetes correlated with increasing OSA severity. (cdc.gov)
  • In addition, significant positive effects could be confirmed on absolute and predicted peak oxygen consumption, oxygen consumption at the individual aerobic-anaerobic threshold, oxygen pulse, as well as left atrial size, and transmitral flow patterns (mean early diastolic lengthening velocity and the ratio of peak early Doppler mitral inflow velocity to this lengthening velocity). (ersjournals.com)
  • In the article, "Magnesium supplementation improves diabetic mitochondrial and cardiac diastolic function," author Samuel Dudley, MD, PhD, Academic Chief of Cardiology at the University of Minnesota Medical School and his fellow researchers found that magnesium can be used to treat diastolic heart failure. (sciencedaily.com)
  • Hypertension and PAF can affect cardiac diastolic function. (hindawi.com)
  • The study aimed to evaluate the effect of RDN on cardiac diastolic function in patients with refractory hypertension and PAF. (hindawi.com)
  • Before RDN, the indices about cardiac diastolic function were out of the normal range. (hindawi.com)
  • Similar to persistent AF, paroxysmal atrial fibrillation (PAF) could also have a significant impact on cardiac diastolic function. (hindawi.com)
  • Theoretically, the RDN also has a certain effect on cardiac diastolic function in these patients. (hindawi.com)
  • The prognosis for heart failure is highly variable. (hdkino.org)
  • Sex-mismatch interaction and prognosis after heart transplantation. (escardio.org)
  • A clinical review 6 published in this issue examines the treatment of heart failure and the prognosis for affected patients. (aafp.org)
  • The faster heart rate and loss of atrial contraction with onset of atrial fibrillation often lead to sudden worsening of symptoms. (msdmanuals.com)
  • Diastolic stress echocardiography has been applied in several clinical settings, including patients with normal systolic function and with myocardial diastolic relaxation at rest. (escardio.org)
  • This clinical in which pulmonary edema occurs in the setting of abnormal diastolic function and relatively normal systolic function has been termed diastolic heart failure . (vin.com)
  • Diastolic stress echocardiography has been applied in several clinical settings, including patients with normal systolic function and patients with ischemic heart disease. (escardio.org)
  • Some of the medical conditions such as coronary artery disease (narrowing of the arteries), hypertension, slowly cause the heart to become weak or hard to fill and pump the blood effectively. (indexofsciences.com)
  • Like coronary artery disease, heart failure may take a slightly different course in women than in men. (harvard.edu)
  • Diabetes doesn't cause heart failure directly, but it promotes coronary artery disease and hypertension, especially in women. (harvard.edu)
  • It is an independent predisposing factor for heart failure, coronary artery disease, stroke, kidney disease, and peripheral arterial disease. (wikipedia.org)
  • Patients with coronary artery disease, hypertension, diabetes mellitus, exposure to cardiotoxic drugs, alcohol abuse, or a family history of cardiomyopathy are at high risk for heart failure and may benefit from routine screening. (aafp.org)
  • If an individual is suffering from hypertension , the heart has to work a bit more hard to pump the blood to different parts of the body. (indexofsciences.com)
  • Hypertension raises the risk of heart failure two to three times, and it's a stronger risk factor in women than in men. (harvard.edu)
  • The capacity of the heart to adapt to short-term changes in preload or afterload is remarkable, but sudden or sustained changes in preload (e.g., acute mitral regurgitation, excessive intravenous hydration), afterload (e.g., aortic stenosis, severe uncontrolled hypertension), or demand (e.g., increased demand because of severe anemia or hyperthyroidism) may lead to progressive failure of myocardial function. (aafp.org)
  • RDN could improve the diastolic function in patients with refractory hypertension and PAF. (hindawi.com)
  • Long-term hypertension, especially long-term uncontrolled hypertension, could directly lead to myocardial hypertrophy, myocardial wall stiffness, and compliance decline, eventually causing a decrease in diastolic function. (hindawi.com)
  • In this study, we studied the changes in diastolic function in patients with refractory hypertension and PAF before and after RDN. (hindawi.com)
  • The diastolic blood pressure is an important hypertension number. (antiessays.com)
  • Pathologic hypertrophy is a result of disease that place increased demand on the heart, such as chronic hypertension, valvular damage, and myocardial infarction. (antiessays.com)
  • He defined hypertension when systolic blood pressure is equal to or above 140 mm Hg and/or a diastolic blood pressure equal to or above 90 mm Hg. (who.int)
  • You may know you have heart failure only because tests such as echocardiography indicate that your heart isn't pumping enough blood with each contraction. (healthline.com)
  • Thoracic radiography is important to help document the presence of heart failure as well as other non-cardiac conditions, but does not substitute for echocardiography. (vin.com)
  • This damage may result from conditions present at birth (such as congenital cardiomyopathy or abnormalities in the formation of the heart chambers) or it may be due to infections or other conditions encountered in youth or adulthood. (harvard.edu)
  • Abnormalities of diastolic function, ranging from asymptomatic heart disease to overt heart failure, are common in hypertensive patients. (wikipedia.org)
  • The paper represents the primary results of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist (TOPCAT) trial. (scienceblog.com)
  • Diastolic heart failure, also known as heart failure with preserved systolic function, is a common heart condition accounting for about half of all heart failure cases. (scienceblog.com)
  • ASV effectively attenuates CSR in patients with HFNEF and improves heart failure symptoms and cardiac function. (ersjournals.com)
  • Heart failure occurs when the heart muscle is not able to function in a manner that can sufficiently supply the body with oxygen. (hdkino.org)
  • And thanks to improved treatments aimed at preserving heart function, women with heart failure can expect to survive longer than in past generations. (harvard.edu)
  • instead, several factors or conditions act in concert to erode heart function. (harvard.edu)
  • Abnormal Cardiac High Energy Phosphate Metabolism and Impaired Diastolic Function after Mt Everest: A Reversible Model of Early Heart Failure? (ox.ac.uk)
  • We measured myocardial triglyceride content (MTG) in HFpEF and assessed its relationships with diastolic function and exercise capacity. (uea.ac.uk)
  • Steatosis may adversely affect exercise capacity by indirect effect occurring via impairment in diastolic function. (uea.ac.uk)
  • The 190 patients were divided into the decreasing HR and nondecreasing HR group, the decreasing MAP and nondecreasing MAP group, the HFPEF group, and the normal diastolic function group, respectively. (hindawi.com)
  • The diastolic function about the indices of NT-proBNP, E / e ′, e ′ was improved in the decreasing HR group, the decreasing mean arterial pressure (MAP) group, and the HFPEF group, correspondingly compared to the nondecreasing HR group, the non-decreasing MAP group, and the preoperative normal diastolic function group. (hindawi.com)
  • In the multivariate analysis, the MAP and HR were the only two indicators significantly associated with the improvement of diastolic function. (hindawi.com)
  • It was speculated that RDN improved the diastolic function mainly through decreasing HR and MAP. (hindawi.com)
  • However, there are others that are less common and still indicate problems with heart function. (healthline.com)
  • This tool is ideal to assess diastolic function of the left ventricle by placing a sample volume at the mitral annulus, where changes in tissue motion are often detected prior to changes in blood flow spectrums through the same valve. (visualsonics.com)
  • And sometimes it lets the heart recover normal function by giving it a chance to rest (although this is rare). (medicinenet.com)
  • Heart failure develops when the heart, via an abnormality of cardiac function (detectable or not), fails to pump blood at a rate commensurate with the requirements of the metabolizing tissues or is able to do so only with an elevated diastolic filling pressure. (medscape.com)
  • Heart failure (see the images below) may be caused by myocardial failure but may also occur in the presence of near-normal cardiac function under conditions of high demand. (medscape.com)
  • Heart failure always causes circulatory failure, but the converse is not necessarily the case, because various noncardiac conditions (eg, hypovolemic shock, septic shock) can produce circulatory failure in the presence of normal, modestly impaired, or even supranormal cardiac function. (medscape.com)
  • HFpEF had significantly reduced diastolic strain rate and maximal oxygen consumption (VO2 max), which both correlated significantly with elevated MTG and reduced PCr/ATP. (uea.ac.uk)
  • CONCLUSIONS: Myocardial steatosis is pronounced in mild HFpEF, and is independently associated with impaired diastolic strain rate which is itself related to exercise capacity. (uea.ac.uk)
  • By stage C, symptomatic heart failure, you will probably have significant limitations on the amount and intensity of any physical activity, according to the American Heart Association . (healthline.com)
  • The most common cause of symptomatic heart disease is diastolic heart failure. (vin.com)
  • Read on to learn more about the prevention, diagnosis, and treatment of systolic heart failure. (medicalnewstoday.com)
  • The evaluation of symptomatic patients with suspected heart failure is directed at confirming the diagnosis, determining the cause, identifying concomitant illnesses, establishing the severity of heart failure, and guiding therapy. (aafp.org)
  • Absence of dyspnea or a normal ECG and chest radiograph make the diagnosis of heart failure highly unlikely. (aafp.org)
  • This article focuses on the diagnosis of heart failure from an evidence-based perspective. (aafp.org)
  • Allan Klein, MD, is the Director of Cardiovascular Imaging Research, Director of the Center for the Diagnosis and Treatment of Pericardial Diseases, and a staff cardiologist in the Section of Cardiovascular Imaging, the Robert and Suzanne Tomsich Department of Cardiovascular Medicine, at the Sydell and Arnold Miller Family Heart, Vascular & Thoracic Institute. (clevelandclinic.org)
  • One of the most important diagnosis uses for the LDH isoenzymes test is in the different diagnosis of myocardial Infarction or heart attack. (antiessays.com)
  • The Framingham criteria for the diagnosis of heart failure consists of the concurrent presence of either 2 major criteria or 1 major and 2 minor criteria. (medscape.com)
  • This is an exciting step forward in the cardiovascular field," said Dudley, "Right now there are no specific treatments for patients with diastolic heart failure, but now we have a theory of why diastolic heart failure occurs and what we can do to get rid of it. (sciencedaily.com)
  • Heart Failure occurs mainly due to heart conditions or illness. (indexofsciences.com)
  • Heart failure usually occurs later in life with ages 41+ at most risk. (khanacademy.org)
  • They experience symptoms of heart failure when at rest. (medicalnewstoday.com)
  • The person is without signs or symptoms of heart failure. (medicalnewstoday.com)
  • The person has current or prior symptoms of heart failure. (medicalnewstoday.com)
  • Shortness of breath and chest pain are among the earliest and most obvious symptoms of heart failure. (healthline.com)
  • Symptoms of heart failure include congested lungs, fluid and water retention, dizziness, fatigue and weakness, and rapid or irregular heartbeats. (medicinenet.com)
  • and detect valvular heart disease . (medscape.com)
  • Overview of Cardiac Valvular Disorders Any heart valve can become stenotic or insufficient (also termed regurgitant or incompetent), causing hemodynamic changes long before symptoms. (msdmanuals.com)
  • As blood vessels narrow because of cholesterol buildup, blood flow to the myocardium (heart muscle tissue) decreases, gradually causing the tissue to deteriorate. (harvard.edu)
  • Heart failure is characterized by an inability of the myocardium to deliver sufficient oxygenated blood to meet the needs of tissues and organs during exercise or at rest. (aafp.org)
  • abstract = "BACKGROUND: Heart failure (HF) is characterized by altered myocardial substrate metabolism which can lead to myocardial triglyceride accumulation (steatosis) and lipotoxicity. (uea.ac.uk)
  • All patients had to be in a stable clinical condition and in New York Heart Association (NYHA) class II-III. (ersjournals.com)
  • According to the American Heart Association , the first is the New York Heart Association (NYHA) Functional Classification, which considers a person's physical ability. (medicalnewstoday.com)
  • Heart Failure is a condition in which heart will not be able to pump good amounts of blood to meet up with the demands of the body i.e. metabolic demands. (indexofsciences.com)
  • Patients with diastolic heart failure have a high morbidity, mortality, and healthcare costs. (sciencedaily.com)
  • Heart failure is a common, progressive, complex clinical syndrome with high morbidity and mortality. (aafp.org)
  • Utility of invasive hemodynamic testing in assessment of functional impairment with diastolic heart failure. (uc.edu)
  • 4 Furthermore, heart failure is a progressive condition: once symptoms appear, subsequent morbidity and mortality are high. (aafp.org)
  • Heart Failure (HF) is the only cardiovascular disease for which incidence, prevalence, morbidity, mortality, and costs are not decreasing. (frontiersin.org)
  • While the goal for managing heart disease is to reduce morbidity and mortality, there remain important gaps in our understanding of several critical areas. (vin.com)
  • The overarching goal when managing heart disease is to improve survival by reducing morbidity and mortality. (vin.com)
  • Systolic blood pressure and Diastolic blood pressure. (antiessays.com)
  • As people become older, the diastolic pressure will begin to decrease and the systolic blood pressure begins to rise and becomes more important. (antiessays.com)
  • A rise in systolic blood pressure will also increase the chance for heart attacks, strokes, and kidney failure. (antiessays.com)
  • Yet, in Japan, he mentioned that the blood pressure is considered to be raised or high when systolic blood pressure is equal to or above 135 mm Hg and/or a diastolic blood pressure equal to or above 85 mm Hg if it is measured at home. (who.int)
  • The Centers for Disease Control and Prevention estimates that 5.7 million people in the United States have heart failure. (scienceblog.com)
  • There is objective evidence of some structural heart disease. (medicalnewstoday.com)
  • This disease results in the heart wall to become thick and finally getting rigid. (indexofsciences.com)
  • Heart valves that have structural defects, whether present at birth or resulting from disease, may fail to open and close properly. (harvard.edu)
  • Conditions like chronic obstructive pulmonary disease and pulmonary fibrosis reduce the amount of oxygen in the blood, forcing the heart to work harder. (harvard.edu)
  • High blood pressure increases your chance of having a stroke, heart attack, heart failure, kidney disease, or early death. (medlineplus.gov)
  • Because there are no symptoms, people can develop heart disease and kidney problems without knowing they have high blood pressure. (medlineplus.gov)
  • Diagnosing high blood pressure early can help prevent heart disease, stroke, eye problems, and chronic kidney disease. (medlineplus.gov)
  • An LVAD restores blood flow to a person whose heart has been weakened by heart disease . (medicinenet.com)
  • More than 95% of feline heart disease is caused by cardiomyopathy (CM). Many affected cats remain asymptomatic for life, although this percentage has never been clarified. (vin.com)
  • Electrocardiography is valuable in the face of arrhythmia, unfortunately, is insensitive for detecting the presence of heart disease. (vin.com)
  • While interesting information is emerging about biomarkers and heart disease, their use for cardiac screening has not yet been validated. (vin.com)
  • NORTHERA is indicated for the treatment of orthostatic dizziness, lightheadedness, or the "feeling that you are about to black out" in adult patients with symptomatic neurogenic orthostatic hypotension (nOH) caused by primary autonomic failure (Parkinson's disease [PD], multiple system atrophy, and pure autonomic failure), dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy. (nih.gov)
  • Ischemic heart disease is one of the leading contributors to HF. (medscape.com)
  • This report was prepared by Eastern Research Group, Inc. (ERG), a contractor to the Agency for Toxic Substances and Disease Registry (ATSDR), as a general record of discussion for the expert panel review meeting on the Vieques Heart Study. (cdc.gov)
  • As a result, it leads to more than nine million deaths every year, including about half of all deaths due to heart disease and stroke. (who.int)
  • signs include an opening snap and a diastolic murmur. (msdmanuals.com)
  • Systolic heart failure is left-sided heart failure or left-ventricle heart failure. (medicalnewstoday.com)
  • On multivariate analyses, MTG was independently associated with diastolic strain rate while diastolic strain rate was independently associated with VO2 max. (uea.ac.uk)
  • At the Ohio State University Wexner Medical Center clinical researchers have begun studying a new treatment for diastolic heart failure, an increasingly recognized cardiac problem. (medgadget.com)
  • These findings support the clinical separation of heart failure patients into SHF and DHF phenotypes. (amsterdamumc.org)
  • Radionuclide angiography or contrast cineangiography may be necessary when clinical suspicion for heart failure is high and the echocardiogram is equivocal. (aafp.org)
  • The passive material properties were determined such that the diastolic pressure-volume behavior of the LV was similar to that shown in published clinical studies of pressure-volume curves. (frontiersin.org)
  • Patients with this condition have similar annual mortality to patients with systolic heart failure, and up until now there was no known specific treatments for this type of heart failure. (sciencedaily.com)
  • This study is an important step in the effort to find effective treatments for diastolic heart failure patients," said Dr. Michael Lauer, director of the NHLBI's Division of Cardiovascular Sciences. (scienceblog.com)
  • Thus also helps to identify the classification of heart failure and treatments for the condition. (indexofsciences.com)
  • The higher the diastolic blood pressure the greater the risk for heart attacks, strokes and kidney failure. (antiessays.com)
  • Dr Iwashima emphasized that high blood pressure could increase risks of heart attack, stroke and kidney failure. (who.int)
  • Risk factors for heart failure include high blood pressure , prior heart attack , obesity , smoking , alcohol abuse , vitamin deficiencies, sleep apnea , heavy metal toxicity, eating an unhealthy diet (including animal fat and salt), and being sedentary. (hdkino.org)
  • Probably because it raises the risk of CAD, obesity is also an independent risk factor for heart failure. (harvard.edu)
  • In the current trial, spironolactone did not improve the combined primary endpoints of cardiovascular death, hospitalization for heart failure, or aborted cardiac arrest. (scienceblog.com)
  • The other method required looked at a person's history of heart failure hospitalization within the last year. (scienceblog.com)
  • Among the Elderly, Heart Failure remains the main cause of hospitalization. (indexofsciences.com)
  • We're less likely to think of heart failure, though it affects more than 2.5 million women and is the leading reason for hospitalization (and a major cause of death) in women over 65. (harvard.edu)
  • In chronic heart failure, myocardial cells die from energy starvation, from cytotoxic mechanisms leading to necrosis, or from the acceleration of apoptosis or programmed cell death. (medscape.com)
  • Etiologies, Trends, and Predictors of 30-Day Readmissions in Patients With Diastolic Heart Failure. (bvsalud.org)
  • An estimated half of all heart failure (HF) populations has been categorized to have diastolic HF (DHF), but sparse data are available describing etiologies and predictors of 30-day readmission in DHF population . (bvsalud.org)
  • There are four stages of heart failure, used to classify the severity of symptoms. (hdkino.org)
  • The American Heart Association describes the stages of heart failure: A, B, C, and D. These stages help the doctor guide the management and treatment of CHF. (healthline.com)
  • Blood pressure assessment is particularly relevant in face of diseases known to raise blood pressure or effect heart structures such as chronic renal failure and hyperthyroidism. (vin.com)
  • As blood pressure increases, the heart has to work harder, putting its muscle tissue under strain. (harvard.edu)
  • Blood pressure is a measurement of the force exerted against the walls of your arteries as your heart pumps blood to your body. (medlineplus.gov)
  • If you have heart or kidney problems, or you had a stroke, your doctor may want your blood pressure to be even lower than that of people who do not have these conditions. (medlineplus.gov)
  • Your doctor may prescribe certain medications to lower your blood pressure and ease the workload of the heart. (healthline.com)
  • With heart failure blood pressure drops so kidneys can't filter blood. (khanacademy.org)
  • So, the kidneys are driving the heart to work harder because without blood pressure, the kidneys can't work. (khanacademy.org)
  • Your physician will use both the systolic and the diastolic blood pressure to determine your blood pressure category and appropriate prevention and treatment activities. (antiessays.com)
  • To prevent risks of high blood pressure, he stressed the importance to regularly check one's blood pressure and to reduce salt intake as the primary prevention of heart diseases is through healthy diet and lifestyle. (who.int)